Cover Page
Cover Page - USD ($) $ in Billions | 12 Months Ended | ||
Dec. 31, 2021 | Feb. 22, 2022 | Jun. 30, 2021 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2021 | ||
Document Transition Report | false | ||
Entity File Number | 001-12930 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 58-1960019 | ||
Entity Address, Address Line One | 4205 River Green Parkway | ||
Entity Address, City or Town | Duluth, | ||
Entity Address, State or Province | GA | ||
Entity Address, Postal Zip Code | 30096 | ||
City Area Code | (770) | ||
Local Phone Number | 813-9200 | ||
Title of 12(b) Security | Common stock | ||
Trading Symbol | AGCO | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 8.2 | ||
Entity Common Stock, Shares Outstanding | 74,536,804 | ||
Documents Incorporated by Reference | Documents Incorporated by Reference Portions of AGCO Corporation’s Proxy Statement for the 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K. | ||
Entity Registrant Name | AGCO CORP /DE | ||
Entity Central Index Key | 0000880266 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2021 | |
Audit Information [Abstract] | |
Auditor Firm ID | 185 |
Auditor Name | KPMG LLP |
Auditor Location | Atlanta, Georgia |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Statement [Abstract] | |||
Net sales | $ 11,138.3 | $ 9,149.7 | $ 9,041.4 |
Cost of goods sold | 8,566 | 7,092.2 | 7,057.1 |
Gross profit | 2,572.3 | 2,057.5 | 1,984.3 |
Operating expenses: | |||
Selling, general and administrative expenses | 1,088.2 | 1,001.5 | 1,040.3 |
Engineering expenses | 405.8 | 342.6 | 343.4 |
Amortization of intangibles | 61.1 | 59.5 | 61.1 |
Impairment charges | 0 | 20 | 176.6 |
Restructuring expenses | 15.3 | 19.7 | 9 |
Bad debt expense | 0.5 | 14.5 | 5.8 |
Income from operations | 1,001.4 | 599.7 | 348.1 |
Interest expense, net | 6.7 | 15 | 19.9 |
Other expense, net | 50.4 | 22.7 | 67.1 |
Income before income taxes and equity in net earnings of affiliates | 944.3 | 562 | 261.1 |
Income tax provision | 108.4 | 187.7 | 180.8 |
Income before equity in net earnings of affiliates | 835.9 | 374.3 | 80.3 |
Equity in net earnings of affiliates | 65.6 | 45.5 | 42.5 |
Net income | 901.5 | 419.8 | 122.8 |
Net (income) loss attributable to noncontrolling interests | (4.5) | 7.3 | 2.4 |
Net income attributable to AGCO Corporation and subsidiaries | $ 897 | $ 427.1 | $ 125.2 |
Net income per common share attributable to AGCO Corporation and subsidiaries: | |||
Basic (in dollars per share) | $ 11.93 | $ 5.69 | $ 1.64 |
Diluted (in dollars per share) | 11.85 | 5.65 | 1.63 |
Cash dividends declared and paid per common share (in dollars per share) | $ 4.74 | $ 0.63 | $ 0.63 |
Weighted average number of common and common equivalent shares outstanding: | |||
Basic (in shares) | 75.2 | 75 | 76.2 |
Diluted (in shares) | 75.7 | 75.6 | 77 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Statement of Comprehensive Income [Abstract] | |||
Net income | $ 901.5 | $ 419.8 | $ 122.8 |
Defined benefit pension plans, net of taxes: | |||
Prior service credit (cost) arising during the year | 10 | 0.3 | (4.7) |
Net loss recognized due to settlement | 0.1 | 0.3 | 0.6 |
Net loss recognized due to curtailment | 6.3 | 0 | 0 |
Net actuarial gain (loss) arising during the year | 53.6 | (32.7) | (23.3) |
Amortization of prior service cost included in net periodic pension cost | 0.6 | 2.1 | 1.6 |
Amortization of net actuarial losses included in net periodic pension cost | 12.3 | 13.1 | 11.8 |
Derivative adjustments: | |||
Net changes in fair value of derivatives | 5.1 | 5.1 | (2.6) |
Net gains reclassified from accumulated other comprehensive loss into income | (3) | (6.3) | (0.1) |
Foreign currency translation adjustments | (45.5) | (201.8) | (20.6) |
Other comprehensive gain (loss), net of reclassification adjustments | 39.5 | (219.9) | (37.3) |
Comprehensive income | 941 | 199.9 | 85.5 |
Comprehensive (income) loss attributable to noncontrolling interests | (4.1) | 11.6 | (0.1) |
Comprehensive income attributable to AGCO Corporation and subsidiaries | $ 936.9 | $ 211.5 | $ 85.4 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Current Assets: | ||
Cash and cash equivalents | $ 889.1 | $ 1,119.1 |
Accounts and notes receivable, net | 991.5 | 856 |
Inventories, net | 2,593.7 | 1,974.4 |
Other current assets | 539.8 | 418.9 |
Total current assets | 5,014.1 | 4,368.4 |
Property, plant and equipment, net | 1,464.8 | 1,508.5 |
Right-of-use lease assets | 154.1 | 165.1 |
Investments in affiliates | 413.5 | 442.7 |
Deferred tax assets | 169.3 | 77.6 |
Other assets | 293.3 | 179.8 |
Intangible assets, net | 392.2 | 455.6 |
Goodwill | 1,280.8 | 1,306.5 |
Total assets | 9,182.1 | 8,504.2 |
Current Liabilities: | ||
Current portion of long-term debt | 2.1 | 325.9 |
Short term borrowings | 90.8 | 33.8 |
Accounts payable | 1,078.3 | 855.1 |
Accrued expenses | 2,062.2 | 1,916.7 |
Other current liabilities | 221.2 | 231.3 |
Total current liabilities | 3,454.6 | 3,362.8 |
Long-term debt, less current portion and debt issuance costs | 1,411.2 | 1,256.7 |
Operating lease liabilities | 115.5 | 125.9 |
Pensions and postretirement health care benefits | 209 | 253.4 |
Deferred tax liabilities | 116.9 | 112.4 |
Other noncurrent liabilities | 431.1 | 375 |
Total liabilities | 5,738.3 | 5,486.2 |
Commitments and contingencies (Note 12) | ||
AGCO Corporation stockholders’ equity: | ||
Preferred stock; $0.01Â par value, 1,000,000Â shares authorized, no shares issued or outstanding in 2021 and 2020 | 0 | 0 |
Common stock; $0.01 par value, 150,000,000 shares authorized, 74,441,312 and 74,962,231 shares issued and outstanding at December 31, 2021 and 2020, respectively | 0.7 | 0.8 |
Additional paid-in capital | 3.9 | 30.9 |
Retained earnings | 5,182.2 | 4,759.1 |
Accumulated other comprehensive loss | (1,770.9) | (1,810.8) |
Total AGCO Corporation stockholders’ equity | 3,415.9 | 2,980 |
Noncontrolling interests | 27.9 | 38 |
Total stockholders’ equity | 3,443.8 | 3,018 |
Total liabilities and stockholders’ equity | $ 9,182.1 | $ 8,504.2 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2021 | Dec. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in shares) | 1,000,000 | 1,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 |
Common stock, shares issued (in shares) | 74,441,312 | 74,962,231 |
Common stock, shares outstanding (in shares) | 74,441,312 | 74,962,231 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Defined Benefit Pension Plans | Cumulative Translation Adjustment | Deferred Gains (Losses) on Derivatives | Noncontrolling Interests |
Beginning balance (in shares) at Dec. 31, 2018 | 76,536,755 | ||||||||
Stockholders' equity, beginning of period at Dec. 31, 2018 | $ 2,993.5 | $ 0.8 | $ 10.2 | $ 4,477.3 | $ (1,555.4) | $ (282.4) | $ (1,274.4) | $ 1.4 | $ 60.6 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income (loss) | 122.8 | 125.2 | (2.4) | ||||||
Payment of dividends to shareholders | (48) | (48) | |||||||
Issuance of restricted stock (in shares) | 14,105 | ||||||||
Issuance of restricted stock | 1 | 1 | |||||||
Issuance of stock awards (in shares) | 608,444 | ||||||||
Issuance of stock awards | (23) | (13.3) | (9.7) | ||||||
SSARs exercised (in shares) | 106,514 | ||||||||
SSARs exercised | (4.8) | (3.1) | (1.7) | ||||||
Stock compensation | 40.3 | 40.3 | |||||||
Investment by noncontrolling interests | 2 | 2 | |||||||
Distribution to noncontrolling interest | (0.4) | (0.4) | |||||||
Changes in/Sale of noncontrolling interest | (9.1) | (9.1) | |||||||
Purchases and retirement of common stock (in shares) | (1,794,256) | ||||||||
Purchases and retirement of common stock | (130) | (30.4) | (99.6) | ||||||
Defined benefit pension plans, net of taxes: | |||||||||
Prior service credit (cost) arising during the year | (4.7) | (4.7) | (4.7) | ||||||
Net loss recognized due to settlement | 0.6 | 0.6 | 0.6 | ||||||
Net loss recognized due to curtailment | 0 | ||||||||
Net actuarial gain (loss) arising during the year | (23.3) | (23.3) | (23.3) | ||||||
Amortization of prior service cost included in net periodic pension cost | 1.6 | 1.6 | 1.6 | ||||||
Amortization of net actuarial losses included in net periodic pension cost | 11.8 | 11.8 | 11.8 | ||||||
Deferred gains and losses on derivatives, net | (2.7) | (2.7) | (2.7) | ||||||
Foreign currency translation adjustments | (20.6) | (23.1) | (23.1) | (2.5) | |||||
Ending balance (in shares) at Dec. 31, 2019 | 75,471,562 | ||||||||
Stockholders' equity, end of period at Dec. 31, 2019 | 2,907 | $ 0.8 | 4.7 | 4,443.5 | (1,595.2) | (296.4) | (1,297.5) | (1.3) | 53.2 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income (loss) | 419.8 | 427.1 | (7.3) | ||||||
Payment of dividends to shareholders | (48) | (48) | |||||||
Issuance of restricted stock (in shares) | 19,862 | ||||||||
Issuance of restricted stock | 1.1 | 1.1 | |||||||
Issuance of stock awards (in shares) | 374,212 | ||||||||
Issuance of stock awards | (15.7) | (7.3) | (8.4) | ||||||
SSARs exercised (in shares) | 66,736 | ||||||||
SSARs exercised | (4.2) | (4.1) | (0.1) | ||||||
Stock compensation | 36.5 | 39.9 | (3.4) | ||||||
Investment by noncontrolling interests | 0.2 | 0.2 | |||||||
Distribution to noncontrolling interest | (3.3) | (3.3) | |||||||
Changes in/Sale of noncontrolling interest | (0.5) | (0.5) | |||||||
Purchases and retirement of common stock (in shares) | (970,141) | ||||||||
Purchases and retirement of common stock | (55) | (3.4) | (51.6) | ||||||
Defined benefit pension plans, net of taxes: | |||||||||
Prior service credit (cost) arising during the year | 0.3 | 0.3 | 0.3 | ||||||
Net loss recognized due to settlement | 0.3 | 0.3 | 0.3 | ||||||
Net loss recognized due to curtailment | 0 | ||||||||
Net actuarial gain (loss) arising during the year | (32.7) | (32.7) | (32.7) | ||||||
Amortization of prior service cost included in net periodic pension cost | 2.1 | 2.1 | 2.1 | ||||||
Amortization of net actuarial losses included in net periodic pension cost | 13.1 | 13.1 | 13.1 | ||||||
Deferred gains and losses on derivatives, net | (1.2) | (1.2) | (1.2) | ||||||
Foreign currency translation adjustments | (201.8) | (197.5) | (197.5) | 4.3 | |||||
Ending balance (in shares) at Dec. 31, 2020 | 74,962,231 | ||||||||
Stockholders' equity, end of period at Dec. 31, 2020 | 3,018 | $ 0.8 | 30.9 | 4,759.1 | (1,810.8) | (313.3) | (1,495) | (2.5) | 38 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income (loss) | 901.5 | 897 | 4.5 | ||||||
Payment of dividends to shareholders | (358.5) | (358.5) | |||||||
Issuance of restricted stock (in shares) | 8,912 | ||||||||
Issuance of restricted stock | 1.3 | 1.3 | |||||||
Issuance of stock awards (in shares) | 362,034 | ||||||||
Issuance of stock awards | (29.5) | (29.5) | |||||||
SSARs exercised (in shares) | 60,339 | ||||||||
SSARs exercised | (5.4) | (5.4) | |||||||
Stock compensation | 26.1 | 26.1 | |||||||
Distribution to noncontrolling interest | (3.6) | (3.6) | |||||||
Sale of noncontrolling interests | (10.6) | (10.6) | |||||||
Purchases and retirement of common stock (in shares) | (952,204) | ||||||||
Purchases and retirement of common stock | (135) | $ (0.1) | (19.5) | (115.4) | |||||
Defined benefit pension plans, net of taxes: | |||||||||
Prior service credit (cost) arising during the year | 10 | 10 | 10 | ||||||
Net loss recognized due to settlement | 0.1 | 0.1 | 0.1 | ||||||
Net loss recognized due to curtailment | 6.3 | 6.3 | 6.3 | ||||||
Net actuarial gain (loss) arising during the year | 53.6 | 53.6 | 53.6 | ||||||
Amortization of prior service cost included in net periodic pension cost | 0.6 | 0.6 | 0.6 | ||||||
Amortization of net actuarial losses included in net periodic pension cost | 12.3 | 12.3 | 12.3 | ||||||
Deferred gains and losses on derivatives, net | 2.1 | 2.1 | 2.1 | ||||||
Foreign currency translation adjustments | (45.5) | (45.1) | (45.1) | 0.4 | |||||
Ending balance (in shares) at Dec. 31, 2021 | 74,441,312 | ||||||||
Stockholders' equity, end of period at Dec. 31, 2021 | $ 3,443.8 | $ 0.7 | $ 3.9 | $ 5,182.2 | $ (1,770.9) | $ (230.4) | $ (1,540.1) | $ (0.4) | $ 27.9 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Cash flows from operating activities: | |||
Net income | $ 901.5 | $ 419.8 | $ 122.8 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation | 220.7 | 212.5 | 210.9 |
Impairment charges | 0 | 20 | 176.6 |
Amortization of intangibles | 61.1 | 59.5 | 61.1 |
Stock compensation expense | 27.4 | 37.6 | 41.3 |
Equity in net earnings of affiliates, net of cash received | (1.9) | (43.7) | 0 |
Deferred income tax (benefit) provision | (117.9) | 3.4 | 15.1 |
Other | 20.5 | (7.4) | 6.9 |
Changes in operating assets and liabilities, net of effects from purchase of businesses: | |||
Accounts and notes receivable, net | (207.7) | (90.5) | 63.8 |
Inventories, net | (762.6) | 119.7 | (216.3) |
Other current and noncurrent assets | (268) | (49.8) | (14.4) |
Accounts payable | 292.2 | (59.1) | 35.7 |
Accrued expenses | 241.2 | 185.3 | 114.5 |
Other current and noncurrent liabilities | 253.7 | 89.2 | 77.9 |
Total adjustments | (241.3) | 476.7 | 573.1 |
Net cash provided by operating activities | 660.2 | 896.5 | 695.9 |
Cash flows from investing activities: | |||
Purchases of property, plant and equipment | (269.8) | (269.9) | (273.4) |
Proceeds from sale of property, plant and equipment | 6.3 | 1.9 | 4.9 |
Purchase of businesses, net of cash acquired | (22.6) | (2.8) | 0 |
Sale of, distributions from (investments in) unconsolidated affiliates, net | 13.1 | 29.1 | (3.1) |
Other | (15.4) | 0 | 0 |
Net cash used in investing activities | (288.4) | (241.7) | (271.6) |
Cash flows from financing activities: | |||
Proceeds from indebtedness | 2,497.6 | 1,195.6 | 2,082.7 |
Repayments of indebtedness | (2,501.4) | (1,045.6) | (2,191.1) |
Purchases and retirement of common stock | (135) | (55) | (130) |
Payment of dividends to stockholders | (358.5) | (48) | (48) |
Payment of minimum tax withholdings on stock compensation | (34.9) | (19.8) | (28.1) |
Payment of debt issuance costs | (3.8) | (1.4) | (0.5) |
(Distributions to) investments by noncontrolling interests, net | (3.5) | (3.1) | 1.6 |
Net cash (used in) provided by financing activities | (539.5) | 22.7 | (313.4) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (62.3) | 8.8 | (4.2) |
(Decrease) increase in cash, cash equivalents and restricted cash | (230) | 686.3 | 106.7 |
Cash, cash equivalents and restricted cash, beginning of year | 1,119.1 | 432.8 | 326.1 |
Cash, cash equivalents and restricted cash, end of year | $ 889.1 | $ 1,119.1 | $ 432.8 |
Operations and Summary of Signi
Operations and Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Operations and Summary of Significant Accounting Policies | Operations and Summary of Significant Accounting Policies Business AGCO Corporation and subsidiaries (“AGCO” or the “Company”) is a leading manufacturer and distributor of agricultural equipment and related replacement parts throughout the world. The Company sells a full range of agricultural equipment, including tractors, combines, hay tools, sprayers, forage equipment, seeding and tillage equipment, implements, and grain storage and protein production systems. The Company’s products are widely recognized in the agricultural equipment industry and are marketed under a number of well-known brand names including: Challenger ® , Fendt ® , GSI ® , Massey Ferguson ® and Valtra ® . The Company distributes most of its products through a combination of approximately 3,200 independent dealers and distributors as well as the Company utilizes associates and licensees to provide a distribution channel for its products. In addition, the Company provides retail financing through its finance joint ventures with CoöperatieveRabobank U.A., or “Rabobank.” Basis of Presentation and Consolidation The Company’s Consolidated Financial Statements represent the consolidation of all wholly-owned companies, majority-owned companies and joint ventures in which the Company has been determined to be the primary beneficiary. The Company consolidates a variable interest entity (“VIE”) if the Company determines it is the primary beneficiary. The primary beneficiary of a VIE is the party that has both the power to direct the activities that most significantly impact the entity’s economic performance and the obligation to absorb losses or the right to receive benefits that potentially could be significant to the VIE. The Company also consolidates all entities that are not considered VIEs if it is determined that the Company has a controlling voting interest to direct the activities that most significantly impact the joint venture or entity. The Company records investments in all other affiliate companies using the equity method of accounting when it has significant influence. Other investments, including those representing an ownership interest of less than 20%, are recorded at cost. All significant intercompany balances and transactions have been eliminated in the Consolidated Financial Statements. Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The estimates made by management primarily relate to accounts and notes receivable, inventories, deferred income tax valuation allowances, uncertain tax positions, goodwill and other identifiable intangible assets, and certain accrued liabilities, principally relating to reserves for volume discounts and sales incentives, warranty obligations, product liability and workers’ compensation obligations, and pensions and postretirement benefits. The Company cannot predict the ongoing impact of the COVID-19 pandemic due to volatility in global economic and political environments, the cyclicality of market demand for its products, supply chain disruptions, possible workforce unavailability, exchange rate and commodity and protein price volatility and availability of financing, and their impact to the Company’s net sales, production volumes, costs and overall financial condition and available funding. The Company may be required to record impairment charges in the future with respect to noncurrent assets such as goodwill and other intangible assets and equity method investments, whose fair values may be negatively affected by the COVID-19 pandemic. The Company also may be required to write-down obsolete inventory due to decreased customer demand and sales orders. The Company monitors the collection of accounts receivable, as well as the operating results of its finance joint ventures around the world. In the event economic conditions were to deteriorate, the Company and its finance joint ventures may not collect accounts receivable at expected levels, and the operating results of its finance joint ventures may be negatively impacted, thus negatively impacting the Company's results of operations and financial condition. The Company also regularly assesses its compliance with debt covenants, cash flow hedging forecasts as compared to actual transactions, the fair value of pension assets, accounting for incentive and stock compensation accruals, revenue recognition and discount reserve setting as well as the realization of deferred tax assets in light of the COVID-19 pandemic. Foreign Currency Translation The financial statements of the Company’s foreign subsidiaries are translated into United States currency in accordance with Accounting Standards Codification (“ASC”) 830, “Foreign Currency Matters.” Assets and liabilities are translated to United States dollars at period-end exchange rates. Income and expense items are translated at average rates of exchange prevailing during the period. Translation adjustments are included in “Accumulated other comprehensive loss” in stockholders’ equity within the Company’s Consolidated Balance Sheets. Gains and losses, which result from foreign currency transactions, are included in the accompanying Consolidated Statements of Operations. The Company changed the functional currency of its wholly-owned subsidiary from the Argentinian peso to the U.S. dollar effective July 1, 2018. Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents reported in the Consolidated Balance Sheets as of December 31, 2021, 2020 and 2019 and cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows for the years ended December 31, 2021, 2020 and 2019 are as follows (in millions): December 31, 2021 December 31, 2020 December 31, 2019 Cash (1) $ 833.0 $ 1,022.0 $ 412.3 Cash equivalents (2) 49.2 89.7 17.3 Restricted cash (3) 6.9 7.4 3.2 Total $ 889.1 $ 1,119.1 $ 432.8 ____________________________________ (1) Consisted primarily of cash on hand and bank deposits. (2) Consisted primarily of money market deposits, certificates of deposits and overnight investments. The Company considers all investments with an original maturity of three months or less to be cash equivalents. (3) Consisted primarily of cash in escrow or held as guarantee to support specific requirements. Accounts and Notes Receivable Accounts and notes receivable arise from the sale of equipment and replacement parts to independent dealers, distributors or other customers. In the United States and Canada, amounts due from sales to dealers are immediately due upon a retail sale of the underlying equipment by the dealer with the exception of sales of grain storage and protein production systems as discussed further below. If not previously paid by the dealer in the United States and Canada, installment payments are required generally beginning after the interest-free period with the remaining outstanding equipment balance generally due within 12 months after shipment or delivery. These interest-free periods vary by product and generally range from one In other international markets, equipment sales generally are payable in full within 30 days to 180 days of shipment or delivery. Payment terms for some highly seasonal products have a specified due date during the year regardless of the shipment or delivery date. For sales in most markets outside of the United States and Canada, the Company generally does not charge interest on outstanding receivables with its dealers and distributors. Sales of replacement parts generally are payable within 30 days to 90 days of shipment, with terms for some larger, seasonal stock orders generally payable within six months of shipment. In certain markets, there is a time lag, which varies based on the timing and level of retail demand, between the date the Company records a sale and when the dealer sells the equipment to a retail customer. Sales of grain storage and protein production systems both in the United States and in other countries generally are payable within 30 days of shipment. In certain countries, sales of such systems for which the Company is responsible for construction or installation may be contingent upon customer acceptance. Payment terms vary by market and product, with fixed payment schedules on all sales. When the Company is responsible for installation services, fixed payment schedules may include upfront deposits, progress payments and final payment upon customer acceptance. The following summarizes by geographic region, as a percentage of the Company’s consolidated net sales, amounts with maximum interest-free periods as presented below (in millions): Year Ended December 31, 2021 North South Europe/ Asia/ Consolidated 0 to 6 months $ 1,909.7 $ 1,307.7 $ 6,217.6 $ 949.7 $ 10,384.7 93.2 % 7 to 12 months 739.7 — 4.1 — 743.8 6.7 % 13 to 24 months 9.8 — — — 9.8 0.1 % $ 2,659.2 $ 1,307.7 $ 6,221.7 $ 949.7 $ 11,138.3 100.0 % The Company has an agreement to permit transferring, on an ongoing basis, a majority of its wholesale interest-bearing and non-interest bearing accounts receivable in North America, Europe and Brazil to its U.S., Canadian, European and Brazilian finance joint ventures. Qualified dealers may obtain additional financing through the Company’s U.S., Canadian, European and Brazilian finance joint ventures at the joint ventures’ discretion. The Company provides various volume bonus and sales incentive programs with respect to its products. These sales incentive programs include reductions in invoice prices, reductions in retail financing rates, dealer commissions and dealer incentive allowances. In most cases, incentive programs are established and communicated to the Company’s dealers on a quarterly basis. The incentives are paid either at the time of the cash settlement of the receivable (which is generally at the time of retail sale), at the time of retail financing, at the time of warranty registration, or at a subsequent time based on dealer purchase volumes. The incentive programs are product-line specific and generally do not vary by dealer. The cost of sales incentives associated with dealer commissions and dealer incentive allowances is estimated based upon the terms of the programs and historical experience, is based on a percentage of the sales price, and estimates for sales incentives are made and recorded at the time of sale for expected incentive programs using the expected value method. These estimates are reassessed each reporting period and are revised in the event of subsequent modifications to incentive programs, as they are communicated to dealers. The related provisions and accruals are made on a product or product-line basis and are monitored for adequacy and revised at least quarterly in the event of subsequent modifications to the programs. Interest rate subsidy payments, which are a reduction in retail finance rates, are recorded in the same manner as dealer commissions and dealer incentive allowances. Volume discounts are estimated and recognized based on historical experience, and related reserves are monitored and adjusted based on actual dealer purchase volumes and the dealer’s progress towards achieving specified cumulative target levels. All incentive programs are recorded and presented as a reduction of revenue, due to the fact that the Company does not receive a distinct good or service in exchange for the consideration provided. In the United States and Canada, reserves for incentive programs related to accounts receivable not sold to Company’s U.S. and Canadian finance joint ventures are recorded as “accounts receivable allowances” within the Company’s Consolidated Balance Sheets due to the fact that the incentives are paid through a reduction of future cash settlement of the receivable. Globally, reserves for incentive programs that will be paid in cash or credit memos, as is the case with most of the Company’s volume discount programs, as well as sales with incentives associated with accounts receivable sold to its finance joint ventures, are recorded within “Accrued expenses” within the Company’s Consolidated Balance Sheets. Accounts and notes receivable are shown net of allowances for sales incentive discounts available to dealers and for doubtful accounts. Cash flows related to the collection of receivables are reported within “Cash flows from operating activities” within the Company’s Consolidated Statements of Cash Flows. Accounts and notes receivable allowances at December 31, 2021 and 2020 were as follows (in millions): 2021 2020 Sales incentive discounts $ 8.0 $ 12.9 Doubtful accounts 32.6 36.4 $ 40.6 $ 49.3 The Company accounts for its provision for doubtful accounts in accordance with Accounting Standards Update (“ASU”) 2016-13, “Measurement of Credit Losses on Financial Instruments,” (“ASU 2016-13”). In the United States and Canada, sales incentives can be paid through future cash settlements of receivables and through credit memos to Company’s dealers or through reductions in retail financing rates paid to the Company’s finance joint ventures. Outside of the United States and Canada, sales incentives can be paid through cash or credit memos to the Company’s dealers or through reductions in retail financing rates paid to the Company’s finance joint ventures. The Company transfers certain accounts receivable under its accounts receivable sales agreements with its finance joint ventures and other financial institutions (see Note 4). The Company records such transfers as sales of accounts receivable when it is considered to have surrendered control of such receivables under the provisions of ASU 2009-16, “Transfers and Servicing (Topic 860): Accounting for Transfers of Financial Assets.” Cash payments made to the Company’s finance joint ventures for sales incentive discounts provided to dealers related to outstanding accounts receivables sold are recorded within “Accrued expenses.” Inventories Inventories are valued at the lower of cost or net realizable value, using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At December 31, 2021 and 2020, the Company had recorded $202.6 million and $209.2 million, respectively, as an adjustment for surplus and obsolete inventories. These adjustments are reflected within “Inventories, net” within the Company’s Consolidated Balance Sheets. Inventories, net at December 31, 2021 and 2020 were as follows (in millions): 2021 2020 Finished goods $ 718.2 $ 641.3 Repair and replacement parts 697.8 652.3 Work in process 282.8 175.1 Raw materials 894.9 505.7 Inventories, net $ 2,593.7 $ 1,974.4 Cash flows related to the sale of inventories are reported within “Cash flows from operating activities” within the Company’s Consolidated Statements of Cash Flows. Recoverable Indirect Taxes The Company’s Brazilian operations incur value added taxes (“VAT”) on certain purchases of raw materials, components and services. These taxes are accumulated as tax credits and create assets that are reduced by the VAT collected from the Company’s sales in the Brazilian market. The Company regularly assesses the recoverability of these tax credits, and establishes reserves when necessary against them, through analyses that include, amongst others, the history of realization, the transfer of tax credits to third parties as authorized by the government, anticipated changes in the supply chain and the future expectation of tax debits from the Company’s ongoing operations. The Company believes that these tax credits, net of established reserves, are realizable. The Company had recorded approximately $114.4 million and $91.2 million, respectively, of VAT tax credits, net of reserves, as of December 31, 2021 and 2020. Property, Plant and Equipment Property, plant and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation is provided on a straight-line basis over the estimated useful lives of two three three Property, plant and equipment, net at December 31, 2021 and 2020 consisted of the following (in millions): 2021 2020 Land $ 141.0 $ 147.2 Buildings and improvements 875.9 899.7 Machinery and equipment 2,702.3 2,772.0 Furniture and fixtures 171.1 168.0 Gross property, plant and equipment 3,890.3 3,986.9 Accumulated depreciation and amortization (2,425.5) (2,478.4) Property, plant and equipment, net $ 1,464.8 $ 1,508.5 Goodwill, Other Intangible Assets and Long-Lived Assets The Company tests goodwill for impairment, at the reporting unit level, annually and when events or circumstances indicate that fair value of a reporting unit may be below its carrying value. A reporting unit is an operating segment or one level below an operating segment, for example, a component. The Company combines and aggregates two or more components of an operating segment as a single reporting unit if the components have similar economic characteristics. The Company’s reportable segments are not its reporting units. Goodwill is evaluated annually as of October 1 for impairment using a qualitative assessment or a quantitative one-step assessment. If the Company elects to perform a qualitative assessment and determines the fair value of its reporting units more likely than not exceed the carrying value of their net assets, no further evaluation is necessary. For reporting units where the Company performs a one-step quantitative assessment, the Company compares the fair value of each reporting unit, which is determined based on a combination of a discounted cash flow valuation approach and a market multiple valuation approach, to its respective carrying value of net assets, including goodwill. If the fair value of the reporting unit exceeds its carrying value of net assets, the goodwill is not considered impaired. If the carrying value of net assets is higher than the fair value of the reporting unit, an impairment charge is recorded in the amount by which the carrying value exceeds the reporting unit’s fair value in accordance with ASU 2017-04. The Company reviews its long-lived assets, which include intangible assets subject to amortization, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The evaluation for recoverability is performed at a level where independent cash flows may be attributed to either an asset or asset group. If the Company determines that the carrying amount of an asset or asset group is not recoverable based on the expected undiscounted future cash flows of the asset or asset group, an impairment loss is recorded equal to the excess of the carrying amounts over the estimated fair value of the long-lived assets. Estimates of future cash flows are based on many factors, including current operating results, expected market trends and competitive influences. The Company also evaluates the amortization periods assigned to its intangible assets to determine whether events or changes in circumstances warrant revised estimates of useful lives. Assets to be disposed of by sale are reported at the lower of the carrying amount or fair value, less estimated costs to sell. The results of our goodwill and long-lived assets impairment analyses conducted as of October 1, 2021 indicated that no indicators of impairment existed and no reduction in the carrying amount of goodwill and long-lived assets was required. The COVID-19 pandemic has adversely impacted the global economy as a whole since its inception. Based on macroeconomic conditions throughout 2020, the Company assessed its goodwill and other intangible assets for indications of impairment, and as of June 30, 2020, the Company concluded there were indicators of impairment during the three months ended June 30, 2020 related to one of its smaller reporting units, which was a 50%-owned tillage and seeding equipment joint venture. As a result, the entire goodwill balance of this reporting unit was impaired, and during the three months ended June 30, 2020, the Company recorded a non-cash impairment charge of approximately $20.0 million as “Impairment charges” within the Company’s Consolidated Statements of Operations, with an offsetting benefit of approximately $10.0 million included within “Net (income) loss attributable to noncontrolling interests.” During the three months ended June 30, 2021, the Company sold its 50% interest in the joint venture. The Company’s goodwill impairment analysis conducted as of October 1, 2020 indicated that no other indicators of impairment existed and no reduction in the carrying amount of goodwill and long-lived assets was required related to the Company’s other reporting units. The Company’s goodwill impairment analysis conducted as of October 1, 2019, indicated that the carrying value of the net assets of the Company’s grain storage and protein production systems operations in Europe/Middle East was in excess of the fair value of the reporting unit, and therefore, the Company recorded a non-cash impairment charge of approximately $173.6 million within “Impairment charges” in the Company’s Consolidated Statements of Operations. During the three months ended December 31, 2019, the Company also recorded a non-cash impairment charge of approximately $3.0 million within “Impairment charges” in the Company’s Consolidated Statements of Operations. The impairment charge related to certain long-lived assets associated with the Company’s grain storage and protein production systems operations within North America, due to the discontinuation of a certain brand name and related product, and customers. The Company’s accumulated goodwill impairment is approximately $354.1 million related to impairment charges the Company recorded during 2019, 2012 and 2006 pertaining to its grain storage and protein production systems business in Europe/Middle East, its Chinese harvesting reporting unit and its former sprayer reporting unit, respectively. The Company’s grain storage and protein production systems Europe/Middle East reporting unit operates within the Europe/Middle East geographical reportable segment. The Chinese harvesting business operates within the Asia/Pacific/Africa geographical reportable segment and the former sprayer reporting unit operates within the North American geographical reportable segment. Changes in the carrying amount of goodwill during the years ended December 31, 2021, 2020 and 2019 are summarized as follows (in millions): North South Europe/ Asia/ Consolidated Balance as of December 31, 2018 $ 611.1 $ 116.7 $ 649.6 $ 118.1 $ 1,495.5 Impairment charge — — (173.6) — (173.6) Sale of a joint venture (5.1) — — — (5.1) Foreign currency translation — (4.5) (12.7) (1.3) (18.5) Balance as of December 31, 2019 606.0 112.2 463.3 116.8 1,298.3 Acquisition 7.2 — — — 7.2 Impairment charge (20.0) — — — (20.0) Foreign currency translation 0.2 (24.7) 38.0 7.5 21.0 Balance as of December 31, 2020 593.4 87.5 501.3 124.3 1,306.5 Acquisitions 16.2 — 0.6 — 16.8 Foreign currency translation — (5.8) (32.4) (4.3) (42.5) Balance as of December 31, 2021 $ 609.6 $ 81.7 $ 469.5 $ 120.0 $ 1,280.8 The Company amortizes certain acquired identifiable intangible assets primarily on a straight-line basis over their estimated useful lives, which range from five Intangible Assets Weighted-Average Useful Life Patents and technology 11 years Customer relationships 13 years Trademarks and trade names 20 years Land use rights 45 years For the years ended December 31, 2021, 2020 and 2019, acquired intangible asset amortization was $60.9 million, $59.5 million and $61.1 million, respectively. The Company estimates amortization of existing intangible assets will be $57.5 million in 2022, $53.8 million in 2023, $52.5 million in 2024, $48.4 million in 2025, and $19.7 million in 2026. The Company has previously determined that two of its trademarks have an indefinite useful life. The Massey Ferguson trademark has been in existence since 1952 and was formed from the merger of Massey-Harris (established in the 1890’s) and Ferguson (established in the 1930’s). The Massey Ferguson brand is currently sold in approximately 110 countries worldwide, making it one of the most widely sold tractor brands in the world. The Company also has identified the Valtra trademark as an indefinite-lived asset. The Valtra trademark has been in existence since the late 1990’s, but is a derivative of the Valmet trademark which has been in existence since 1951. The Valmet name transitioned to the Valtra name over a period of time in the marketplace. The Valtra brand is currently sold in approximately 60 countries around the world. Both the Massey Ferguson brand and the Valtra brand are primary product lines of the Company’s business, and the Company plans to use these trademarks for an indefinite period of time. The Company plans to continue to make investments in product development to enhance the value of these brands into the future. There are no legal, regulatory, contractual, competitive, economic or other factors that the Company is aware of or that the Company believes would limit the useful lives of the trademarks. The Massey Ferguson and Valtra trademark registrations can be renewed at a nominal cost in the countries in which the Company operates. Changes in the carrying amount of acquired intangible assets during 2021 and 2020 are summarized as follows (in millions): Trademarks and Customer Patents and Land Use Total Gross carrying amounts: Balance as of December 31, 2019 $ 199.3 $ 579.0 $ 151.1 $ 8.5 $ 937.9 Foreign currency translation 6.7 6.4 6.9 0.6 20.6 Balance as of December 31, 2020 206.0 585.4 158.0 9.1 958.5 Acquisitions 0.7 3.2 6.1 — 10.0 Sale of business (1.3) (4.4) (17.1) — (22.8) Foreign currency translation (5.5) (10.8) (6.3) 0.2 (22.4) Balance as of December 31, 2021 $ 199.9 $ 573.4 $ 140.7 $ 9.3 $ 923.3 Accumulated Amortization Trademarks and Customer Patents and Land Use Total Balance as of December 31, 2019 $ 83.3 $ 347.4 $ 88.7 $ 3.1 $ 522.5 Amortization expense 10.1 39.9 9.4 0.1 59.5 Foreign currency translation 2.0 3.0 5.1 0.2 10.3 Balance as of December 31, 2020 95.4 390.3 103.2 3.4 592.3 Amortization expense 10.8 37.4 12.5 0.2 60.9 Sale of business (1.3) (4.4) (15.2) — (20.9) Foreign currency translation (1.7) (8.0) (5.0) 0.2 (14.5) Balance as of December 31, 2021 $ 103.2 $ 415.3 $ 95.5 $ 3.8 $ 617.8 Indefinite-Lived Intangible Assets Trademarks and Balance as of December 31, 2019 $ 86.3 Foreign currency translation 3.1 Balance as of December 31, 2020 89.4 Foreign currency translation (2.7) Balance as of December 31, 2021 $ 86.7 During the year ended December 31, 2021, the Company acquired approximately $16.3 million of functional intellectual property licenses associated with various component technology related to the Company’s products. The Company is amortizing these licenses over a period of five years, and recorded amortization expense of approximately $0.2 million during 2021, resulting in a remaining unamortized amount of approximately $16.1 million as of December 31, 2021, reflected within “Other assets” in the Company's Consolidated Balance Sheets. Accrued Expenses Accrued expenses at December 31, 2021 and 2020 consisted of the following (in millions): 2021 2020 Reserve for volume discounts and sales incentives $ 602.3 $ 582.9 Warranty reserves 492.7 431.6 Accrued employee compensation and benefits 322.3 329.2 Accrued taxes 282.5 249.6 Other 362.4 323.4 Balance at the end of the year $ 2,062.2 $ 1,916.7 Warranty Reserves The warranty reserve activity for the years ended December 31, 2021, 2020 and 2019 consisted of the following (in millions): 2021 2020 2019 Balance at beginning of the year $ 521.8 $ 392.8 $ 360.9 Acquisitions — 0.2 — Accruals for warranties issued during the year 344.9 310.2 234.1 Settlements made (in cash or in kind) during the year (241.8) (204.3) (198.7) Foreign currency translation (32.4) 22.9 (3.5) Balance at the end of the year $ 592.5 $ 521.8 $ 392.8 The Company’s agricultural equipment products generally are under warranty against defects in materials and workmanship for a period of one The Company recognizes recoveries of the costs associated with warranties it provides when the collection is probable. When specifics of the recovery have been agreed upon with the Company’s suppliers through confirmation of liability for the recovery, the Company records the recovery within “Accounts and notes receivable, net.” Estimates of the amount of warranty claim recoveries to be received from the Company’s suppliers based upon contractual supplier arrangements are recorded within “Other current assets.” Insurance Reserves Under the Company’s insurance programs, coverage is obtained for significant liability limits as well as those risks required to be insured by law or contract. It is the policy of the Company to self-insure a portion of certain expected losses primarily related to workers’ compensation and comprehensive general liability, product and vehicle liability. Provisions for losses expected under these programs are recorded based on the Company’s estimates of the aggregate liabilities for the claims incurred. Revenue The Company accounts for revenue recognition pursuant to ASU 2014-09, “Revenue from Contracts with Customers.” Revenue is recognized when the Company satisfies the performance obligation by transferring control over goods or services to a dealer, distributor or other customer. The amount of revenue recognized is measured as the consideration the Company expects to receive in exchange for those goods or services pursuant to a contract with the customer. A contract exists once the Company receives and accepts a purchase order under a dealer sales agreement, or once the Company enters into a contract with an end user. The Company does not recognize revenue in cases where collectability is not probable, and defers the recognition until collection is probable or payment is received. The Company generates revenue from the manufacture and distribution of agricultural equipment and replacement parts. Sales of equipment and replacement parts, which represents a majority of the Company’s net sales, are recorded by the Company at the point in time when title and control have been transferred to an independent dealer, distributor or other customer. Title generally passes to the dealer or distributor upon shipment or specified delivery, and the risk of loss upon damage, theft or destruction of the equipment is the responsibility of the dealer, distributor or designated third-party carrier. The Company believes control passes and the performance obligation is satisfied at the point of the stated shipping or delivery term with respect to such sales. As previously discussed, the amount of consideration the Company receives and the revenue recognized varies with certain sales incentives the Company offers to dealers and distributors. Estimates for sales incentives are made at the time of sale for expected incentive programs using the expected value method. These estimates are revised in the event of subsequent modification to the incentive program. All incentive programs are recorded and presented as a reduction of revenue, due to the fact that the Company does not receive a distinct good or service in exchange for the consideration provided. Dealers or distributors may not return equipment or replacement parts while its contract with the Company is in force, except for under established promotional and annual replacement parts return programs. At the time of sale, the Company estimates the amount of returns based on the terms of promotional and annual return programs and anticipated returns in the future. Sales and other related taxes are excluded from the transaction price. Shipping and handling costs associated with freight activities after the customer has obtained control are accounted for as fulfillment costs and are expensed and accrued at the time revenue is recognized in “Cost of goods sold” and “Selling, general and administrative expenses” in the Company’s Consolidated Statements of Operations. As afforded under the practical expedient in ASU 2014-09, the Company does not adjust the amount of revenue to be recognized under a contract with a dealer |
Business Combinations and Asset
Business Combinations and Asset Acquisitions | 12 Months Ended |
Dec. 31, 2021 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Combination Disclosure [Text Block] | Acquisitions On January 01, 2022 the Company acquired Appareo Systems, LLC (“Appareo”) for approximately $61.4 million, net of cash acquired of approximately $0.5 million, as well as indebtedness payable to the Company's former 50% joint venture with Appareo of approximately $0.9 million. Appareo is headquartered in Fargo, North Dakota and specializes in the research, development, design, and manufacture of tangible technology focused on communication, monitoring, sensing, tracking and controlling devices and systems used in the agricultural and aviation industries as well as other off-road businesses. The Company is in the process of determining the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed. On December 01, 2021, the Company acquired Creatives Sites Media, Inc. (“CSM”) for approximately $5.7 million. CSM is headquartered in Bloomington, Illinois and creates and designs customized mobile-enabled technology applications and websites. The acquired net assets were insignificant. The Company recorded approximately $5.7 million of goodwill associated with the acquisition. The associated goodwill has been included in the Company’s North American geographical reportable segment. On September 10, 2021, the Company acquired Farm Robotics and Automation S.L. (“Faromatics”) for approximately €4.6 million (or approximately $5.5 million) net of approximately €0.1 million (or approximately $0.1 million) of cash and €0.8 million (or approximately $0.9 million) of escrowed cash which could be payable by the Company within 18 months of the acquisition date. Faromatics is headquartered in Barcelona, Spain, and manufactures and sells ChickenBoy ® , the world's first ceiling-suspended robot that monitors broiler chickens and helps farmers increase animal welfare and farm productivity. The Company recorded approximately €4.4 million (or approximately $5.2 million) of technology and approximately €1.8 million (or approximately $2.2 million) of goodwill associated with the acquisition. The associated goodwill has been included in the Company’s North American and Europe/Middle East geographical reportable segments. On August 13, 2021, the Company acquired Headsight, LLC (“Headsight”) for approximately $16.8 million. Headsight is headquartered in Bremen, Indiana and manufactures header height sensors used in corn and grain harvesting operations. The Company recorded approximately $4.8 million of customer relationship, technology and trademark identifiable intangible assets and approximately $8.9 million of goodwill associated with the acquisition. The associated goodwill has been included in the Company’s North American geographical reportable segment. The acquired identifiable intangible assets of Headsight and Faromatics as of the date of their respective acquisitions during 2021 are summarized in the following table (in millions): Intangible Asset Amount Weighted-Average Useful Life Customer relationships $ 3.2 7 years Technology 6.1 10 - 15 years Trademarks 0.7 7 years $ 10.0 The Company allocated the purchase price of the assets acquired and liabilities assumed of the CSM, Faromatics and Headsight acquisitions based on estimates of their fair values of their respective acquisition dates. The acquired net assets related to these acquisitions generally consisted of accounts receivable, inventories, lease right-of-use assets and liabilities, property, plant and equipment, accounts payable and accrued expenses. Proforma financial information related to these acquisitions was not material to the Company's results of operations. |
Restructuring Expenses
Restructuring Expenses | 12 Months Ended |
Dec. 31, 2021 | |
Restructuring and Related Activities [Abstract] | |
Restructuring Expenses | Restructuring Expenses The Company has announced and initiated actions over the course of several years to rationalize employee headcount at various manufacturing facilities and various administrative offices located in Europe, South America, Africa, China and the United States, as well as the rationalization of its grain storage and protein production system operations. These rationalizations were taken to reduce costs in response to fluctuating global market demand. During 2021, the Company recorded severance and related costs associated with these rationalizations in connection with the termination of approximately 150 employees. The components of the restructuring expenses are summarized as follows (in millions): Employee Severance Facility Closure Costs Write-down of Property, Plant Other Related Loss on Sale of Total Balance as of December 31, 2018 $ 7.1 $ — $ — $ — $ — $ 7.1 2019 provision 5.6 0.5 1.5 — 2.1 9.7 Less: Non-cash expense — — (1.5) — (2.1) (3.6) Cash expense 5.6 0.5 — — — 6.1 2019 provision reversal (0.7) — — — — (0.7) 2019 cash activity (6.8) (0.5) — — — (7.3) Foreign currency translation (0.4) — — — — (0.4) Balance as of December 31, 2019 4.8 — — — — 4.8 2020 provision 11.3 4.5 2.5 1.8 — 20.1 Less: Non-cash expense — — (2.5) — — (2.5) Cash expense 11.3 4.5 — 1.8 — 17.6 2020 provision reversal (0.4) — — — — (0.4) 2020 cash activity (4.5) (0.6) — — — (5.1) Foreign currency translation (0.1) — — — — (0.1) Balance as of December 31, 2020 11.1 3.9 — 1.8 — 16.8 2021 provision 18.4 — 0.2 1.5 — 20.1 Less: Non-cash expense — — (0.2) — — (0.2) Cash expense 18.4 — — 1.5 — 19.9 2021 provision reversal (2.2) — — (0.1) (2.5) (4.8) 2021 cash activity (12.3) (3.9) — (2.9) 2.5 (16.6) Foreign currency translation (0.5) — — (0.1) — (0.6) Balance as of December 31, 2021 $ 14.5 $ — $ — $ 0.2 $ — $ 14.7 During the three months ended December 31, 2019, the Company exited and sold its 50% interest in its USC, LLC joint venture to its joint venture partner for approximately $5.1 million. The operations of the joint venture were part of the Company's grain storage and production system operations, and the decision to sell the joint venture was as a result of the overall rationalization of the business. The Company recorded a loss of approximately $2.1 million associated with the sale, which was reflected within “Restructuring expenses” in the Company’s Consolidated Statements of Operations. As a result of the final payments received from the former joint venture partner related to the sale during 2021 the Company recorded a gain of approximately $2.5 million, also reflected within “Restructuring expenses” in the Company’s Condensed Consolidated Statements of Operations. |
Accounts Receivable Sales Agree
Accounts Receivable Sales Agreements | 12 Months Ended |
Dec. 31, 2021 | |
Accounts Receivable Sales Agreements [Abstract] | |
Accounts Receivable Sales Agreements | Accounts Receivable Sales Agreements The Company has accounts receivable sales agreements that permit the sale, on an ongoing basis, of a majority of its wholesale receivables in North America, Europe and Brazil to its U.S., Canadian, European and Brazilian finance joint ventures. As of December 31, 2021 and 2020, the cash received from receivables sold under the U.S., Canadian, European and Brazilian accounts receivable sales agreements was approximately $1.3 billion and $1.5 billion, respectively. Under the terms of the accounts receivable sales agreements in North America, Europe and Brazil, the Company pays an annual fee related to the servicing of the receivables sold. The Company also pays the respective AGCO Finance entities a subsidized interest payment with respect to the accounts receivable sales agreements, calculated based upon LIBOR plus a margin on any non-interest bearing accounts receivable outstanding and sold under the accounts receivables sales agreements. Following the phase out of LIBOR-denominated rates, the Company expects this funding to be based upon the interest rate charged by Rabobank to its affiliate, and such affiliate then lends to the AGCO Finance entities plus an agreed-upon margin. These fees are reflected within losses on the sales of receivables included within “Other expense, net” in the Company’s Consolidated Statements of Operations. The Company does not service the receivables after the sale occurs and does not maintain any direct retained interest in the receivables. The Company reviewed its accounting for the accounts receivable sales agreements and determined that these facilities should be accounted for as off-balance sheet transactions. In addition, the Company sells certain trade receivables under factoring arrangements to other financial institutions around the world. As of December 31, 2021 and 2020, the cash received from these arrangements was approximately $215.4 million and $199.9 million, respectively. Losses on sales of receivables associated with the accounts receivable financing facilities discussed above, reflected within “Other expense, net” in the Company’s Consolidated Statements of Operations, were approximately $24.5 million, $24.1 million and $42.4 million during 2021, 2020 and 2019, respectively. The Company’s finance joint ventures in Europe, Brazil and Australia also provide wholesale financing directly to the Company’s dealers. The receivables associated with these arrangements are without recourse to the Company. The Company does not service the receivables after the sale occurs and does not maintain any direct retained interest in the receivables. As of December 31, 2021 and 2020, these finance joint ventures had approximately $82.1 million and $85.2 million, respectively, of outstanding accounts receivable associated with these arrangements. The Company reviewed its accounting for these arrangements and determined that these arrangements should be accounted for as off-balance sheet transactions. |
Investments in Affiliates
Investments in Affiliates | 12 Months Ended |
Dec. 31, 2021 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Investments in Affiliates | Investments in Affiliates Investments in affiliates as of December 31, 2021 and 2020 were as follows (in millions): 2021 2020 Finance joint ventures $ 359.2 $ 395.3 Manufacturing joint ventures 31.0 31.8 Other affiliates 23.3 15.6 $ 413.5 $ 442.7 The Company's finance joint ventures provide retail financing and wholesale financing to its dealers. The majority of the assets of the Company’s finance joint ventures represent finance receivables. The majority of the liabilities represent notes payable and accrued interest. Under the various joint venture agreements, Rabobank or its affiliates provide financing to the joint venture companies. AGCO has a 49% interest in the Company’s finance joint ventures (Note 14). The Company’s manufacturing joint ventures consist of Groupement International De Mecanique Agricole SA (“GIMA”) (a joint venture with a third-party manufacturer to purchase, design and manufacture components for agricultural equipment in France) and a joint venture with a third-party manufacturer to manufacture protein production equipment in China. The other joint ventures represent investments in farm equipment manufacturers, an electronic and software system manufacturer, precision agriculture technology providers, distributors and licensees. The Company’s equity in net earnings of affiliates for the years ended December 31, 2021, 2020 and 2019 were as follows (in millions): 2021 2020 2019 Finance joint ventures $ 64.4 $ 45.0 $ 41.5 Manufacturing and other joint ventures 1.2 0.5 1.0 $ 65.6 $ 45.5 $ 42.5 Summarized combined financial information of the Company’s finance joint ventures as of December 31, 2021 and 2020 and for the years ended December 31, 2021, 2020 and 2019 were as follows (in millions): As of December 31, 2021 2020 Total assets $ 7,863.6 $ 8,033.4 Total liabilities 7,130.5 7,226.7 Partners’ equity 733.1 806.7 For the Years Ended December 31, 2021 2020 2019 Revenues $ 411.1 $ 402.2 $ 417.6 Costs 228.1 274.0 299.9 Income before income taxes $ 183.0 $ 128.2 $ 117.7 At December 31, 2021 and 2020, the Company’s receivables from affiliates were approximately $55.1 million and $47.5 million, respectively. The receivables from affiliates are reflected within “Accounts and notes receivable, net” within the Company’s Consolidated Balance Sheets. The portion of the Company’s retained earnings balance that represents undistributed retained earnings of equity method investees was approximately $365.6 million and $375.5 million as of December 31, 2021 and 2020, respectively. During 2021, the Company received dividends of approximately $84.4 million from certain finance joint ventures. Approximately $22.7 million of these dividends were a return of investment in excess of earnings related to a certain finance joint venture. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The sources of income before income taxes and equity in net earnings of affiliates were as follows for the years ended December 31, 2021, 2020 and 2019 (in millions): 2021 2020 2019 United States $ 46.8 $ (73.4) $ (53.1) Foreign 897.5 635.4 314.2 Income before income taxes and equity in net earnings of affiliates $ 944.3 $ 562.0 $ 261.1 The provision for income taxes by location of the taxing jurisdiction for the years ended December 31, 2021, 2020 and 2019 consisted of the following (in millions): 2021 2020 2019 Current: United States $ 3.4 $ 4.1 $ (4.4) Foreign 222.9 180.2 170.1 226.3 184.3 165.7 Deferred: United States (70.0) 1.3 1.3 Foreign (47.9) 2.1 13.8 (117.9) 3.4 15.1 $ 108.4 $ 187.7 $ 180.8 The Company’s income tax provision as of December 31, 2021 includes the benefit of the reversals of approximately $67.8 million and $55.6 million related to valuation allowances previously established against the Company’s net deferred tax assets in the United States and Brazil, respectively. The Company recorded the reversal of a portion of the United States valuation allowance during the three months ended June 30, 2021, and the reversal of a portion of its Brazilian valuation allowance during the three months ended December 31, 2021. Improvements in income in the United States and Brazil during 2020 and 2021, along with updated future projected income levels, supported the reversal of both valuation allowances during those respective periods in 2021. During the three months ended September 30, 2019, the Company recorded a non-cash deferred income tax charge of approximately $53.7 million to establish a valuation allowance against its Brazilian net deferred income tax assets. Swiss tax reform was enacted during 2019 and eliminated certain preferential tax items as well as implemented new tax rates at both the federal and cantonal levels. During the three months ended December 31, 2019, the Company recognized a one-time income tax gain of approximately $21.8 million associated with the changing of Swiss federal and cantonal tax rates as well as recognition of a deferred tax asset associated with the estimated value of a tax basis step-up of the Company’s Swiss subsidiary’s assets. A reconciliation of income taxes computed at the United States federal statutory income tax rate (21% for 2021, 2020, and 2019) to the provision for income taxes reflected in the Company’s Consolidated Statements of Operations for the years ended December 31, 2021, 2020 and 2019 is as follows (in millions): 2021 2020 2019 Provision for income taxes at United States federal statutory rate $ 198.3 $ 118.0 $ 54.8 State and local income taxes, net of federal income tax effects 2.2 (3.5) (2.5) Taxes on foreign income which differ from the United States statutory rate 16.2 13.9 6.7 Tax effect of permanent differences (6.4) 13.4 63.9 Change in valuation allowance (130.8) 16.3 84.6 Change in tax contingency reserves 36.6 37.2 3.2 Research and development tax credits (7.4) (9.0) (7.1) Impacts related to changes in tax laws — — (21.8) Other (0.3) 1.4 (1.0) $ 108.4 $ 187.7 $ 180.8 The significant components of the deferred tax assets and liabilities at December 31, 2021 and 2020 were as follows (in millions): 2021 2020 Deferred Tax Assets: Net operating loss carryforwards $ 69.5 $ 62.9 Sales incentive discounts 40.1 50.8 Inventory valuation reserves 33.6 35.9 Pensions and postretirement health care benefits 18.5 55.8 Warranty and other reserves 102.9 126.3 Research and development tax credits 3.8 12.9 Foreign tax credits 9.4 5.9 Other 14.0 10.4 Total gross deferred tax assets 291.8 360.9 Valuation allowance (47.4) (181.0) Total deferred tax assets 244.4 179.9 Deferred Tax Liabilities: Tax over book depreciation and amortization 159.3 167.5 Investment in affiliates 24.4 33.1 Other 8.3 14.1 Total deferred tax liabilities 192.0 214.7 Net deferred tax assets (liabilities) $ 52.4 $ (34.8) Amounts recognized in Consolidated Balance Sheets: Deferred tax assets - noncurrent $ 169.3 $ 77.6 Deferred tax liabilities - noncurrent (116.9) (112.4) $ 52.4 $ (34.8) As reflected in the preceding table, the Company recorded a net deferred tax asset of $52.4 million as of December 31, 2021 and a net deferred tax liability of $34.8 million as of December 31, 2020, and had a valuation allowance against its gross deferred tax assets of approximately $47.4 million and $181.0 million as of December 31, 2021 and 2020, respectively. The Company maintains a valuation allowance to reserve a portion of its net deferred tax assets in the United States and certain foreign jurisdictions. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets may not be realized. The Company assessed the likelihood that its deferred tax assets would be recovered from estimated future taxable income and the current economic climate, as well as available tax planning strategies, and determined that all adjustments to the valuation allowance were appropriate. The Company believes it is more likely than not that it will realize its remaining net deferred tax assets, net of the valuation allowance, in future years. The Company had net operating loss carryforwards of $235.6 million as of December 31, 2021, with expiration dates as follows: 2022 - $14.2 million; 2023 - $23.9 million; 2024 and thereafter - $51.0 million and unlimited - $146.5 million. The net operating loss carryforwards of $235.6 million are entirely in tax jurisdictions outside of the United States. The amount of the Company's U.S. state net operating loss carryforwards is not material. The Company paid income taxes of $247.3 million, $181.4 million and $144.4 million for the years ended December 31, 2021, 2020 and 2019, respectively. The Company recognizes income tax benefits from uncertain tax positions only when there is a more than 50% likelihood that the tax positions will be sustained upon examination by the taxing authorities based on the technical merits of the positions. At December 31, 2021 and 2020, the Company had $246.4 million and $227.9 million, respectively, of unrecognized income tax benefits, all of which would affect the Company’s effective tax rate if recognized. At December 31, 2021 and 2020, the Company had approximately $40.1 million and $57.1 million, respectively, of accrued or deferred taxes related to uncertain income tax positions connected with ongoing income tax audits in various jurisdictions that it expects to settle or pay in the next 12 months. The Company accrued approximately $4.8 million and $7.1 million of interest and penalties related to unrecognized tax benefits in its provision for income taxes during 2021 and 2020, respectively. At December 31, 2021 and 2020, the Company had accrued interest and penalties related to unrecognized tax benefits of $32.7 million and $39.4 million, respectively. A reconciliation of the beginning and ending balances of the total amounts of gross unrecognized tax benefits as of and during the years ended December 31, 2021 and 2020 is as follows (in millions): 2021 2020 Gross unrecognized income tax benefits at the beginning of the year $ 227.9 $ 210.7 Additions for tax positions of the current year 43.0 32.0 Additions for tax positions of prior years 8.4 9.4 Reductions for tax positions of prior years for: Changes in judgments 3.2 9.1 Settlements during the year (19.1) (52.9) Lapses of applicable statute of limitations (0.6) (0.2) Foreign currency translation and other (16.4) 19.8 Gross unrecognized income tax benefits at the end of the year $ 246.4 $ 227.9 The reconciliation of gross unrecognized income tax benefits above for 2021 and 2020 excludes certain indirect favorable effects that relate to other tax jurisdictions of approximately $70.2 million and $64.1 million, respectively. The change in certain indirect favorable effects between 2021 and 2020 includes approximately $9.9 million related to additions and reductions for tax positions of current and prior years, changes in judgments and lapses of statutes of limitations. In addition, the gross unrecognized income tax benefits as of December 31, 2021 exclude certain deposits made in a foreign jurisdiction of approximately $6.7 million associated with an ongoing audit. The Company and its subsidiaries file income tax returns in the United States and in various state, local and foreign jurisdictions. The Company and its subsidiaries are routinely examined by tax authorities in these jurisdictions. As of December 31, 2021, a number of income tax examinations in foreign jurisdictions, as well as the United States, were ongoing. It is possible that certain of these ongoing examinations may be resolved within 12 months. Due to the potential for resolution of federal, state and foreign examinations, and the expiration of various statutes of limitation, it is reasonably possible that the Company’s gross unrecognized income tax benefits balance may materially change within the next 12 months. In certain foreign jurisdictions, there are either statutory expirations or the Company’s settlement expectations such that approximately |
Indebtedness
Indebtedness | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Indebtedness | Indebtedness Long-term debt consisted of the following at December 31, 2021 and 2020 (in millions): December 31, 2021 December 31, 2020 Senior term loan due 2022 $ — $ 184.0 Credit facility, expires 2023 — 277.9 1.002% Senior term loan due 2025 283.7 306.7 Senior term loans due between 2023 and 2028 (1) 445.9 806.0 0.800% Senior Notes Due 2028 680.8 — Other long-term debt 7.7 10.5 Debt issuance costs (4.8) (2.5) 1,413.3 1,582.6 Less: Senior term loans due 2021, net of debt issuance costs — (323.6) Current portion of other long-term debt (2.1) (2.3) Total long-term indebtedness, less current portion $ 1,411.2 $ 1,256.7 ____________________________________ (1) Maturity dates are reflected as of December 31, 2021. At December 31, 2021, the aggregate scheduled maturities of long-term debt, excluding the current portion of long-term debt, are as follows (in millions): 2023 $ 281.7 2024 2.3 2025 355.1 2026 59.7 Thereafter 712.4 $ 1,411.2 Cash payments for interest were approximately $23.8 million, $23.6 million and $26.3 million for the years ended December 31, 2021, 2020 and 2019, respectively. Current Indebtedness 0.800% Senior Notes Due 2028 On October 6, 2021, the Company issued €600.0 million (or approximately $680.8 million as of December 31, 2021) of senior notes at an issue price of 99.993%. The notes mature on October 6, 2028, and interest is payable annually, in arrears, at 0.800%. The senior notes contain covenants restricting, among other things, the incurrence of certain secured indebtedness. The senior notes are subject to both optional and mandatory redemption in certain events. During October 2021, the Company used the proceeds received from the senior notes to repay its €150.0 million (or approximately $173.4 million as of October 8, 2021) senior term loan due 2022, $370.0 million related to its multi-currency revolving credit facility, and two of its 2016 senior term loans due October 2021 with an aggregate amount outstanding of €192.0 million (or approximately $223.8 million as of October 19, 2021). In August 2021, prior to the issuance of the senior notes, the Company repaid two of its 2018 senior term loans due August 2021 with an aggregate amount of €72.0 million (or approximately $85.5 million as of August 1, 2021). Credit Facility In October 2018, the Company entered into a multi-currency revolving credit facility of $800.0 million. The maturity date of the credit facility is October 17, 2023. Interest accrues on amounts outstanding under the credit facility, at the Company’s option, at either (1) LIBOR plus a margin ranging from 0.875% to 1.875% based on the Company’s credit rating, or (2) the base rate, which is equal to the higher of (i) the administrative agent’s base lending rate for the applicable currency, (ii) the federal funds rate plus 0.5%, and (iii) one-month LIBOR for loans denominated in U.S. dollars plus 1.0%, plus a margin ranging from 0.0% to 0.875% based on the Company’s credit rating. The credit facility contains covenants restricting, among other things, the incurrence of indebtedness and the making of certain payments, including dividends. The Company also has to fulfill financial covenants with respect to a total debt to EBITDA ratio and an interest coverage ratio. As mentioned previously, on October 15, 2021, the Company repaid $370.0 million of its multicurrency revolving credit facility as a result of the issuance of our 0.800% senior notes due 2028. As of December 31, 2021 and 2020, the Company had no outstanding borrowings under the revolving credit facility and had the ability to borrow approximately $800.0 million under the facility. On April 9, 2020, the Company entered into an amendment to its $800.0 million multi-currency revolving credit facility to include incremental term loans (“2020 term loans”) that allow the Company to borrow an aggregate principal amount of €235.0 million and $267.5 million, respectively (or an aggregate amount of approximately $534.1 million as of December 31, 2021). Amounts can be drawn incrementally at any time prior to maturity, but must be drawn down proportionately. Amounts drawn must be in a minimum principal amount of $100.0 million and integral multiples of $50.0 million in excess thereof. Once amounts have been repaid, those amounts are not permitted to be re-drawn. The maturity date of the 2020 term loans is April 8, 2022. Interest accrues on amounts outstanding under the 2020 term loans, at the Company’s option, at either (1) LIBOR plus a margin based on the Company’s credit rating ranging from 1.125% to 2.125% until April 8, 2021 and ranging from 1.375% to 2.375% thereafter, or (2) the base rate, which is equal to the higher of (i) the administrative agent’s base lending rate for the applicable currency, (ii) the federal funds rate plus 0.5%, and (iii) one-month LIBOR for loans denominated in U.S. dollars plus 1.0%, plus a margin based on the Company’s credit rating ranging from 0.125% to 1.375% until April 8, 2021 and ranging from 0.375% to 1.375% thereafter. The 2020 term loans contain covenants restricting, among other things, the incurrence of indebtedness and the making of certain payments, including dividends. The Company also has to fulfill financial covenants with respect to a total debt to EBITDA ratio and an interest coverage ratio. On April 15, 2020, the Company borrowed €117.5 million and $133.8 million of 2020 term loans. The Company simultaneously repaid €100.0 million (or approximately $108.7 million) of its revolving credit facility from the borrowings received. There were no other borrowings on the 2020 term loans subsequent to the initial borrowings in April 2020. On February 16, 2021, the Company repaid the 2020 term loans of €117.5 million and $133.8 million (or an aggregate amount of approximately $276.0 million as of February 16, 2021). As of December 31, 2021, the Company had the ability to borrow approximately €117.5 million and $133.7 million of 2020 term loans (or an aggregate amount of approximately $267.0 million). As described above, the Company’s credit facility allows it to select from among various interest rate options. Due to the phase-out of LIBOR, LIBOR-based rates no longer will be available for borrowings denominated in U.S. dollars after December 31, 2022, and for loans denominated in other currencies after December 31, 2021. The rates reflected in the Company’s credit facility were designed to accommodate the discontinuation of LIBOR-based rates, and a shift to the “Secured Overnight Financing Rate” (“SOFR”) or a base rate, and, as such, the Company does not believe that moving to the other rates will have a materially adverse effect on the Company’s results of operations. In addition, the credit facility agreement also provides for an expedited amendment process once a replacement for LIBOR is established, which the Company may elect to utilize to add additional interest-rate alternatives. 1.002% Senior Term Loan Due 2025 On January 25, 2019, the Company borrowed €250.0 million (or approximately $283.7 million as of December 31, 2021) from the European Investment Bank. The loan matures on January 24, 2025. The Company is permitted to prepay the term loan before its maturity date. Interest is payable on the term loan at 1.002% per annum, payable semi-annually in arrears. Senior Term Loans Due Between 2023 and 2028 In October 2016, the Company borrowed an aggregate amount of €375.0 million through a group of seven related term loan agreements, and in August 2018, the Company borrowed an additional aggregate amount of €338.0 million through a group of another seven related term loan agreements. Of the 2016 term loans, an aggregate amount of €56.0 million (or approximately $61.1 million) was repaid upon maturity of two term loan agreements in October 2019. Additionally, as mentioned previously, the Company repaid €192.0 million (or approximately $223.8 million as of October 19, 2021) upon maturity of two of its 2016 senior term loans in October 2021. In August 2021, prior to the issuance of the senior notes due 2028, the Company repaid two of its 2018 senior term loans upon maturity with an aggregate amount of €72.0 million (or approximately $85.5 million as of August 1, 2021). On February 1, 2022, the Company repaid €72.5 million (or approximately $81.7 million) of one of its 2018 senior term loans due August 2023 with existing cash on hand. In aggregate, the Company had indebtedness of €393.0 million (or approximately $445.9 million as of December 31, 2021) through a group of eight remaining related term loan agreements. As of February 1, 2022, as a result of a further repayment discussed previously, the Company had indebtedness of €320.5 million (or approximately $361.0 million) through a group of seven remaining related term loan agreements. The provisions of the term loan agreements are substantially identical, with the exception of interest rate terms and maturities. As of December 31, 2021, for the term loans with a fixed interest rate, interest is payable in arrears on an annual basis, with interest rates ranging from 0.90% to 2.26% and maturity dates between August 2023 and August 2028. For the term loans with a floating interest rate, interest is payable in arrears on a semi-annual basis, with interest rates based on the EURIBOR plus a margin ranging from 0.90% to 1.25% and maturity dates between August 2023 and August 2025. The term loans contain covenants restricting, among other things, the incurrence of indebtedness and the making of certain payments, including dividends, and are subject to acceleration in the event of default. Former Indebtedness Senior Term Loan Due 2022 In October 2018, the Company entered in a term loan agreement with Rabobank in the amount of €150.0 million. The Company was permitted to prepay the term loan before its maturity date of October 28, 2022. Interest was payable on the term loan quarterly in arrears at an annual rate, equal to the EURIBOR plus a margin ranging from 0.875% to 1.875% based on the Company’s credit rating. The Company had to fulfill financial covenants with respect to a total debt to EBITDA ratio and an interest coverage ratio. As mentioned previously, during October 2021, the Company repaid its senior term loan of €150.0 million (or approximately $173.4 million as of October 8, 2021) with the proceeds from its 0.800% senior notes due 2028. Short-Term Borrowings As of December 31, 2021 and 2020, the Company had short-term borrowings due within one year of approximately $90.8 million and $33.8 million, respectively. Standby Letters of Credit and Similar Instruments The Company has arrangements with various banks to issue standby letters of credit or similar instruments, which guarantee the Company’s obligations for the purchase or sale of certain inventories and for potential claims exposure for insurance coverage. At December 31, 2021 and 2020, outstanding letters of credit totaled $14.6 million and $14.4 million, respectively. |
Employee Benefit Plans
Employee Benefit Plans | 12 Months Ended |
Dec. 31, 2021 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plans | Employee Benefit Plans The Company sponsors defined benefit pension plans covering certain employees, principally in the United Kingdom, the United States, Germany, Switzerland, Finland, France, Norway and Argentina. The Company also provides certain postretirement health care and life insurance benefits for certain employees, principally in the United States and Brazil. The Company also maintains an Executive Nonqualified Pension Plan (“ENPP”) that provides certain senior executives with retirement income for a period of 15 years or up to a lifetime annuity, if certain requirements are met. Benefits under the ENPP vest if the participant has attained age 50 and has at least ten years of service (including five years as a participant in the ENPP), but are not payable until the participant reaches age 65. The lifetime annuity benefit generally is available only to vested participants who retire on or after reaching age 65 and was eliminated during 2021 for participants reaching age 65 subsequent to December 31, 2022. The ENPP is an unfunded, nonqualified defined benefit pension plan. Net annual pension costs for the years ended December 31, 2021, 2020 and 2019 for the Company’s defined benefit pension plans and ENPP are set forth below (in millions): Pension benefits 2021 2020 2019 Service cost $ 15.0 $ 16.2 $ 15.5 Interest cost 12.6 16.5 20.7 Expected return on plan assets (31.3) (28.4) (28.1) Amortization of net actuarial losses 16.5 15.5 14.3 Amortization of prior service cost 0.7 2.1 1.6 Net loss recognized due to settlement 0.1 0.2 0.5 Curtailment gain (1) (1.2) — — Net annual pension cost $ 12.4 $ 22.1 $ 24.5 ___________________________________ (1) During 2021, the Company amended its Executive Nonqualified Pension Plan (“ENPP”) to freeze the plan as of December 31, 2024 to future salary benefit accruals, and to eliminate a lifetime annuity feature for participants reaching age 65 subsequent to December 31, 2022. This amendment resulted in a curtailment gain as well as a net prior service credit. The components of net periodic pension and postretirement benefits cost, other than the service cost component, are included in “Other expense, net” in the Company’s Consolidated Statements of Operations. The weighted average assumptions used to determine the net annual pension costs for the Company’s defined benefit pension plans and ENPP for the years ended December 31, 2021, 2020 and 2019 are as follows: 2021 2020 2019 All plans: Weighted average discount rate 1.5 % 2.0 % 2.8 % Weighted average expected long-term rate of return on plan assets 3.9 % 4.1 % 4.6 % Rate of increase in future compensation 1.5%-5.0% 1.8%-5.0% 1.8%-5.0% U.S.-based plans: Weighted average discount rate 2.75 % 3.45 % 4.35 % Weighted average expected long-term rate of return on plan assets (1) 5.0 % 5.0 % 5.5 % Rate of increase in future compensation (2) 5.0 % 5.0 % 5.0 % ___________________________________ (1) Applicable for U.S. funded, qualified plans. (2) Applicable for U.S. unfunded, nonqualified plan. For the Company’s Swiss cash balance plan, the interest crediting rate of 1.0% for both 2021 and 2020 was set equal to the current annual minimum rate set by the government for the mandatory portion of the account balance. Above mandatory amounts have an interest crediting rate of 0.25% for 2021 and 0.0% for 2020. Net annual postretirement benefit costs, and the weighted average discount rate used to determine them, for the years ended December 31, 2021, 2020 and 2019 are set forth below (in millions, except percentages): Postretirement benefits 2021 2020 2019 Service cost $ 0.1 $ 0.1 $ 0.1 Interest cost 0.9 1.2 1.3 Amortization of net actuarial losses 0.1 0.1 — Amortization of prior service cost 0.1 0.1 0.1 Net annual postretirement benefit cost $ 1.2 $ 1.5 $ 1.5 Weighted average discount rate 3.8 % 4.5 % 5.2 % The following tables set forth reconciliations of the changes in benefit obligation, plan assets and funded status as of December 31, 2021 and 2020 (in millions): Pension and ENPP Benefits Postretirement Benefits Change in benefit obligation 2021 2020 2021 2020 Benefit obligation at beginning of year $ 1,033.7 $ 917.3 $ 26.4 $ 29.4 Service cost 15.0 16.2 0.1 0.1 Interest cost 12.6 16.5 0.9 1.2 Plan participants’ contributions 1.4 1.3 — — Actuarial losses (gains) (70.7) 86.8 (3.7) (1.1) Amendments (13.6) (0.3) 0.4 — Curtailment (9.7) — — — Settlements (0.2) (0.3) — — Benefits paid (47.2) (44.6) (1.3) (1.5) Foreign currency exchange rate changes (16.5) 40.8 (0.2) (1.7) Benefit obligation at end of year $ 904.8 $ 1,033.7 $ 22.6 $ 26.4 Pension and ENPP Benefits Postretirement Benefits Change in plan assets 2021 2020 2021 2020 Fair value of plan assets at beginning of year $ 808.6 $ 711.0 $ — $ — Actual return on plan assets 27.7 76.6 — — Employer contributions 36.0 32.4 1.3 1.5 Plan participants’ contributions 1.4 1.3 — — Benefits paid (47.2) (44.6) (1.3) (1.5) Settlements (0.2) (0.3) — — Foreign currency exchange rate changes (10.7) 32.2 — — Fair value of plan assets at end of year $ 815.6 $ 808.6 $ — $ — Funded status $ (89.2) $ (225.1) $ (22.6) $ (26.4) Unrecognized net actuarial losses (gains) 291.7 385.1 (1.1) 2.6 Unrecognized prior service cost 7.1 20.1 3.2 2.9 Accumulated other comprehensive loss (298.8) (405.2) (2.1) (5.5) Net amount recognized $ (89.2) $ (225.1) $ (22.6) $ (26.4) Amounts recognized in Consolidated Other long-term asset $ 109.4 $ 13.2 $ — $ — Other current liabilities (7.1) (6.7) (1.5) (1.4) Accrued expenses (3.6) (3.2) — — Pensions and postretirement health care benefits (noncurrent) (187.9) (228.4) (21.1) (25.0) Net amount recognized $ (89.2) $ (225.1) $ (22.6) $ (26.4) The following table summarizes the activity in accumulated other comprehensive loss related to the Company’s ENPP and defined pension and postretirement benefit plans during the years ended December 31, 2021 and 2020 (in millions): Before-Tax Income After-Tax Accumulated other comprehensive loss as of December 31, 2019 $ (393.2) $ (96.8) $ (296.4) Prior service credit arising during the year 0.3 — 0.3 Net loss recognized due to settlement 0.3 — 0.3 Net actuarial loss arising during the year (37.8) (5.1) (32.7) Amortization of prior service cost 2.2 0.1 2.1 Amortization of net actuarial losses 15.7 2.6 13.1 Accumulated other comprehensive loss as of December 31, 2020 $ (412.5) $ (99.2) $ (313.3) Prior service credit arising during the year 13.1 3.1 10.0 Net loss recognized due to settlement 0.1 — 0.1 Net loss recognized due to curtailment 8.5 2.2 6.3 Net actuarial gain arising during the year 71.0 17.4 53.6 Amortization of prior service cost 0.8 0.2 0.6 Amortization of net actuarial losses 16.6 4.3 12.3 Accumulated other comprehensive loss as of December 31, 2021 $ (302.4) $ (72.0) $ (230.4) The unrecognized net actuarial losses included in accumulated other comprehensive loss related to the Company’s defined benefit pension plans and ENPP as of December 31, 2021 and 2020 are set forth below (in millions): 2021 2020 Unrecognized net actuarial losses $ 291.7 $ 385.1 The decrease in unrecognized net actuarial losses between years primarily resulted from higher discount rates at December 31, 2021 compared to December 31, 2020, as well as a result of the amendment to the Company's ENPP as previously discussed. The unrecognized net actuarial losses will be impacted in future periods by actual asset returns, discount rate changes, currency exchange rate fluctuations, actual demographic experience and certain other factors. For some of the Company’s defined benefit pension plans, these losses, to the extent they exceed 10% of the greater of the plan’s liabilities or the fair value of assets (“the gain/loss corridor”), will be amortized on a straight-line basis over the periods discussed as follows. For the Company’s U.S. salaried, U.S. hourly and U.K. defined benefit pension plans, the population covered is predominantly inactive participants, and losses related to those plans, to the extent they exceed the gain/loss corridor, will be amortized over the average remaining lives of those participants while covered by the respective plan. For the Company’s ENPP, the population is predominantly active participants, and losses related to the plan will be amortized over the average future working lifetime of the active participants expected to receive benefits. As of December 31, 2021, the average amortization periods were as follows: ENPP U.S. Plans U.K. Plan Average amortization period of losses related to defined benefit pension plans 7 years 14 years 19 years The following table summarizes the unrecognized prior service cost related to the Company’s defined benefit pension plans as of December 31, 2021 and 2020 (in millions): 2021 2020 Unrecognized prior service cost $ 7.1 $ 20.1 The decrease in the unrecognized prior service cost between years is due primarily to the amortization of unrecognized prior service cost related to prior plan amendments. The decrease also reflects the 2021 plan amendment to the Company's ENPP, as previously discussed. The amortization of unrecognized prior service cost during 2020 also included the initial amortization impacts of an amendment to the Company’s ENPP during 2019. The following table summarizes the unrecognized net actuarial (gains) losses included in the Company’s accumulated other comprehensive loss related to the Company’s U.S. and Brazilian postretirement health care benefit plans as of December 31, 2021 and 2020 (in millions): 2021 2020 Unrecognized net actuarial (gains) losses (1) $ (1.1) $ 2.6 ___________________________________ (1) Includes a gain of approximately $0.2 million and a loss of $1.0 million, respectively, related to the Company’s U.S. postretirement benefit plans. The unrecognized net actuarial gains related to the Company’s U.S. and Brazilian postretirement benefit plans was primarily due to liability gain due to the experience of the plans and assumption changes as of December 31, 2021 as compared to December 31, 2020. The unrecognized net actuarial gains or losses will be impacted in future periods by discount rate changes, actual demographic experience, actual health care inflation and certain other factors. These gains or losses, to the extent they exceed the gain/loss corridor, will be amortized on a straight-line basis over the average remaining service period of active employees expected to receive benefits, or the average remaining lives of inactive participants, covered under the postretirement benefit plans. As of December 31, 2021, the average amortization period was 10 years for the Company’s U.S. postretirement benefit plans. As of December 31, 2021 and 2020, the net prior service cost related to the Company’s Brazilian postretirement health care benefit plans was as follows (in millions): 2021 2020 Net prior service cost $ 3.2 $ 2.9 The following table summarizes the fair value of plan assets, aggregate projected benefit obligation and accumulated benefit obligation as of December 31, 2021 and 2020 for defined benefit pension plans, ENPP and other postretirement plans with accumulated benefit obligations in excess of plan assets (in millions): 2021 2020 All plans: Fair value of plan assets $ 43.4 $ 41.6 Projected benefit obligation 264.1 306.2 Accumulated benefit obligation 246.6 269.4 U.S.-based plans and ENPP: Fair value of plan assets $ 4.9 $ 5.1 Projected benefit obligation 130.9 157.4 Accumulated benefit obligation 125.4 135.4 The amounts for 2021 and 2020 disclosed above do not include the fair value of plan assets, the projected benefit obligation or the accumulated benefit obligation related to the Company’s U.K. plan. The Company’s U.K. plan’s fair value of plan assets was in excess of the plan’s accumulated benefit obligation as of December 31, 2021 and 2020. The Company’s accumulated comprehensive loss as of December 31, 2021 and 2020 reflects a reduction in equity related to the following items (in millions): 2021 2020 All plans: (1) Reduction in equity, net of taxes of $72.0 and $98.6 at December 31, 2021 and 2020, respectively $ 300.9 $ 410.8 GIMA joint venture: (2) Reduction in equity, net of taxes of $0.5 and $0.6 at December 31, 2021 and 2020, respectively 1.5 1.7 ______________________________________ (1) Primarily related to the Company’s U.K. pension plan. (2) These amounts represented 50% of GIMA’s unrecognized net actuarial losses and unrecognized prior service cost associated with its pension plan. In addition, GIMA recognized a net actuarial loss due to settlements of approximately $0.1 million in 2020. The Company’s defined benefit pension obligation has been reflected based on the manner in which its defined benefit plans are being administered. The obligation and resulting liability is calculated employing both actuarial and legal assumptions. These assumptions include, but are not limited to, future inflation, the return on pension assets, discount rates, life expectancy and potential salary increases. There are also assumptions related to the manner in which individual benefit plan benefits are calculated, some of which are legal in nature and include, but are not limited to, member eligibility, years of service and the uniformity of both guaranteed minimum pension benefits and member normal retirement ages for men and women. Some of these assumptions also are subject to the outcome of certain legal cases, which are currently unknown. In the event that any of these assumptions or the administration approach are proven to be different from the Company’s current interpretations and approach, there could be material increases in the Company’s defined benefit pension obligation and the related amounts and timing of future contributions to be paid by the Company. The weighted average assumptions used to determine the benefit obligation for the Company’s defined benefit pension plans and ENPP as of December 31, 2021 and 2020 are as follows: 2021 2020 All plans: Weighted average discount rate 1.9 % 1.5 % Rate of increase in future compensation 1.50%-5.0% 1.50%-5.0% U.S.-based plans: Weighted average discount rate 3.05 % 2.75 % Rate of increase in future compensation (1) 4.25 % 5.0 % ____________________________________ (1) Applicable for U.S. unfunded, nonqualified plan. The weighted average discount rate used to determine the benefit obligation for the Company’s postretirement benefit plans for the years ended December 31, 2021 and 2020 was 4.1% and 3.8%, respectively. For the years ended December 31, 2021, 2020 and 2019, the Company used a globally consistent methodology to set the discount rate in the countries where its largest benefit obligations exist. In the United States, the United Kingdom and the Euro Zone, the Company constructed a hypothetical bond portfolio of high-quality corporate bonds and then applied the cash flows of the Company’s benefit plans to those bond yields to derive a discount rate. The bond portfolio and plan-specific cash flows vary by country, but the methodology in which the portfolio is constructed is consistent. In the United States, the bond portfolio is large enough to result in taking a “settlement approach” to derive the discount rate, in which high-quality corporate bonds are assumed to be purchased and the resulting coupon payments and maturities are used to satisfy the Company’s U.S. pension plans’ projected benefit payments. In the United Kingdom and the Euro Zone, the discount rate is derived using a “yield curve approach,” in which an individual spot rate, or zero coupon bond yield, for each future annual period is developed to discount each future benefit payment and, thereby, determine the present value of all future payments. The Company uses a spot yield curve to determine the discount rate applicable in the United Kingdom to measure the U.K. pension plan’s service cost and interest cost. Under the settlement and yield curve approaches, the discount rate is set to equal the single discount rate that produces the same present value of all future payments. For measuring the expected U.S. postretirement benefit obligation at December 31, 2021, the Company assumed a 6.8% health care cost trend rate for 2022 decreasing to 5.0% by 2029. For measuring the expected U.S. postretirement benefit obligation at December 31, 2020, the Company assumed a 7.0% health care cost trend rate for 2021 decreasing to 5.0% by 2029. For measuring the Brazilian postretirement benefit plan obligation at December 31, 2021, the Company assumed a 9.96% health care cost trend rate for 2022, decreasing to 4.28% by 2033. For measuring the Brazilian postretirement benefit plan obligation at December 31, 2020, the Company assumed a 9.96% health care cost trend rate for 2021, decreasing to 4.28% by 2032. The Company currently estimates its minimum contributions and benefit payments to its U.S.-based underfunded defined benefit pension plans and unfunded ENPP for 2022 will aggregate approximately $5.0 million. The Company currently estimates its minimum contributions for underfunded plans and benefit payments for unfunded plans for 2022 to its non-U.S.-based defined benefit pension plans will aggregate approximately $31.3 million, of which approximately $21.1 million relates to its U.K. pension plan. The Company currently estimates its benefit payments for 2022 to its U.S.-based postretirement health care and life insurance benefit plans will aggregate approximately $1.5 million and its benefit payments for 2022 to its Brazilian postretirement health care benefit plans will aggregate less than $0.1 million. During 2021, approximately $47.4 million of benefit payments were made related to the Company’s defined benefit pension plans and ENPP. At December 31, 2021, the aggregate expected benefit payments for the Company’s defined benefit pension plans and ENPP are as follows (in millions): 2022 $ 53.2 2023 51.6 2024 51.8 2025 52.2 2026 52.5 2027 through 2031 279.1 $ 540.4 During 2021, approximately $1.3 million of benefit payments were made related to the Company’s U.S. and Brazilian postretirement benefit plans. At December 31, 2021, the aggregate expected benefit payments for the Company’s U.S. and Brazilian postretirement benefit plans are as follows (in millions): 2022 $ 1.5 2023 1.6 2024 1.6 2025 1.6 2026 1.6 2027 through 2031 7.5 $ 15.4 Investment Strategy and Concentration of Risk The weighted average asset allocation of the Company’s U.S. pension benefit plans as of December 31, 2021 and 2020 are as follows: Asset Category 2021 2020 Equity securities 14 % 36 % Fixed income securities 75 % 57 % Other investments 11 % 7 % Total 100 % 100 % The weighted average asset allocation of the Company’s non-U.S. pension benefit plans as of December 31, 2021 and 2020 are as follows: Asset Category 2021 2020 Equity securities 14 % 41 % Fixed income securities 80 % 53 % Other investments 6 % 6 % Total 100 % 100 % The Company categorizes its pension plan assets into one of three levels based on the assumptions used in valuing the asset. See Note 13 for a discussion of the fair value hierarchy as per the guidance in ASC 820, “Fair Value Measurements” (“ASC 820”). The Company’s valuation techniques are designed to maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses the following valuation methodologies to measure the fair value of its pension plan assets: • Equity Securities : Equity securities are valued on the basis of the closing price per unit on each business day as reported on the applicable exchange. Equity funds are valued using the net asset value of the fund, which is based on the fair value of the underlying securities. • Fixed Income : Fixed income securities are valued using the closing prices in the active market in which the fixed income investment trades. Fixed income funds are valued using the net asset value of the fund, which is based on the fair value of the underlying securities. • Cash : These investments primarily consist of short-term investment funds which are valued using the net asset value. • Alternative Investments : These investments are reported at fair value as determined by the general partner of the alternative investment. The “market approach” valuation technique is used to value investments in these funds. The funds typically are open-end funds as they generally offer subscription and redemption options to investors. The frequency of such subscriptions or redemptions is dictated by each fund’s governing documents. The amount of liquidity provided to investors in a particular fund generally is consistent with the liquidity and risk associated with the underlying portfolio (i.e., the more liquid the investments in the portfolio, the greater the liquidity provided to investors). Liquidity of individual funds varies based on various factors and may include “gates,” “holdbacks” and “side pockets” imposed by the manager of the fund, as well as redemption fees that may also apply. Investments in these funds typically are valued utilizing the net asset valuations provided by their underlying investment managers, general partners or administrators. The funds consider subscription and redemption rights, including any restrictions on the disposition of the interest, in its determination of the fair value. • Insurance Contracts : Insurance contracts are valued using current prevailing interest rates. The fair value of the Company’s pension assets as of December 31, 2021 is as follows (in millions): Total Level 1 Level 2 Level 3 Equity securities: Global equities $ 102.5 $ 18.2 $ 84.3 $ — U.S. large cap equities 5.6 5.6 — — Total equity securities 108.1 23.8 84.3 — Fixed income: Aggregate fixed income 615.9 615.9 — — Total fixed income share (1) 615.9 615.9 — — Alternative investments: Private equity fund 3.5 — — 3.5 Hedge funds measured at net asset value (4) 41.7 — — — Total alternative investments (2) 45.2 — — 3.5 Miscellaneous funds (3) 40.2 — — 40.2 Cash and equivalents measured at net asset value (4) 6.2 — — — Total assets $ 815.6 $ 639.7 $ 84.3 $ 43.7 ______________________________________ (1) 50% of "fixed income" securities are in government treasuries; 20% are in foreign securities; 13% are in investment-grade corporate bonds; 8% are in high-yield securities; 6% are in other various fixed income securities and 3% are in asset-backed and mortgage-backed securities. (2) 42% of “alternative investments” are in relative value funds; 28% are in long-short equity funds; 14% are in event-driven funds; 8% are in credit funds; and 8% are distributed in hedged and non-hedged funds. (3) “Miscellaneous funds” is comprised of insurance contracts in Finland, Norway and Switzerland. (4) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The following is a reconciliation of Level 3 assets as of December 31, 2021 (in millions): Total Alternative Investments Miscellaneous Funds Beginning balance as of December 31, 2020 $ 38.7 $ 2.1 $ 36.6 Actual return on plan assets: (a) Relating to assets still held at reporting date 3.3 1.4 1.9 (b) Relating to assets sold during period — — — Purchases, sales and /or settlements 4.7 — 4.7 Foreign currency exchange rate changes (3.0) — (3.0) Ending balance as of December 31, 2021 $ 43.7 $ 3.5 $ 40.2 The fair value of the Company’s pension assets as of December 31, 2020 is as follows (in millions): Total Level 1 Level 2 Level 3 Equity securities: Global equities $ 235.3 $ 156.5 $ 78.8 $ — Non-U.S. equities 4.7 4.7 — — U.K. equities 65.2 65.2 — — U.S. large cap equities 5.2 5.2 — — U.S. small cap equities 3.9 3.9 — — Total equity securities 314.3 235.5 78.8 — Fixed income: Aggregate fixed income 162.9 162.9 — — International fixed income 249.5 249.5 — — Total fixed income share (1) 412.4 412.4 — — Alternative investments: Private equity fund 2.1 — — 2.1 Hedge funds measured at net asset value (4) 38.5 — — — Total alternative investments (2) 40.6 — — 2.1 Miscellaneous funds (3) 36.6 — — 36.6 Cash and equivalents measured at net asset value (4) 4.7 — — — Total assets $ 808.6 $ 647.9 $ 78.8 $ 38.7 _______________________________________ (1) 44% of “fixed income” securities are in investment-grade corporate bonds; 20% are in government treasuries; 11% are in high-yield securities; 10% are in foreign securities; 6% are in asset-backed and mortgage-backed securities; and 9% are in other various fixed income securities. (2) 42% of “alternative investments” are in relative value funds; 25% are in long-short equity funds; 14% are in event-driven funds; 5% are distributed in hedged and non-hedged funds; and 14% are in credit funds. (3) “Miscellaneous funds” is comprised of insurance contracts in Finland, Norway and Switzerland. (4) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The following is a reconciliation of Level 3 assets as of December 31, 2020 (in millions): Total Alternative Investments Miscellaneous Funds Beginning balance as of December 31, 2019 $ 33.1 $ 2.3 $ 30.8 Actual return on plan assets: (a) Relating to assets still held at reporting date 0.1 (0.2) 0.3 (b) Relating to assets sold during period — — — Purchases, sales and /or settlements 2.4 — 2.4 Foreign currency exchange rate changes 3.1 — 3.1 Ending balance as of December 31, 2020 $ 38.7 $ 2.1 $ 36.6 All tax-qualified pension fund investments in the United States are held in the AGCO Corporation Master Pension Trust. The Company’s global pension fund strategy is to diversify investments across broad categories of equity and fixed income securities with appropriate use of alternative investment categories to minimize risk and volatility. The primary investment objective of the Company’s pension plans is to secure participant retirement benefits. As such, the key objective in the pension plans’ financial management is to promote stability and, to the extent appropriate, growth in funded status. The investment strategy for the plans’ portfolio of assets balances the requirement to generate returns with the need to control risk. The asset mix is recognized as the primary mechanism to influence the reward and risk structure of the pension fund investments in an effort to accomplish the plans’ funding objectives. The overall investment strategies and target allocations of retirement fund investments for the Company’s U.S.-based pension plans and the non-U.S. based pension plans are as follows: U.S. Pension Plans Non-U.S. Pension Plans (1) Overall investment strategies: (2) Assets for the near-term benefit payments 80.0 % 82.5 % Assets for longer-term growth 20.0 % 17.5 % Total 100.0 % 100.0 % Target allocations: Equity securities 17.0 % 12.5 % Fixed income securities 75.0 % 82.5 % Alternative investments 3.0 % 5.0 % Cash and cash equivalents 5.0 % — % Total 100.0 % 100.0 % _______________________________________ (1) The majority of the Company’s non-U.S. pension fund investments are related to the Company’s pension plan in the United Kingdom. (2) The overall U.S. and non-U.S. pension funds invest in a broad diversification of asset types. The Company has noted that over very long periods, this mix of investments would achieve an average return on its U.S.-based pension plans of approximately 4.87%. In arriving at the choice of an expected return assumption of 4.25% for its U.S. plans for the year ended December 31, 2022, the Company has tempered this historical indicator with lower expectations for returns and changes to investments in the future as well as the administrative costs of the plans. The Company has noted that over very long periods, this mix of investments would achieve an average return on its non-U.S. based pension plans of approximately 2.50%. In arriving at the choice of an expected return assumption of 2.25% for its U.K.-based plans for the year ended December 31, 2022, the Company has tempered this historical indicator with lower expectations for returns and changes to investments in the future as well as the administrative costs of the plans. Equity securities primarily include investments in large-cap and small-cap companies located across the globe. Fixed income securities include corporate bonds of companies from diversified industries, mortgage-backed securities, agency mortgages, asset-backed securities and government securities. Alternative and other assets include investments in hedge fund of funds that follow diversified investment strategies. To date, the Company has not invested pension funds in its own stock and has no intention of doing so in the future. Within each asset class, careful consideration is given to balancing the portfolio among industry sectors, geographies, interest rate sensitivity, dependence on economic growth, currency and other factors affecting investment returns. The assets are managed by professional investment firms, who are bound by precise mandates and are measured against specific benchmarks. Among asset managers, consideration is given, among others, to balancing security concentration, issuer concentration, investment style and reliance on particular active investment strategies. The Company participates in a small number of multiemployer plans in the Netherlands and Sweden. The Company has assessed and determined that none of the multiemployer plans which it participates in are individually, or in the aggregate, significant to the Company’s Consolidated Financial Statements. The Company does not expect to incur a withdrawal liability or expect to significantly increase its contributions over the remainder of the multiemployer plans’ contract periods. The Company maintains separate defined contribution plans covering certain employees and executives, primarily in the United States, the United Kingdom and Brazil. Under the plans, the Company contributes a specified percentage of each eligible employee’s compensation. The Company contributed approximately $16.9 million, $15.4 million and $15.8 million for the years ended December 31, 2021, 2020 and 2019, respectively. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2021 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders’ Equity Common Stock At December 31, 2021, the Company had 150,000,000 authorized shares of common stock with a par value of $0.01 per share, with approximately 74,441,312 shares of common stock outstanding and approximately 4,000,968 shares reserved for issuance under the Company’s 2006 Long-Term Incentive Plan (the “Plan”) (See Note 10). Share Repurchase Program In August and November 2021, the Company entered into two accelerated share repurchase ("ASR") agreements with financial institutions to repurchase an aggregate of $135.0 million of shares of its common stock. The Company received approximately 952,204 shares associated with these transactions as of December 31, 2021. On January 19, 2022, the Company received additional 113,824 shares upon final settlement of its November 2021 ASR agreement. In February and March 2020, the Company entered into two ASR agreements with financial institutions to repurchase an aggregate of $55.0 million of shares of its common stock. The Company received approximately 970,141 shares in these transactions as of December 31, 2020. All shares received under the ASR agreements were retired upon receipt, and the excess of the purchase price over par value per share was recorded to a combination of “Additional paid-in capital” and “Retained earnings” within our Consolidated Balance Sheets. As of December 31, 2021, the remaining amount authorized to be repurchased under board-approved share repurchase authorizations was approximately $110.0 million, which has no expiration date. Dividends The Company’s Board of Directors has declared and the Company has paid cash dividends per common share during the following years: 2021 (1)(2) 2020 (2) 2019 (2) Dividends declared and paid per common share $ 4.74 $ 0.63 $ 0.63 ____________________________________ (1) The Company’s Board of Directors declared and the Company has paid quarterly cash dividends of $0.20 per common share beginning in the second quarter of 2021, from $0.16 per common share in the first quarter of 2021. On January 20, 2022, the Company's Board of Directors approved a quarterly dividend of $0.20 per common share outstanding commencing in the first quarter of 2022. In addition, the Company's Board of Directors also declared and the Company paid a special cash dividend of $4.00 per common share during 2021 totaling approximately $301.5 million. (2) The Company’s Board of Directors declared and the Company has paid quarterly cash dividends of $0.16 per common share beginning in the second quarter of 2019, from $0.15 per common share in the first quarter of 2019, through the first quarter of 2021. Accumulated Other Comprehensive Loss The following table sets forth changes in accumulated other comprehensive loss by component, net of tax, attributed to AGCO Corporation and its subsidiaries for the years ended December 31, 2021 and 2020 (in millions): Defined Benefit Pension Plans Cumulative Translation Adjustment Deferred Net Gains (Losses) on Derivatives Total Accumulated other comprehensive loss, December 31, 2019 $ (296.4) $ (1,297.5) $ (1.3) $ (1,595.2) Other comprehensive (loss) income before reclassifications (32.1) (197.5) 5.1 (224.5) Net losses (gains) reclassified from accumulated other comprehensive loss 15.2 — (6.3) 8.9 Other comprehensive loss, net of reclassification adjustments (16.9) (197.5) (1.2) (215.6) Accumulated other comprehensive loss, December 31, 2020 (313.3) (1,495.0) (2.5) (1,810.8) Other comprehensive income (loss) before reclassifications 70.0 (45.1) 5.1 30.0 Net losses (gains) reclassified from accumulated other comprehensive income (loss) 12.9 — (3.0) 9.9 Other comprehensive income (loss), net of reclassification adjustments 82.9 (45.1) 2.1 39.9 Accumulated other comprehensive loss, December 31, 2021 $ (230.4) $ (1,540.1) $ (0.4) $ (1,770.9) The following table sets forth reclassification adjustments out of accumulated other comprehensive loss by component attributed to AGCO Corporation and its subsidiaries for the years ended December 31, 2021 and 2020 (in millions): Details about Accumulated Other Comprehensive Loss Components Amount Reclassified from Accumulated Other Comprehensive Loss Affected Line Item within the Consolidated Year ended December 31, 2021 (1) Year ended December 31, 2020 (1) Derivatives: Net losses (gains) on foreign currency contracts $ 11.4 $ (6.4) Cost of goods sold Net gains on commodity contracts (17.2) — Cost of goods sold Reclassification before tax (5.8) (6.4) 2.8 0.1 Income tax provision Reclassification net of tax $ (3.0) $ (6.3) Defined benefit pension plans: Amortization of net actuarial losses $ 16.6 $ 15.7 Other expense, net (2) Amortization of prior service cost 0.8 2.2 Other expense, net (2) Reclassification before tax 17.4 17.9 (4.5) (2.7) Income tax provision Reclassification net of tax $ 12.9 $ 15.2 Net losses reclassified from accumulated other comprehensive loss $ 9.9 $ 8.9 ____________________________________ (1) (Gains) losses included within the Consolidated Statements of Operations for the years ended December 31, 2021 and 2020, respectively. (2) These accumulated other comprehensive loss components are included in the computation of net periodic pension and postretirement benefit cost. See Note 8 to the Company’s Consolidated Financial Statements. |
Stock Incentive Plan
Stock Incentive Plan | 12 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Stock Incentive Plan | Stock Incentive Plan Under the Plan, up to 10,000,000 shares of AGCO’s common stock may be issued. As of December 31, 2021, of the 10,000,000 shares reserved for issuance under the Plan, approximately 4,000,968 shares remained available for grant, assuming the maximum number of shares are earned related to the performance award grants discussed below. The Plan allows the Company, under the direction of the Board of Directors’ Compensation Committee, to make grants of performance shares, stock appreciation rights, restricted stock units and restricted stock awards to employees, officers and non-employee directors of the Company. Long-Term Incentive Plan and Related Performance Awards The Company’s primary long-term incentive plan is a performance share plan that provides for awards of shares of the Company’s common stock based on achieving financial targets, such as targets for return on invested capital, operating margins, return on net assets and revenue growth, as determined by the Company’s Board of Directors. The stock awards under the Plan are earned over a performance period, and the number of shares earned is determined based on annual cumulative or average results for the specified period, depending on the measurement. Performance periods for the Company’s primary long-term incentive plan are consecutive and overlapping three-year cycles, and performance targets are set at the beginning of each cycle. The primary long-term incentive plan provides for participants to earn 33% to 200% of the target awards depending on the actual performance achieved, with no shares earned if performance is below the established minimum target. Awards earned under the Plan are paid in shares of common stock at the end of each three-year performance period. The percentage level achievement is determined annually or over the three-year cycle in aggregate, with the ultimate award that is earned determined based upon the average of the three annual percentages. The 2021 grant of performance award shares is subject to a total shareholder return modifier. The compensation expense associated with these awards is amortized ratably over the vesting or performance period based on the Company’s projected assessment of the level of performance that will be achieved and earned. During 2021, the Company granted 281,310 performance awards related to varying performance periods. Compensation expense recorded during 2021, 2020 and 2019 with respect to awards granted was based upon the fair value as of the grant date. For the 2021 awards that included a market condition, the Company measured the fair value using a Monte Carlo simulation. The weighted average grant-date fair value of performance awards granted under the Plan during 2021, 2020 and 2019 was as follows: Years Ended December 31, 2021 2020 2019 Weighted average grant-date fair value $ 123.33 $ 70.84 $ 61.01 Performance award transactions during 2021 were as follows and are presented as if the Company were to achieve its maximum levels of performance under the plan: Shares awarded but not earned at January 1 582,952 Shares awarded 281,310 Shares forfeited (40,350) Shares earned (309,198) Shares awarded but not earned at December 31 514,714 Based on the level of performance achieved as of December 31, 2021, 330,174 shares were earned under the related performance period, including 97,818 shares earned as of December 31, 2020 related to certain retirees and other individuals. 330,174 shares were issued in February 2022, net of 125,363 shares that were withheld for taxes related to the earned awards. The Plan allows for the participant to have the option of forfeiting a portion of the shares awarded in lieu of a cash payment contributed to the participant’s tax withholding to satisfy the participant’s statutory minimum federal, state and employment taxes which would be payable at the time of grant. I n addition, assuming the maximum target levels of performance achieved, there were 59,182 shares earned as of December 31, 2021 related to certain retirees and other individuals that will be issued at the end of the relevant performance periods based on the ultimate level of performance achieved with respect to those periods. As of December 31, 2021, the total compensatio n cost related to unearned performance awards not yet recognized, assuming the Company’s current projected assessment of the level of performance that will be achieved, was approximately $20.6 million , and the weighted average period over which it is expected to be recognized is approximately one and one-half years. This estimate is based on the current projected levels of performance of outstanding awards. The compensation cost not yet recognized could be higher or lower based on actual achieved levels of performance. Restricted Stock Units During the year ended December 31, 2021, the Company granted 92,848 restricted stock unit (“RSU”) awards. These awards entitle the participant to receive one share of the Company’s common stock for each RSU granted and vest one-third per year over a three-year requisite service period. The 2020 grant of RSUs to certain executives has a three-year cliff vesting requirement subject to adjustment based on a total shareholders return metric relative to the Company's defined peer group. The compensation expense associated with all RSU awards is being amortized ratably over the requisite service period for the awards that are expected to vest. The weighted average grant-date fair value of the RSUs granted under the Plan during the years ended December 31, 2021, 2020 and 2019 were $113.91, $70.83 and $61.01, respectively. RSU transactions during the year ended December 31, 2021 were as follows: Shares awarded but not vested at January 1 143,287 Shares awarded 92,848 Shares forfeited (9,797) Shares vested (67,110) Shares awarded but not vested at December 31 159,228 A majority of the 67,110 shares vested with respect to RSU awards during 2021 were issued in January 2021. 3,830 shares earned during 2021 related to certain retirees. During January 2022, 44,991 RSUs shares were issued, net of 23,726 shares that were withheld for taxes. The Plan allows for the participant to have the option of forfeiting a portion of the shares awarded in lieu of a cash payment contributed to the participant's tax withholding to satisfy the participant's statutory minimum federal, state and employment taxes which would be payable at the time of grant. As of December 31, 2021, the total compensation cost related to the unvested RSUs not yet recognized was approximately $8.5 million, and the weighted average period over which it is expected to be recognized is approximately one and one-half years. Stock-settled Appreciation Rights Certain executives and key managers were eligible to receive grants of SSARs through the year ended December 31, 2020. The Company did not grant any SSARs during the year ended December 31, 2021. The SSARs provide a participant with the right to receive the aggregate appreciation in stock price over the market price of the Company’s common stock at the date of grant, payable in shares of the Company’s common stock. The participant may exercise his or her SSARs at any time after the grant is vested but no later than seven years after the date of grant. The SSARs vest ratably over a four-year period from the date of grant. SSAR awards made to certain executives and key managers under the Plan are made with the base price equal to the price of the Company’s common stock on the date of grant. The Company recorded stock compensation expense of approximately $0.8 million, $1.9 million and $2.4 million associated with SSAR awards during 2021, 2020 and 2019, respectively. The compensation expense associated with these awards is being amortized ratably over the vesting period. The Company estimated the fair value of the grants using the Black-Scholes option pricing model. The weighted average grant-date fair value of SSAR awards granted under the Plan and the weighted average assumptions under the Black-Scholes option model were as follows for the years ended December 31, 2020 and 2019: 2020 2019 Weighted average grant-date fair value $ 12.31 $ 11.34 Weighted average assumptions under Black-Scholes option model: Expected life of awards (years) 3.0 3.0 Risk-free interest rate 1.5 % 2.6 % Expected volatility 24.1 % 24.2 % Expected dividend yield 0.9 % 1.0 % SSAR transactions during the year ended December 31, 2021 were as follows: SSARs outstanding at January 1 403,150 SSARs granted — SSARs exercised (194,661) SSARs canceled or forfeited (13,878) SSARs outstanding at December 31 194,611 SSAR price ranges per share: Granted $ — Exercised 43.88 - 73.14 Canceled or forfeited 46.58 - 73.14 Weighted average SSAR exercise prices per share: Granted $ — Exercised 64.41 Canceled or forfeited 68.51 Outstanding at December 31 68.33 At December 31, 2021, the weighted average remaining contractual life of SSARs outstanding was approximately four years. As of December 31, 2021, the total compensation cost related to unvested SSARs not yet recognized was approximately $0.8 million and the weighted-average period over which it is expected to be recognized is approximately one and one-half years. The following table sets forth the exercise price range, number of shares, weighted average exercise price, and remaining contractual lives by groups of similar price as of December 31, 2021: SSARs Outstanding SSARs Exercisable Range of Exercise Prices Number of Weighted Average Weighted Average Exercisable as of December 31, 2021 Weighted Average $46.58 - $63.47 80,523 3.51 $ 61.91 38,923 $ 60.91 $72.74 - $73.14 114,088 4.41 $ 72.86 35,013 $ 72.99 194,611 73,936 $ 66.63 The total fair value of SSARs vested during 2021 was approximately $1.5 million. There were 120,675 SSARs that were not vested as of December 31, 2021. The total intrinsic value of outstanding and exercisable SSARs as of December 31, 2021 was $9.3 million and $3.7 million, respectively. The total intrinsic value of SSARs exercised during 2021 was approximately $13.6 million. The excess tax benefit realized for tax deductions in the United States related to the exercise of SSARs, vesting of RSU awards and vesting of performance awards under the Plan was approximately $3.3 million for the year ended December 31, 2021. The excess tax benefit realized for tax deductions in the United States related to the exercise of SSARs and vesting of RSU awards and vesting of performance awards under the Plan was approximately $2.5 million for the year ended December 31, 2020. The excess tax benefit realized for tax deductions in the United States related to the exercise of SSARs and vesting of RSU awards and vesting of performance awards under the Plan was approximately $2.7 million for the year ended December 31, 2019. The Company realized an insignificant tax benefit from the exercise of SSARs, vesting of performance awards and vesting of RSU awards in certain foreign jurisdictions during the years ended December 31, 2021, 2020 and 2019. On January 20, 2022, the Company granted 137,283 performance award shares (subject to the Company achieving future target levels of performance) and 91,583 RSUs under the Plan. The 2022 grant of performance award shares is subject to a total shareholder return modifier. Director Restricted Stock Grants Pursuant to the Plan, all non-employee directors receive annual restricted stock grants of the Company’s common stock. All restricted stock grants made to the Company’s directors are restricted as to transferability for a period of one year. In the event a director departs from the Company’s Board of Directors, the non-transferability period expires immediately. The plan allows each director to have the option of forfeiting a portion of the shares awarded in lieu of a cash payment contributed to the participant’s tax withholding to satisfy the statutory minimum federal, state and employment taxes that would be payable at the time of grant. The 2021 grant was made on April 22, 2021 and equated to 9,117 shares of common stock, of which 7,899 shares of common stock were issued, after shares were withheld for taxes. The Company recorded stock compensation expense of approximately $1.4 million during 2021 associated with these grants. |
Derivative Instruments and Hedg
Derivative Instruments and Hedging Activities | 12 Months Ended |
Dec. 31, 2021 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments and Hedging Activities | Derivative Instruments and Hedging Activities The Company attempts to manage its transactional foreign exchange exposure by hedging foreign currency cash flow forecasts and commitments arising from the anticipated settlement of receivables and payables and from future purchases and sales. Where naturally offsetting currency positions do not occur, the Company hedges certain, but not all, of its exposures through the use of foreign currency contracts. The Company’s translation exposure resulting from translating the financial statements of foreign subsidiaries into United States dollars may be partially hedged from time to time. When practical, the translation impact is reduced by financing local operations with local borrowings. The Company uses floating rate and fixed rate debt to finance its operations. The floating rate debt obligations expose the Company to variability in interest payments due to changes in the EURIBOR, LIBOR or other applicable benchmark interest rates such as SOFR upon the discontinuation of LIBOR. The Company believes it is prudent to limit the variability of a portion of its interest payments, and to meet that objective, the Company periodically enters into interest rate swaps to manage the interest rate risk associated with the Company’s borrowings. The Company designates interest rate contracts used to convert the interest rate exposure on a portion of the Company’s debt portfolio from a floating rate to a fixed rate as cash flow hedges, while those contracts converting the Company’s interest rate exposure from a fixed rate to a floating rate are designated as fair value hedges. To protect the value of the Company’s investment in foreign operations against adverse changes in foreign currency exchange rates, the Company from time to time, may hedge a portion of the Company’s net investment in the foreign subsidiaries by using a cross currency swap. The component of the gains and losses on the Company’s net investment in the designated foreign operations driven by changes in foreign exchange rates are economically offset by movements in the fair value of the cross currency swap contracts. The Company is exposed to commodity risk from steel and other raw material purchases where a portion of the contractual purchase price is linked to a variable rate based on publicly available market data. From time to time, the Company enters into cash flow hedges to mitigate its exposure to variability in commodity prices. The Company’s senior management establishes the Company’s foreign currency and interest rate risk management policies. These policies are reviewed periodically by the Finance Committee of the Company’s Board of Directors. The policies allow for the use of derivative instruments to hedge exposures to movements in foreign currency and interest rates. The Company’s policies prohibit the use of derivative instruments for speculative purposes. All derivatives are recognized on the Company’s Consolidated Balance Sheets at fair value. On the date the derivative contract is entered into, the Company designates the derivative as either (1) a cash flow hedge of a forecasted transaction, (2) a fair value hedge of a recognized liability, (3) a hedge of a net investment in a foreign operation, or (4) a non-designated derivative instrument. The Company categorizes its derivative assets and liabilities into one of three levels based on the assumptions used in valuing the asset or liability. See Note 13 for a discussion of the fair value hierarchy as per the guidance in ASC 820. The Company’s valuation techniques are designed to maximize the use of observable inputs and minimize the use of unobservable inputs. Counterparty Risk The Company regularly monitors the counterparty risk and credit ratings of all the counterparties to the derivative instruments. The Company believes that its exposures are appropriately diversified across counterparties and that these counterparties are creditworthy financial institutions. If the Company perceives any risk with a counterparty, then the Company would cease to do business with that counterparty. There have been no negative impacts to the Company from any non-performance of any counterparties. Derivative Transactions Designated as Hedging Instruments Cash Flow Hedges Foreign Currency Contracts The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency exchange rates. The changes in the fair values of these cash flow hedges are recorded in accumulated other comprehensive loss and are subsequently reclassified into “Cost of goods sold” during the period the sales and purchases are recognized. These amounts offset the effect of the changes in foreign currency rates on the related sale and purchase transactions. During 2021, 2020 and 2019, the Company designated certain foreign currency contracts as cash flow hedges of expected future sales and purchases. The Company did not have any derivatives that were designated as cash flow hedges related to foreign currency contracts as of December 31, 2021. The total notional value of derivatives that were designated as cash flow hedges was $395.8 million as of December 31, 2020. Steel Commodity Contracts In December 2020, the Company designated certain steel commodity contracts as cash flow hedges of expected future purchases of steel. The total notional value of derivatives that were designated as cash flow hedges was approximately $31.9 million and $14.7 million as of December 31, 2021 and 2020, respectively. The following table summarizes the after-tax impact that changes in the fair value of derivatives designated as cash flow hedges had on accumulated other comprehensive loss and net income during 2021, 2020 and 2019 (in millions): Recognized in Net Income Gain (Loss) Recognized in Accumulated Classification of Gain (Loss) Gain (Loss) Reclassified from Accumulated Total Amount of the Line Item in the Consolidated Statements of Operations Containing Hedge Gains (Losses) 2021 Foreign currency contracts $ (7.4) Cost of goods sold $ (10.2) $ 8,566.0 Commodity contracts (1) 12.5 Cost of goods sold 13.2 $ 8,566.0 Total $ 5.1 $ 3.0 2020 Foreign currency contracts $ 4.6 Cost of goods sold $ 6.3 $ 7,092.2 Commodity contracts (1) 0.5 Cost of goods sold — $ 7,092.2 Total $ 5.1 $ 6.3 2019 Foreign currency contracts $ (2.6) Cost of goods sold $ 0.1 $ 7,057.1 (1) The outstanding contracts as of December 31, 2021 range in maturity through July 2022. The following table summarizes the activity in accumulated other comprehensive loss related to the derivatives held by the Company during the years ended December 31, 2021, 2020 and 2019 (in millions): Before-Tax Income After-Tax Accumulated derivative net gains as of December 31, 2018 $ 1.6 $ 0.2 $ 1.4 Net changes in fair value of derivatives (3.0) (0.4) (2.6) Net gains reclassified from accumulated other comprehensive loss into income (0.1) — (0.1) Accumulated derivative net losses as of December 31, 2019 $ (1.5) $ (0.2) $ (1.3) Net changes in fair value of derivatives 4.9 (0.2) 5.1 Net gains reclassified from accumulated other comprehensive loss into income (6.4) (0.1) (6.3) Accumulated derivative net losses as of December 31, 2020 $ (3.0) $ (0.5) $ (2.5) Net changes in fair value of derivatives 8.3 3.2 5.1 Net gains reclassified from accumulated other comprehensive loss into income (5.8) (2.8) (3.0) Accumulated derivative net losses as of December 31, 2021 (1) $ (0.5) $ (0.1) $ (0.4) (1) As of December 31, 2021, approximately $0.2 million of derivative realized net losses and approximately $1.5 million of derivative realized net gains, before taxes, remain in accumulated other comprehensive loss related to foreign currency contracts and commodity contracts, respectively, associated with inventory that had not yet been sold. Net Investment Hedges The Company uses non-derivative and derivative instruments, to hedge a portion of its net investment in foreign operations against adverse movements in exchange rates. For instruments that are designated as hedges of net investments in foreign operations, changes in the fair value of the derivative instruments are recorded in foreign currency translation adjustments, a component of accumulated other comprehensive loss, to offset changes in the value of the net investments being hedged. When the net investment in foreign operations is sold or substantially liquidates, the amounts recorded in accumulated other comprehensive loss are reclassified to earnings. To the extent foreign currency denominated debt is de-designated from a net investment hedge relationship, changes in the value of the foreign currency denominated debt are recorded in earnings through the maturity date. In January 2018, the Company entered into a cross currency swap contract as a hedge of its net investment in foreign operations to offset foreign currency translation gains or losses on the net investment. The cross currency swap expired on January 19, 2021. At maturity of the cross currency swap contract, the Company delivered the notional amount of approximately €245.7 million (or approximately $297.1 million as of January 19, 2021) and received $300.0 million from the counterparties, resulting in a gain of approximately $2.9 million that was recognized in accumulated other comprehensive loss. The Company received quarterly interest payments from the counterparties based on a fixed interest rate until maturity of the cross currency swap. On January 29, 2021, the Company entered into a new cross currency swap contract as a hedge of its net investment in foreign operations to offset foreign currency translation gains or losses on the net investment. The cross currency swap has an expiration date of January 29, 2028. At maturity of the cross currency swap contract, the Company will deliver the notional amount of approximately €247.9 million (or approximately $281.3 million as of December 31, 2021) and will receive $300.0 million from the counterparties. The Company will receive quarterly interest payments from the counterparties based on a fixed interest rate until maturity of the cross currency swap. The following table summarizes the notional values of the instrument designated as a net investment hedge (in millions): Notional Amount as of December 31, 2021 December 31, 2020 Cross currency swap contract $ 300.0 $ 300.0 The following table summarizes the after-tax impact of changes in the fair value of the instrument designated as a net investment hedge (in millions): Gain (Loss) Recognized in Accumulated Other Comprehensive Loss for the Years Ended December 31, 2021 December 31, 2020 December 31, 2019 Foreign currency denominated debt $ — $ 1.7 $ 2.5 Cross currency swap contract 11.0 (25.5) 9.3 Derivative Transactions Not Designated as Hedging Instruments During 2021, 2020 and 2019, the Company entered into foreign currency contracts to economically hedge receivables and payables on the Company and its subsidiaries’ balance sheets that are denominated in foreign currencies other than the functional currency. These contracts were classified as non-designated derivative instruments. Gains and losses on such contracts are substantially offset by losses and gains on the remeasurement of the underlying asset or liability being hedged and are immediately recognized into earnings. As of December 31, 2021 and 2020, the Company had outstanding foreign currency contracts with a notional amount of approximately $3,681.9 million and $3,326.6 million, respectively. The following table summarizes the impact that changes in the fair value of derivatives not designated as hedging instruments had on net income (in millions): For the Years Ended Classification of December 31, 2021 December 31, 2020 December 31, 2019 Foreign currency contracts Other expense, net $ 54.8 $ 3.7 $ 20.4 The table below sets forth the fair value of derivative instruments as of December 31, 2021 (in millions): Asset Derivatives as of Liability Derivatives as of Balance Sheet Fair Balance Sheet Fair Derivative instruments designated as hedging instruments: Foreign currency contracts Other current assets $ — Other current liabilities $ — Commodity contracts Other current assets 0.2 Other current liabilities 2.0 Cross currency swap contract Other noncurrent assets 12.5 Other noncurrent liabilities — Derivative instruments not designated as hedging instruments: Foreign currency contracts (1) Other current assets 15.1 Other current liabilities 5.1 Total derivative instruments $ 27.8 $ 7.1 (1) The outstanding contracts as of December 31, 2021 range in maturity through October 2022. The table below sets forth the fair value of derivative instruments as of December 31, 2020 (in millions): Asset Derivatives as of Liability Derivatives as of Balance Sheet Fair Balance Sheet Fair Derivative instruments designated as hedging instruments: Foreign currency contracts Other current assets $ 1.0 Other current liabilities $ 4.5 Commodity contracts Other current assets 0.5 Other current liabilities — Cross currency swap contract Other noncurrent assets 1.5 Other noncurrent liabilities — Derivative instruments not designated as hedging instruments: Foreign currency contracts Other current assets 12.3 Other current liabilities 22.2 Total derivative instruments $ 15.3 $ 26.7 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies The future payments required under the Company’s significant commitments, excluding indebtedness, as of December 31, 2021 are as follows (in millions): Interest payments on indebtedness – As of December 31, 2021, the Company had interest payments of approximately $15.1 million due during the year ended December 31, 2022. Interest payments generally do not vary materially year to year. Indebtedness amounts reflect the principal amount of the Company's senior term loan, senior notes, credit facility and certain short-term borrowings, gross of any debt issuance costs. Refer to Note 7 of the Consolidated Financial Statements for additional information regarding indebtedness. Unconditional purchase obligations – As of December 31, 2021, the Company had approximately $131.1 million of outstanding purchase obligations payable during the year ended December 31, 2022. These obligations generally do not vary materially year to year. Other short-term and long-term obligations – As of December 31, 2021, the Company had approximately $40.1 million of income tax liabilities related to uncertain income tax provisions connected with ongoing income tax audits in various jurisdictions that it expects to pay or settle within the next 12 months. These liabilities and related income tax audits are subject to statutory expiration. Additionally, the Company had approximately $37.8 million of estimated future minimum contribution requirements under its U.S. and non-U.S. defined benefit pension and postretirement plans due during the year ended December 31, 2022. Refer to Notes 6 and 8 of the Consolidated Financial Statements for additional information regarding the Company's uncertain tax positions and pension and postretirement plans, respectively. These obligations comprise a majority of the Company's other short-term and long-term obligations. Off-Balance Sheet Arrangements Guarantees The Company maintains a remarketing agreement with its U.S. finance joint venture, AGCO Finance LLC, whereby the Company is obligated to repurchase up to $6.0 million of repossessed equipment each calendar year. The Company believes that any losses that might be incurred on the resale of this equipment will not materially impact the Company’s financial position or results of operations, due to the fair value of the underlying equipment. At December 31, 2021, the Company has outstanding guarantees of indebtedness owed to related and third parties of approximately $25.2 million, primarily related to dealer and end-user financing of equipment. Such guarantees generally obligate the Company to repay outstanding finance obligations owed to financial institutions if dealers or end users default on such loans through 2027. Losses under such guarantees historically have been insignificant. In addition, the Company generally would expect to be able to recover a significant portion of the amounts paid under such guarantees from the sale of the underlying financed farm equipment, as the fair value of such equipment is expected to be sufficient to offset a substantial portion of the amounts paid. The Company also guarantees indebtedness owed to certain of its finance joint ventures if dealers or end users default on loans. Losses under such guarantees historically have been insignificant and the guarantees are not material. The Company believes the credit risk associated with these guarantees is not material. In addition, at December 31, 2021, the Company had accrued approximately $23.3 million of outstanding guarantees of minimum residual values that may be owed to its finance joint ventures in the United States and Canada due upon expiration of certain eligible operating leases between the finance joint ventures and end users. The maximum potential amount of future payments under the guarantee is approximately $160.7 million. Other At December 31, 2021, the Company had outstanding designated and non-designated foreign exchange contracts with a gross notional amount of approximately $3,681.9 million. The outstanding contracts as of December 31, 2021 range in maturity through October 2022. The Company also had outstanding designated steel commodity contracts with a gross notional amount of approximately $31.9 million that range in maturity through July 2022 (see Note 11). The Company sells a majority of its wholesale receivables in North America, Europe and Brazil to its U.S., Canadian, European and Brazilian finance joint ventures. The Company also sells certain accounts receivable under factoring arrangements to financial institutions around the world. The Company reviewed the sale of such receivables and determined that these facilities should be accounted for as off-balance sheet transactions. Contingencies In August 2008, as part of routine audits, the Brazilian taxing authorities disallowed deductions relating to the amortization of certain goodwill recognized in connection with a reorganization of the Company’s Brazilian operations and the related transfer of certain assets to the Company’s Brazilian subsidiaries. The amount of the tax disallowance through December 31, 2021, not including interest and penalties, was approximately 131.5 million Brazilian reais (or approximately $23.6 million). The amount ultimately in dispute will be significantly greater because of interest and penalties. The Company has been advised by its legal and tax advisors that its position with respect to the deductions is allowable under the tax laws of Brazil. The Company is contesting the disallowance and believes that it is not likely that the assessment, interest or penalties will be required to be paid. However, the ultimate outcome will not be determined until the Brazilian tax appeal process is complete, which could take several years. During 2017, the Company purchased Precision Planting, which provides precision agricultural technology solutions. In 2018, Deere & Company filed separate complaints in the U.S. District Court of Delaware against the Company and its Precision Planting subsidiary alleging that certain products of those entities infringe certain patents of Deere. The two complaints subsequently were consolidated into a single case, Case No. 1:18-cv-00827-CFC (CONSOLIDATED), that currently is scheduled for trial in July 2022. It is the Company’s position that no patents have been, or are continuing to be, infringed, and the Company is vigorously contesting the allegations in the complaint. The Company has an indemnity right under the purchase agreement related to the acquisition of Precision Planting from its previous owner. Pursuant to that right, the previous owner of Precision Planting currently is responsible for the litigation costs associated with the complaint and is obligated to reimburse AGCO for some or all of the damages in the event of an adverse outcome in the litigation. In the event of an adverse outcome, the Company estimates that the range of possible damages, based upon the advice of third-party specialists, would be up to approximately $7.0 million. Deere & Company has provided an estimate of its damages that is significantly higher than the Company estimates and that the Company believes does not have merit. The Company is a party to various other legal claims and actions incidental to its business. The Company believes that none of these claims or actions, either individually or in the aggregate, is material to its business or financial statements as a whole, including its results of operations and financial condition. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company categorizes its assets and liabilities into one of three levels based on the assumptions used in valuing the asset or liability. Estimates of fair value for financial assets and liabilities are based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Observable inputs (highest level) reflect market data obtained from independent sources, while unobservable inputs (lowest level) reflect internally developed market assumptions. In accordance with this guidance, fair value measurements are classified under the following hierarchy: • Level 1 - Quoted prices in active markets for identical assets or liabilities. • Level 2 - Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 - Model-derived valuations in which one or more significant inputs are unobservable. The Company categorizes its pension plan assets into one of the three levels of the fair value hierarchy. See Note 8 for a discussion of the valuation methods used to measure the fair value of the Company’s pension plan assets. The Company enters into foreign currency, commodity and interest rate swap contracts. The fair values of the Company’s derivative instruments are determined using discounted cash flow valuation models. The significant inputs used in these models are readily available in public markets, or can be derived from observable market transactions, and therefore have been classified as Level 2. Inputs used in these discounted cash flow valuation models for derivative instruments include the applicable exchange rates, forward rates or interest rates. Such models used for option contracts also use implied volatility. See Note 11 for a discussion of the Company’s derivative instruments and hedging activities. Assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 and 2020 are summarized below (in millions): As of December 31, 2021 Level 1 Level 2 Level 3 Total Derivative assets $ — $ 27.8 $ — $ 27.8 Derivative liabilities — 7.1 — 7.1 As of December 31, 2020 Level 1 Level 2 Level 3 Total Derivative assets $ — $ 15.3 $ — $ 15.3 Derivative liabilities — 26.7 — 26.7 Cash and cash equivalents, accounts and notes receivable, net and accounts payable are valued at their carrying amounts in the Company’s Consolidated Balance Sheets, due to the immediate or short-term maturity of these financial instruments. The carrying amounts of long-term debt under the Company’s 1.002% senior term loan due 2025 and senior term loans due between 2023 and 2028 approximate fair value based on the borrowing rates currently available to the Company for loans with similar terms and average maturities. At December 31, 2021, the estimated fair value of the Company's 0.800% senior notes due 2028, based on listed market values, was approximately €595.1 million (or approximately $675.2 million as of December 31, 2021), compared to the carrying value of €600.0 million (or approximately $680.8 million as of December 31, 2021). See Note 7 for additional information on the Company’s long-term debt. |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2021 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party Transactions Rabobank, a financial institution based in the Netherlands, is a 51% owner in the Company’s finance joint ventures, which are located in the United States, Canada, Europe, Brazil, Argentina and Australia. Rabobank is also the principal agent and participant in the Company’s revolving credit facility (see Note 7). The majority of the assets of the Company’s finance joint ventures represents finance receivables. The majority of the liabilities represents notes payable and accrued interest. Under the various joint venture agreements, Rabobank or its affiliates provide financing to the joint venture companies, primarily through lines of credit. During 2021, the Company did not make additional investments in its finance joint ventures. During 2020, the Company made a total of approximately $1.9 million of additional investments in its finance joint venture in the Netherlands. During 2019, the Company did not make additional investments in its finance joint ventures. During 2021, the Company received approximately $84.4 million dividends from certain of its finance joint ventures. During 2020, the Company did not receive dividends from its finance joint ventures. During 2019, the Company received approximately $40.5 million dividends from certain of its finance joint ventures. The Company’s finance joint ventures provide retail financing and wholesale financing to its dealers. The terms of the financing arrangements offered to the Company’s dealers are similar to arrangements the finance joint ventures provide to unaffiliated third parties. In addition, the Company transfers, on an ongoing basis, a majority of its wholesale receivables in North America, Europe and Brazil to its U.S., Canadian, European and Brazilian finance joint ventures (see Note 4). The Company maintains a remarketing agreement with its U.S. finance joint venture and has outstanding guarantees of minimum residual values that may be owed to its finance joint ventures in the U.S. and Canada upon the expiration of certain eligible operating leases and has guarantees with its other finance joint ventures which were not material (see Note 12). In addition, as part of sales incentives provided to end users, the Company may from time to time subsidize interest rates of retail financing provided by its finance joint ventures. The cost of those programs is recognized at the time of sale to the Company’s dealers (see Note 1). The Company has a minority equity interest in Tractors and Farm Equipment Limited (“TAFE”), which manufactures and sells Massey Ferguson-branded equipment primarily in India, and also supplies tractors and components to the Company for sale in other markets. On October 15, 2020, TAFE repurchased 461,000 shares of its common stock from the Company for approximately $33.9 million, resulting in an approximate remaining 20.7% ownership interest. Mallika Srinivasan, who is the Chairman and Managing Director of TAFE, is currently a member of the Company’s Board of Directors. As of December 31, 2021, TAFE beneficially owned 12,150,152 shares of the Company’s common stock, not including shares of the Company’s common stock received by Ms. Srinivasan for service as a director. The Company and TAFE are parties to an agreement pursuant to which, among other things, TAFE has agreed not to purchase in excess of 12,150,152 shares of the Company’s common stock, subject to certain adjustments, and the Company has agreed to annually nominate a TAFE representative to its Board of Directors. During 2021, 2020 and 2019, the Company purchased approximately $137.6 million, $78.9 million and $92.7 million, respectively, of tractors and components from TAFE. During 2021, 2020 and 2019, the Company sold approximately $1.4 million, $1.3 million and $1.5 million, respectively, of parts to TAFE. The Company received dividends from TAFE of approximately $2.0 million, $1.8 million and $2.0 million during 2021, 2020 and 2019, respectively. |
Segment Reporting
Segment Reporting | 12 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Segment Reporting | Segment Reporting The Company’s four reportable segments distribute a full range of agricultural equipment and related replacement parts. The Company evaluates segment performance primarily based on income from operations. Sales for each segment are based on the location of the third-party customer. The Company’s selling, general and administrative expenses and engineering expenses are generally charged to each segment based on the region and division where the expenses are incurred. As a result, the components of income from operations for one segment may not be comparable to another segment. Segment results for the years ended December 31, 2021, 2020 and 2019 based on the Company’s reportable segments are as follows (in millions): Years Ended December 31, North America South America Europe/Middle East Asia/Pacific/Africa Consolidated 2021 Net sales $ 2,659.2 $ 1,307.7 $ 6,221.7 $ 949.7 $ 11,138.3 Income from operations 238.1 132.2 755.4 113.9 1,239.6 Depreciation 60.8 26.5 116.5 16.9 220.7 Assets 1,328.1 922.7 2,348.7 610.6 5,210.1 Capital expenditures 41.2 32.5 184.6 11.5 269.8 2020 Net sales $ 2,175.0 $ 873.8 $ 5,366.9 $ 734.0 $ 9,149.7 Income from operations 193.7 29.3 585.3 62.1 870.4 Depreciation 61.3 25.8 110.5 14.9 212.5 Assets 1,051.9 687.6 2,238.7 536.2 4,514.4 Capital expenditures 42.2 18.8 201.8 7.1 269.9 2019 Net sales $ 2,191.8 $ 802.2 $ 5,328.8 $ 718.6 $ 9,041.4 Income (loss) from operations 121.6 (39.4) 638.2 43.4 763.8 Depreciation 61.6 32.4 102.7 14.2 210.9 Assets 1,125.6 758.0 2,187.7 430.2 4,501.5 Capital expenditures 52.1 32.9 173.5 14.9 273.4 A reconciliation from the segment information to the consolidated balances for income from operations and total assets is set forth below (in millions): 2021 2020 2019 Segment income from operations $ 1,239.6 $ 870.4 $ 763.8 Corporate expenses (135.2) (134.7) (129.0) Amortization of intangibles (61.1) (59.5) (61.1) Stock compensation expense (26.6) (36.8) (40.0) Impairment charges — (20.0) (176.6) Restructuring expenses (15.3) (19.7) (9.0) Consolidated income from operations $ 1,001.4 $ 599.7 $ 348.1 Segment assets $ 5,210.1 $ 4,514.4 $ 4,501.5 Cash and cash equivalents 889.1 1,119.1 432.8 Investments in affiliates 413.5 442.7 380.2 Deferred tax assets, other current and noncurrent assets 996.4 665.9 645.2 Intangible assets, net 392.2 455.6 501.7 Goodwill 1,280.8 1,306.5 1,298.3 Consolidated total assets $ 9,182.1 $ 8,504.2 $ 7,759.7 Property, plant and equipment, right-of-use lease assets and amortizable intangible assets by country as of December 31, 2021 and 2020 was as follows (in millions): 2021 2020 United States $ 499.1 $ 541.2 Germany 446.7 456.6 Finland 189.5 191.4 Brazil 144.9 150.4 France 133.2 137.6 Italy 112.7 129.0 China 91.6 98.9 Denmark 84.7 101.9 Other 222.0 232.8 $ 1,924.4 $ 2,039.8 |
Revenue
Revenue | 12 Months Ended |
Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Contract Liabilities Contract liabilities relate to the following: (1) unrecognized revenues where advance payment of consideration precedes the Company’s performance with respect to extended warranty and maintenance contracts and where the performance obligation is satisfied over time, (2) unrecognized revenues where advance payment of consideration precedes the Company’s performance with respect to certain grain storage and protein production systems and where the performance obligation is satisfied over time and (3) unrecognized revenues where advance payment consideration precedes the Company’s performance with respect to precision technology services and where the performance obligation is satisfied over time. Significant changes in the balance of contract liabilities for the years ended December 31, 2021 and 2020 were as follows (in millions): Year Ended December 31, 2021 Year Ended December 31, 2020 Balance at beginning of period $ 172.0 $ 104.0 Advance consideration received 227.8 192.7 Revenue recognized during the period for extended warranty contracts, maintenance services and technology services (64.0) (46.6) Revenue recognized during the period related to grain storage and protein production systems (103.5) (85.6) Foreign currency translation (6.1) 7.5 Balance as of December 31 $ 226.2 $ 172.0 The contract liabilities are classified as either “Other current liabilities” and "Other noncurrent liabilities" or “Accrued expenses” in the Company’s Consolidated Balance Sheets. In 2021, the Company recognized approximately $80.7 million of revenue that was recorded as a contract liability at the beginning of 2021. In 2020, the Company recognized approximately $44.0 million of revenue that was recorded as a contract liability at the beginning of 2020. Remaining Performance Obligations The estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) as of December 31, 2021 are $73.2 million in 2022, $62.5 million in 2023, $35.4 million in 2024, $16.9 million in 2025 and $7.6 million thereafter, and relate primarily to extended warranty contracts. The Company applied the practical expedient in ASU 2014-09 and has not disclosed information about remaining performance obligations that have original expected durations of 12 months or less. Disaggregated Revenue Net sales for the year ended December 31, 2021 disaggregated by primary geographical markets and major products consisted of the following (in millions): North America South Europe/ Asia/ Consolidated Primary geographical markets: United States $ 2,116.2 $ — $ — $ — $ 2,116.2 Canada 436.7 — — — 436.7 Germany — — 1,332.0 — 1,332.0 France — — 1,129.1 — 1,129.1 United Kingdom and Ireland — — 635.3 — 635.3 Finland and Scandinavia — — 836.3 — 836.3 Other Europe — — 2,104.6 — 2,104.6 South America — 1,294.8 — — 1,294.8 Middle East and Algeria — — 184.4 — 184.4 Africa — — — 152.3 152.3 Asia — — — 436.5 436.5 Australia and New Zealand — — — 360.9 360.9 Mexico, Central America and Caribbean 106.3 12.9 — — 119.2 $ 2,659.2 $ 1,307.7 $ 6,221.7 $ 949.7 $ 11,138.3 Major products: Tractors $ 940.4 $ 664.6 $ 4,338.2 $ 443.7 $ 6,386.9 Replacement parts 379.1 131.8 1,070.5 106.5 1,687.9 Grain storage and protein production systems 534.9 140.1 174.0 227.1 1,076.1 Combines, application equipment and other machinery 804.8 371.2 639.0 172.4 1,987.4 $ 2,659.2 $ 1,307.7 $ 6,221.7 $ 949.7 $ 11,138.3 Net sales for the year ended December 31, 2020 disaggregated by primary geographical markets and major products consisted of the following (in millions): North South Europe/ Asia/ Consolidated Primary geographical markets: United States $ 1,763.2 $ — $ — $ — $ 1,763.2 Canada 325.9 — — — 325.9 Germany — — 1,280.6 — 1,280.6 France — — 1,080.2 — 1,080.2 United Kingdom and Ireland — — 557.8 — 557.8 Finland and Scandinavia — — 698.5 — 698.5 Other Europe — — 1,613.1 — 1,613.1 South America — 865.4 — — 865.4 Middle East and Algeria — — 136.7 — 136.7 Africa — — — 58.3 58.3 Asia — — — 373.1 373.1 Australia and New Zealand — — — 302.6 302.6 Mexico, Central America and Caribbean 85.9 8.4 — — 94.3 $ 2,175.0 $ 873.8 $ 5,366.9 $ 734.0 $ 9,149.7 Major products: Tractors $ 692.0 $ 469.8 $ 3,814.3 $ 296.1 $ 5,272.2 Replacement parts 338.4 84.0 936.1 87.2 1,445.7 Grain storage and protein production systems 471.0 82.8 122.2 226.0 902.0 Combines, application equipment and other machinery 673.6 237.2 494.3 124.7 1,529.8 $ 2,175.0 $ 873.8 $ 5,366.9 $ 734.0 $ 9,149.7 Net sales for the year ended December 31, 2019 disaggregated by primary geographical markets and major products consisted of the following (in millions): North America South Europe/ Asia/ Consolidated Primary geographical markets: United States $ 1,787.4 $ — $ — $ — $ 1,787.4 Canada 302.0 — — — 302.0 Germany — — 1,194.3 — 1,194.3 France — — 1,097.6 — 1,097.6 United Kingdom and Ireland — — 561.9 — 561.9 Finland and Scandinavia — — 772.8 — 772.8 Other Europe — — 1,629.0 — 1,629.0 South America — 789.7 — — 789.7 Middle East and Algeria — — 73.2 — 73.2 Africa — — — 116.2 116.2 Asia — — — 344.7 344.7 Australia and New Zealand — — — 257.7 257.7 Mexico, Central America and Caribbean 102.4 12.5 — — 114.9 $ 2,191.8 $ 802.2 $ 5,328.8 $ 718.6 $ 9,041.4 Major products: Tractors $ 662.4 $ 447.7 $ 3,772.0 $ 300.6 $ 5,182.7 Replacement parts 310.2 88.2 874.8 74.6 1,347.8 Grain storage and protein production systems 547.9 79.5 172.8 234.6 1,034.8 Combines, application equipment and other machinery 671.3 186.8 509.2 108.8 1,476.1 $ 2,191.8 $ 802.2 $ 5,328.8 $ 718.6 $ 9,041.4 |
Leases
Leases | 12 Months Ended |
Dec. 31, 2021 | |
Leases [Abstract] | |
Leases | Leases The Company leases certain land, buildings, machinery, equipment, vehicles and office and computer equipment under finance and operating leases. The Company accounts for these leases pursuant to ASU 2016-02, “Leases”. Under the standard, lessees are required to record an asset (ROU asset or finance lease asset) and a lease liability. ROU assets represent the Company’s right to use an underlying asset during the lease term while lease liabilities represent the Company’s obligation to make lease payments during the lease term. The standard allows for two types of leases for income statement recognition purposes: operating leases and finance leases. Operating leases result in the recognition of a single lease expense on a straight-line basis over the lease term whereas finance leases result in an accelerated expense. ASU 2016-02 also contains guidance regarding the identification of embedded leases in service and supply contracts, as well as the identification of lease and nonlease components of an arrangement. All leases greater than 12 months result in the recognition of an ROU asset and liability at the lease commencement date based on the present value of the lease payments over the lease term. The present value of the lease payments is calculated using the applicable weighted-average discount rate. The weighted-average discount rate is based on the discount rate implicit in the lease, or if the implicit rate is not readily determinable from the lease, then the Company estimates an applicable incremental borrowing rate. The incremental borrowing rate is estimated using the currency denomination of the lease, the contractual lease term and the Company’s applicable borrowing rate. The Company does not recognize an ROU asset or lease liability with respect to operating leases with an initial term of 12 months or less and recognizes expense on such leases on a straight-line basis over the lease term. The Company accounts for lease components separately from nonlease components other than for real estate and office equipment. The Company evaluated its supplier agreements for the existence of leases and determined these leases comprised an insignificant portion of its supplier agreements. As such, these leases were not material to the Company’s Consolidated Balance Sheets. The Company has certain leases that contain one or more options to terminate or renew that can extend the lease term up to 15 years. Options that the company is reasonably certain to exercise are included in the lease term. The depreciable life of ROU assets and leasehold improvements are limited by the expected lease term. The Company has certain lease agreements that include variable rental payments that are adjusted periodically for inflation based on the index rate as defined by the applicable government authority. Generally, the Company’s lease agreements do not contain any residual value guarantees or restrictive covenants. Total lease assets and liabilities at December 31, 2021 and 2020 were as follows (in millions): Lease Assets Classification As of December 31, 2021 As of December 31, 2020 Operating ROU assets Right-of-use lease assets $ 154.1 $ 165.1 Finance lease assets Property, plant and equipment, net (1) 10.6 15.1 Total lease assets $ 164.7 $ 180.2 Lease Liabilities Classification As of December 31, 2021 As of December 31, 2020 Current: Operating Accrued expenses $ 42.3 $ 43.5 Finance Other current liabilities 3.8 3.0 Noncurrent: Operating Operating lease liabilities 115.5 125.9 Finance Other noncurrent liabilities 6.0 9.8 Total lease liabilities $ 167.6 $ 182.2 ____________________________________ (1) Finance lease assets are recorded net of accumulated depreciation of $7.8 million and $15.6 million as of December 31, 2021 and 2020, respectively. Total lease costs for 2021 and 2020 are set forth below (in millions): Classification Year Ended Year Ended Operating lease cost Selling, general and administrative expenses $ 59.0 $ 54.0 Variable lease cost Selling, general and administrative expenses 1.0 1.7 Short-term lease cost Selling, general and administrative expenses 18.7 11.0 Finance lease cost: Amortization of lease assets Depreciation expense (1) 2.4 3.7 Interest on lease liabilities Interest expense, net 0.3 0.6 Total lease cost $ 81.4 $ 71.0 ____________________________________ (1) Depreciation expense was included in both cost of goods sold and selling, general and administrative expenses. Lease payment amounts for operating and finance leases with remaining terms greater than one year as of December 31, 2021 were as follows (in millions): December 31, 2021 Operating Leases Finance Leases 2022 $ 45.7 $ 4.0 2023 36.2 0.9 2024 24.5 0.6 2025 17.3 0.4 2026 12.3 0.2 Thereafter 39.1 6.3 Total lease payments 175.1 12.4 Less: imputed interest (1) (17.3) (2.5) Present value of lease liabilities $ 157.8 $ 9.9 ____________________________________ (1) Calculated using the implicit interest rate for each lease. Lease payment amounts for operating and finance leases with remaining terms greater than one year as of December 31, 2020 were as follows (in millions): December 31, 2020 Operating Leases Finance Leases 2021 $ 47.6 $ 3.3 2022 37.7 1.4 2023 28.6 1.1 2024 18.9 0.8 2025 13.6 0.6 Thereafter 44.5 9.1 Total lease payments 190.9 16.3 Less: imputed interest (1) (21.5) (3.5) Present value of lease liabilities $ 169.4 $ 12.8 ____________________________________ (1) Calculated using the implicit interest rate for each lease. The following table summarizes the weighted-average remaining lease term and weighted-average discount rate: As of December 31, 2021 As of December 31, 2020 Weighted-average remaining lease term: Operating leases 7 years 7 years Finance leases 12 years 15 years Weighted-average discount rate: Operating leases 3.1 % 3.5 % Finance leases 2.4 % 2.7 % The following table summarizes the supplemental cash flow information for 2021 and 2020 (in millions): Year Ended December 31, 2021 Year Ended December 31, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 59.8 $ 54.1 Operating cash flows from finance leases 0.2 0.4 Financing cash flows from finance leases 2.6 3.8 Leased assets obtained in exchange for lease obligations: Operating leases $ 50.6 $ 30.8 Finance leases 0.9 0.9 |
Leases | Leases The Company leases certain land, buildings, machinery, equipment, vehicles and office and computer equipment under finance and operating leases. The Company accounts for these leases pursuant to ASU 2016-02, “Leases”. Under the standard, lessees are required to record an asset (ROU asset or finance lease asset) and a lease liability. ROU assets represent the Company’s right to use an underlying asset during the lease term while lease liabilities represent the Company’s obligation to make lease payments during the lease term. The standard allows for two types of leases for income statement recognition purposes: operating leases and finance leases. Operating leases result in the recognition of a single lease expense on a straight-line basis over the lease term whereas finance leases result in an accelerated expense. ASU 2016-02 also contains guidance regarding the identification of embedded leases in service and supply contracts, as well as the identification of lease and nonlease components of an arrangement. All leases greater than 12 months result in the recognition of an ROU asset and liability at the lease commencement date based on the present value of the lease payments over the lease term. The present value of the lease payments is calculated using the applicable weighted-average discount rate. The weighted-average discount rate is based on the discount rate implicit in the lease, or if the implicit rate is not readily determinable from the lease, then the Company estimates an applicable incremental borrowing rate. The incremental borrowing rate is estimated using the currency denomination of the lease, the contractual lease term and the Company’s applicable borrowing rate. The Company does not recognize an ROU asset or lease liability with respect to operating leases with an initial term of 12 months or less and recognizes expense on such leases on a straight-line basis over the lease term. The Company accounts for lease components separately from nonlease components other than for real estate and office equipment. The Company evaluated its supplier agreements for the existence of leases and determined these leases comprised an insignificant portion of its supplier agreements. As such, these leases were not material to the Company’s Consolidated Balance Sheets. The Company has certain leases that contain one or more options to terminate or renew that can extend the lease term up to 15 years. Options that the company is reasonably certain to exercise are included in the lease term. The depreciable life of ROU assets and leasehold improvements are limited by the expected lease term. The Company has certain lease agreements that include variable rental payments that are adjusted periodically for inflation based on the index rate as defined by the applicable government authority. Generally, the Company’s lease agreements do not contain any residual value guarantees or restrictive covenants. Total lease assets and liabilities at December 31, 2021 and 2020 were as follows (in millions): Lease Assets Classification As of December 31, 2021 As of December 31, 2020 Operating ROU assets Right-of-use lease assets $ 154.1 $ 165.1 Finance lease assets Property, plant and equipment, net (1) 10.6 15.1 Total lease assets $ 164.7 $ 180.2 Lease Liabilities Classification As of December 31, 2021 As of December 31, 2020 Current: Operating Accrued expenses $ 42.3 $ 43.5 Finance Other current liabilities 3.8 3.0 Noncurrent: Operating Operating lease liabilities 115.5 125.9 Finance Other noncurrent liabilities 6.0 9.8 Total lease liabilities $ 167.6 $ 182.2 ____________________________________ (1) Finance lease assets are recorded net of accumulated depreciation of $7.8 million and $15.6 million as of December 31, 2021 and 2020, respectively. Total lease costs for 2021 and 2020 are set forth below (in millions): Classification Year Ended Year Ended Operating lease cost Selling, general and administrative expenses $ 59.0 $ 54.0 Variable lease cost Selling, general and administrative expenses 1.0 1.7 Short-term lease cost Selling, general and administrative expenses 18.7 11.0 Finance lease cost: Amortization of lease assets Depreciation expense (1) 2.4 3.7 Interest on lease liabilities Interest expense, net 0.3 0.6 Total lease cost $ 81.4 $ 71.0 ____________________________________ (1) Depreciation expense was included in both cost of goods sold and selling, general and administrative expenses. Lease payment amounts for operating and finance leases with remaining terms greater than one year as of December 31, 2021 were as follows (in millions): December 31, 2021 Operating Leases Finance Leases 2022 $ 45.7 $ 4.0 2023 36.2 0.9 2024 24.5 0.6 2025 17.3 0.4 2026 12.3 0.2 Thereafter 39.1 6.3 Total lease payments 175.1 12.4 Less: imputed interest (1) (17.3) (2.5) Present value of lease liabilities $ 157.8 $ 9.9 ____________________________________ (1) Calculated using the implicit interest rate for each lease. Lease payment amounts for operating and finance leases with remaining terms greater than one year as of December 31, 2020 were as follows (in millions): December 31, 2020 Operating Leases Finance Leases 2021 $ 47.6 $ 3.3 2022 37.7 1.4 2023 28.6 1.1 2024 18.9 0.8 2025 13.6 0.6 Thereafter 44.5 9.1 Total lease payments 190.9 16.3 Less: imputed interest (1) (21.5) (3.5) Present value of lease liabilities $ 169.4 $ 12.8 ____________________________________ (1) Calculated using the implicit interest rate for each lease. The following table summarizes the weighted-average remaining lease term and weighted-average discount rate: As of December 31, 2021 As of December 31, 2020 Weighted-average remaining lease term: Operating leases 7 years 7 years Finance leases 12 years 15 years Weighted-average discount rate: Operating leases 3.1 % 3.5 % Finance leases 2.4 % 2.7 % The following table summarizes the supplemental cash flow information for 2021 and 2020 (in millions): Year Ended December 31, 2021 Year Ended December 31, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 59.8 $ 54.1 Operating cash flows from finance leases 0.2 0.4 Financing cash flows from finance leases 2.6 3.8 Leased assets obtained in exchange for lease obligations: Operating leases $ 50.6 $ 30.8 Finance leases 0.9 0.9 |
Schedule II - Valuation and Qua
Schedule II - Valuation and Qualifying Accounts | 12 Months Ended |
Dec. 31, 2021 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
Valuation and Qualifying Accounts | SCHEDULE II AGCO CORPORATION AND SUBSIDIARIES SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS (in millions) Additions Description Balance at Acquired Charged to Deductions Foreign Balance at Year ended December 31, 2021 Allowances for doubtful accounts $ 36.4 $ 0.2 $ 0.5 $ (2.8) $ (1.7) $ 32.6 Year ended December 31, 2020 Allowances for doubtful accounts $ 28.8 $ — $ 14.5 $ (6.8) $ (0.1) $ 36.4 Year ended December 31, 2019 Allowances for doubtful accounts $ 31.7 $ — $ 5.8 $ (8.3) $ (0.4) $ 28.8 Additions Description Balance at Charged to Reversal of Deductions Foreign Balance at Year ended December 31, 2021 Accruals of severance, relocation and other closure costs $ 16.8 $ 19.9 $ (2.3) $ (19.1) $ (0.6) $ 14.7 Year ended December 31, 2020 Accruals of severance, relocation and other closure costs $ 4.8 $ 17.6 $ (0.4) $ (5.1) $ (0.1) $ 16.8 Year ended December 31, 2019 Accruals of severance, relocation and other closure costs $ 7.1 $ 6.1 $ (0.7) $ (7.3) $ (0.4) $ 4.8 Additions Description Balance at Acquired Charged (Credited) to Costs and Expenses (1) Deductions Foreign Balance at Year ended December 31, 2021 Deferred tax valuation allowance $ 181.0 $ 0.4 $ (130.8) $ — $ (3.3) $ 47.3 Year ended December 31, 2020 Deferred tax valuation allowance $ 169.1 $ 0.9 $ 28.7 $ — $ (17.7) $ 181.0 Year ended December 31, 2019 Deferred tax valuation allowance $ 83.9 $ — $ 87.1 $ — $ (1.9) $ 169.1 (1) There were no amounts credited or charged through other comprehensive income during 2021. Amounts credited through other comprehensive income (loss) during the years ended December 31, 2020 and 2019 were approximately $12.4 million and approximately $2.5 million, respectively. |
Operations and Summary of Sig_2
Operations and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Consolidation | Basis of Presentation and Consolidation The Company’s Consolidated Financial Statements represent the consolidation of all wholly-owned companies, majority-owned companies and joint ventures in which the Company has been determined to be the primary beneficiary. The Company consolidates a variable interest entity (“VIE”) if the Company determines it is the primary beneficiary. The primary beneficiary of a VIE is the party that has both the power to direct the activities that most significantly impact the entity’s economic performance and the obligation to absorb losses or the right to receive benefits that potentially could be significant to the VIE. The Company also consolidates all entities that are not considered VIEs if it is determined that the Company has a controlling voting interest to direct the activities that most significantly impact the joint venture or entity. The Company records investments in all other affiliate companies using the equity method of accounting when it has significant influence. Other investments, including those representing an ownership interest of less than 20%, are recorded at cost. All significant intercompany balances and transactions have been eliminated in the Consolidated Financial Statements. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The estimates made by management primarily relate to accounts and notes receivable, inventories, deferred income tax valuation allowances, uncertain tax positions, goodwill and other identifiable intangible assets, and certain accrued liabilities, principally relating to reserves for volume discounts and sales incentives, warranty obligations, product liability and workers’ compensation obligations, and pensions and postretirement benefits. The Company cannot predict the ongoing impact of the COVID-19 pandemic due to volatility in global economic and political environments, the cyclicality of market demand for its products, supply chain disruptions, possible workforce unavailability, exchange rate and commodity and protein price volatility and availability of financing, and their impact to the Company’s net sales, production volumes, costs and overall financial condition and available funding. The Company may be required to record impairment charges in the future with respect to noncurrent assets such as goodwill and other intangible assets and equity method investments, whose fair values may be negatively affected by the COVID-19 pandemic. The Company also may be required to write-down obsolete inventory due to decreased customer demand and sales orders. The Company monitors the collection of accounts receivable, as well as the operating results of its finance joint ventures around the world. In the event economic conditions were to deteriorate, the Company and its finance joint ventures may not collect accounts receivable at expected levels, and the operating results of its finance joint ventures may be negatively impacted, thus negatively impacting the Company's results of operations and financial condition. The Company also regularly assesses its compliance with debt covenants, cash flow hedging forecasts as compared to actual transactions, the fair value of pension assets, accounting for incentive and stock compensation accruals, revenue recognition and discount reserve setting as well as the realization of deferred tax assets in light of the COVID-19 pandemic. |
Foreign Currency Transaction | Foreign Currency Translation The financial statements of the Company’s foreign subsidiaries are translated into United States currency in accordance with Accounting Standards Codification (“ASC”) 830, “Foreign Currency Matters.” Assets and liabilities are translated to United States dollars at period-end exchange rates. Income and expense items are translated at average rates of exchange prevailing during the period. Translation adjustments are included in “Accumulated other comprehensive loss” in stockholders’ equity within the Company’s Consolidated Balance Sheets. Gains and losses, which result from foreign currency transactions, are included in the accompanying Consolidated Statements of Operations. The Company changed the functional currency of its wholly-owned subsidiary from the Argentinian peso to the U.S. dollar effective July 1, 2018. |
Accounts and Notes Receivable | Accounts and Notes Receivable Accounts and notes receivable arise from the sale of equipment and replacement parts to independent dealers, distributors or other customers. In the United States and Canada, amounts due from sales to dealers are immediately due upon a retail sale of the underlying equipment by the dealer with the exception of sales of grain storage and protein production systems as discussed further below. If not previously paid by the dealer in the United States and Canada, installment payments are required generally beginning after the interest-free period with the remaining outstanding equipment balance generally due within 12 months after shipment or delivery. These interest-free periods vary by product and generally range from one In other international markets, equipment sales generally are payable in full within 30 days to 180 days of shipment or delivery. Payment terms for some highly seasonal products have a specified due date during the year regardless of the shipment or delivery date. For sales in most markets outside of the United States and Canada, the Company generally does not charge interest on outstanding receivables with its dealers and distributors. Sales of replacement parts generally are payable within 30 days to 90 days of shipment, with terms for some larger, seasonal stock orders generally payable within six months of shipment. In certain markets, there is a time lag, which varies based on the timing and level of retail demand, between the date the Company records a sale and when the dealer sells the equipment to a retail customer. Sales of grain storage and protein production systems both in the United States and in other countries generally are payable within 30 days of shipment. In certain countries, sales of such systems for which the Company is responsible for construction or installation may be contingent upon customer acceptance. Payment terms vary by market and product, with fixed payment schedules on all sales. When the Company is responsible for installation services, fixed payment schedules may include upfront deposits, progress payments and final payment upon customer acceptance. The following summarizes by geographic region, as a percentage of the Company’s consolidated net sales, amounts with maximum interest-free periods as presented below (in millions): Year Ended December 31, 2021 North South Europe/ Asia/ Consolidated 0 to 6 months $ 1,909.7 $ 1,307.7 $ 6,217.6 $ 949.7 $ 10,384.7 93.2 % 7 to 12 months 739.7 — 4.1 — 743.8 6.7 % 13 to 24 months 9.8 — — — 9.8 0.1 % $ 2,659.2 $ 1,307.7 $ 6,221.7 $ 949.7 $ 11,138.3 100.0 % The Company has an agreement to permit transferring, on an ongoing basis, a majority of its wholesale interest-bearing and non-interest bearing accounts receivable in North America, Europe and Brazil to its U.S., Canadian, European and Brazilian finance joint ventures. Qualified dealers may obtain additional financing through the Company’s U.S., Canadian, European and Brazilian finance joint ventures at the joint ventures’ discretion. The Company provides various volume bonus and sales incentive programs with respect to its products. These sales incentive programs include reductions in invoice prices, reductions in retail financing rates, dealer commissions and dealer incentive allowances. In most cases, incentive programs are established and communicated to the Company’s dealers on a quarterly basis. The incentives are paid either at the time of the cash settlement of the receivable (which is generally at the time of retail sale), at the time of retail financing, at the time of warranty registration, or at a subsequent time based on dealer purchase volumes. The incentive programs are product-line specific and generally do not vary by dealer. The cost of sales incentives associated with dealer commissions and dealer incentive allowances is estimated based upon the terms of the programs and historical experience, is based on a percentage of the sales price, and estimates for sales incentives are made and recorded at the time of sale for expected incentive programs using the expected value method. These estimates are reassessed each reporting period and are revised in the event of subsequent modifications to incentive programs, as they are communicated to dealers. The related provisions and accruals are made on a product or product-line basis and are monitored for adequacy and revised at least quarterly in the event of subsequent modifications to the programs. Interest rate subsidy payments, which are a reduction in retail finance rates, are recorded in the same manner as dealer commissions and dealer incentive allowances. Volume discounts are estimated and recognized based on historical experience, and related reserves are monitored and adjusted based on actual dealer purchase volumes and the dealer’s progress towards achieving specified cumulative target levels. All incentive programs are recorded and presented as a reduction of revenue, due to the fact that the Company does not receive a distinct good or service in exchange for the consideration provided. In the United States and Canada, reserves for incentive programs related to accounts receivable not sold to Company’s U.S. and Canadian finance joint ventures are recorded as “accounts receivable allowances” within the Company’s Consolidated Balance Sheets due to the fact that the incentives are paid through a reduction of future cash settlement of the receivable. Globally, reserves for incentive programs that will be paid in cash or credit memos, as is the case with most of the Company’s volume discount programs, as well as sales with incentives associated with accounts receivable sold to its finance joint ventures, are recorded within “Accrued expenses” within the Company’s Consolidated Balance Sheets. Accounts and notes receivable are shown net of allowances for sales incentive discounts available to dealers and for doubtful accounts. Cash flows related to the collection of receivables are reported within “Cash flows from operating activities” within the Company’s Consolidated Statements of Cash Flows. Accounts and notes receivable allowances at December 31, 2021 and 2020 were as follows (in millions): 2021 2020 Sales incentive discounts $ 8.0 $ 12.9 Doubtful accounts 32.6 36.4 $ 40.6 $ 49.3 The Company accounts for its provision for doubtful accounts in accordance with Accounting Standards Update (“ASU”) 2016-13, “Measurement of Credit Losses on Financial Instruments,” (“ASU 2016-13”). In the United States and Canada, sales incentives can be paid through future cash settlements of receivables and through credit memos to Company’s dealers or through reductions in retail financing rates paid to the Company’s finance joint ventures. Outside of the United States and Canada, sales incentives can be paid through cash or credit memos to the Company’s dealers or through reductions in retail financing rates paid to the Company’s finance joint ventures. The Company transfers certain accounts receivable under its accounts receivable sales agreements with its finance joint ventures and other financial institutions (see Note 4). The Company records such transfers as sales of accounts receivable when it is considered to have surrendered control of such receivables under the provisions of ASU 2009-16, “Transfers and Servicing (Topic 860): Accounting for Transfers of Financial Assets.” Cash payments made to the Company’s finance joint ventures for sales incentive discounts provided to dealers related to outstanding accounts receivables sold are recorded within “Accrued expenses.” |
Inventories | Inventories    Inventories are valued at the lower of cost or net realizable value, using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. |
Recoverable Indirect Taxes | Recoverable Indirect Taxes    The Company’s Brazilian operations incur value added taxes (“VAT”) on certain purchases of raw materials, components and services. These taxes are accumulated as tax credits and create assets that are reduced by the VAT collected from the Company’s sales in the Brazilian market. The Company regularly assesses the recoverability of these tax credits, and establishes reserves when necessary against them, through analyses that include, amongst others, the history of realization, the transfer of tax credits to third parties as authorized by the government, anticipated changes in the supply chain and the future expectation of tax debits from the Company’s ongoing operations. The Company believes that these tax credits, net of established reserves, are realizable. The Company had recorded approximately $114.4 million and $91.2 million, respectively, of VAT tax credits, net of reserves, as of December 31, 2021 and 2020. |
Property, Plant and Equipment | Property, Plant and Equipment Property, plant and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation is provided on a straight-line basis over the estimated useful lives of two three three |
Goodwill, Other Intangible Assets and Long-Lived Assets | Goodwill, Other Intangible Assets and Long-Lived Assets The Company tests goodwill for impairment, at the reporting unit level, annually and when events or circumstances indicate that fair value of a reporting unit may be below its carrying value. A reporting unit is an operating segment or one level below an operating segment, for example, a component. The Company combines and aggregates two or more components of an operating segment as a single reporting unit if the components have similar economic characteristics. The Company’s reportable segments are not its reporting units. Goodwill is evaluated annually as of October 1 for impairment using a qualitative assessment or a quantitative one-step assessment. If the Company elects to perform a qualitative assessment and determines the fair value of its reporting units more likely than not exceed the carrying value of their net assets, no further evaluation is necessary. For reporting units where the Company performs a one-step quantitative assessment, the Company compares the fair value of each reporting unit, which is determined based on a combination of a discounted cash flow valuation approach and a market multiple valuation approach, to its respective carrying value of net assets, including goodwill. If the fair value of the reporting unit exceeds its carrying value of net assets, the goodwill is not considered impaired. If the carrying value of net assets is higher than the fair value of the reporting unit, an impairment charge is recorded in the amount by which the carrying value exceeds the reporting unit’s fair value in accordance with ASU 2017-04. The Company reviews its long-lived assets, which include intangible assets subject to amortization, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The evaluation for recoverability is performed at a level where independent cash flows may be attributed to either an asset or asset group. If the Company determines that the carrying amount of an asset or asset group is not recoverable based on the expected undiscounted future cash flows of the asset or asset group, an impairment loss is recorded equal to the excess of the carrying amounts over the estimated fair value of the long-lived assets. Estimates of future cash flows are based on many factors, including current operating results, expected market trends and competitive influences. The Company also evaluates the amortization periods assigned to its intangible assets to determine whether events or changes in circumstances warrant revised estimates of useful lives. Assets to be disposed of by sale are reported at the lower of the carrying amount or fair value, less estimated costs to sell. The results of our goodwill and long-lived assets impairment analyses conducted as of October 1, 2021 indicated that no indicators of impairment existed and no reduction in the carrying amount of goodwill and long-lived assets was required. The COVID-19 pandemic has adversely impacted the global economy as a whole since its inception. Based on macroeconomic conditions throughout 2020, the Company assessed its goodwill and other intangible assets for indications of impairment, and as of June 30, 2020, the Company concluded there were indicators of impairment during the three months ended June 30, 2020 related to one of its smaller reporting units, which was a 50%-owned tillage and seeding equipment joint venture. As a result, the entire goodwill balance of this reporting unit was impaired, and during the three months ended June 30, 2020, the Company recorded a non-cash impairment charge of approximately $20.0 million as “Impairment charges” within the Company’s Consolidated Statements of Operations, with an offsetting benefit of approximately $10.0 million included within “Net (income) loss attributable to noncontrolling interests.” During the three months ended June 30, 2021, the Company sold its 50% interest in the joint venture. The Company’s goodwill impairment analysis conducted as of October 1, 2020 indicated that no other indicators of impairment existed and no reduction in the carrying amount of goodwill and long-lived assets was required related to the Company’s other reporting units. |
Warranty Reserves | The Company’s agricultural equipment products generally are under warranty against defects in materials and workmanship for a period of one |
Insurance Reserves | Insurance Reserves Under the Company’s insurance programs, coverage is obtained for significant liability limits as well as those risks required to be insured by law or contract. It is the policy of the Company to self-insure a portion of certain expected losses primarily related to workers’ compensation and comprehensive general liability, product and vehicle liability. Provisions for losses expected under these programs are recorded based on the Company’s estimates of the aggregate liabilities for the claims incurred. |
Revenue | Revenue The Company accounts for revenue recognition pursuant to ASU 2014-09, “Revenue from Contracts with Customers.” Revenue is recognized when the Company satisfies the performance obligation by transferring control over goods or services to a dealer, distributor or other customer. The amount of revenue recognized is measured as the consideration the Company expects to receive in exchange for those goods or services pursuant to a contract with the customer. A contract exists once the Company receives and accepts a purchase order under a dealer sales agreement, or once the Company enters into a contract with an end user. The Company does not recognize revenue in cases where collectability is not probable, and defers the recognition until collection is probable or payment is received. The Company generates revenue from the manufacture and distribution of agricultural equipment and replacement parts. Sales of equipment and replacement parts, which represents a majority of the Company’s net sales, are recorded by the Company at the point in time when title and control have been transferred to an independent dealer, distributor or other customer. Title generally passes to the dealer or distributor upon shipment or specified delivery, and the risk of loss upon damage, theft or destruction of the equipment is the responsibility of the dealer, distributor or designated third-party carrier. The Company believes control passes and the performance obligation is satisfied at the point of the stated shipping or delivery term with respect to such sales. As previously discussed, the amount of consideration the Company receives and the revenue recognized varies with certain sales incentives the Company offers to dealers and distributors. Estimates for sales incentives are made at the time of sale for expected incentive programs using the expected value method. These estimates are revised in the event of subsequent modification to the incentive program. All incentive programs are recorded and presented as a reduction of revenue, due to the fact that the Company does not receive a distinct good or service in exchange for the consideration provided. Dealers or distributors may not return equipment or replacement parts while its contract with the Company is in force, except for under established promotional and annual replacement parts return programs. At the time of sale, the Company estimates the amount of returns based on the terms of promotional and annual return programs and anticipated returns in the future. Sales and other related taxes are excluded from the transaction price. Shipping and handling costs associated with freight activities after the customer has obtained control are accounted for as fulfillment costs and are expensed and accrued at the time revenue is recognized in “Cost of goods sold” and “Selling, general and administrative expenses” in the Company’s Consolidated Statements of Operations. As afforded under the practical expedient in ASU 2014-09, the Company does not adjust the amount of revenue to be recognized under a contract with a dealer, distributor or other customer for the time value of money when the difference between the receipt of payment and the recognition of revenue is less than one year. Although, substantially all revenue is recognized at a point in time, a relatively insignificant amount of installation revenue associated with the sale of grain storage and protein production systems is recognized on an “over time” basis as discussed below. The Company also recognizes revenue “over time” with respect to extended warranty and maintenance contracts and certain precision technology services. Generally, almost all of the grain storage and protein production systems contracts with customers that relate to “over time” revenue recognition have contract durations of less than 12 months. Extended warranty, maintenance services contracts and certain precision technology services generally have contract durations of more than 12 months. Grain Storage and Protein Production Systems Installation Revenue. In certain countries, the Company sells grain storage and protein production systems where the Company is responsible for construction and installation, and the sale is contingent upon customer acceptance. Under these conditions, the revenues are recognized over the term of the contract when the Company can objectively determine control has been transferred to the customer in accordance with agreed-upon specifications in the contract. For these contracts, the Company may be entitled to receive an advance payment, which is recognized as a contract liability for the amount in excess of the revenue recognized. The Company uses the input method using costs incurred to date relative to total estimated costs at completion to measure the progress toward satisfaction of the performance obligation. Revenues are recorded proportionally as costs are incurred. Costs include labor, material and overhead. The estimation of the progress toward completion is subject to various assumptions. As part of the estimation process, the Company reviews the length of time to complete the performance obligation, the cost of materials and labor productivity. If a significant change in one of the assumptions occurs, then the Company will recognize an adjustment under the cumulative catch-up method and the impact of the adjustment on the revenue recorded to date is recognized in the period the adjustment is identified. Extended Warranty Contracts. The Company sells separately priced extended warranty contracts and maintenance contracts, which extends coverage beyond the base warranty period, or covers maintenance over a specified period. Revenue is recognized for the extended warranty contract on a straight-line basis, which the Company believes approximates the costs expected to be incurred in satisfying the obligations, over the extended warranty period. The extended warranty period ranges from one Precision Technology Services Revenue. The Company sells a combination of precision technology products and services. When the bundled package of technology products and services is sold, the portion of the consideration received related to the services component is recognized over time as the Company satisfies the future performance obligation. Revenue is recognized for the hardware component when control is transferred to the dealer or distributor. Payment is received or revenue is deferred for free subscriptions at inception of the precision technology subscription period, which is recognized as a contract liability for the amount in excess of the revenue recognized. The revenue associated with the sale of precision technology services is not significant. The costs of the software directly associated with the installation and functionality of precision technology products and services, including amortization and hosting costs, are reflected within "Cost of goods sold" and "Engineering expenses" within the Company's Consolidated Statements of Operations. See Note 16 for additional information regarding the Company’s sources of revenue and associated contract liabilities and performance obligations. |
Research and Development Expenses | Research and Development Expenses Research and development expenses are expensed as incurred and are included in “Engineering expenses” in the Company’s Consolidated Statements of Operations. |
Advertising Costs | Advertising Costs    The Company expenses all advertising costs as incurred. Cooperative advertising costs normally are expensed at the time the revenue is earned. |
Shipping and Handling Expenses | Shipping and Handling Expenses All shipping and handling fees charged to customers are included as a component of net sales, and are associated with freight activities after the customer has obtained control. Shipping and handling costs are accounted for as fulfillment costs and are expensed and accrued at the time revenue is recognized within “Cost of goods sold,” with the exception of certain handling costs included in “Selling, general and administrative expenses” in the amount of $43.6 million, $38.0 million and $38.9 million for the years ended December 31, 2021, 2020 and 2019, respectively. |
Income Taxes | Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. See Note 6 for additional information regarding the Company’s income taxes. |
Net Income Per Common Share | Net Income Per Common Share Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted net income per common share assumes the exercise of outstanding stock-settled stock appreciation rights (“SSARs”) and the vesting of performance share awards and restricted stock units using the treasury stock method when the effects of such assumptions are dilutive. |
Comprehensive Income (Loss) | Comprehensive Income (Loss)    The Company reports comprehensive income (loss), defined as the total of net income (loss) and all other non-owner changes in equity, and the components thereof in its Consolidated Statements of Stockholders’ Equity and Consolidated Statements of Comprehensive Income. |
Derivatives | Derivatives The Company uses foreign currency contracts to hedge the foreign currency exposure of certain receivables and payables. The contracts are for periods consistent with the exposure being hedged and generally have maturities of one year or less. These contracts are classified as non-designated derivative instruments. The Company also enters into foreign currency contracts designated as cash flow hedges of expected sales. The Company’s foreign currency contracts mitigate risk due to exchange rate fluctuations because gains and losses on these contracts generally offset losses and gains on the exposure being hedged. The notional amounts of the foreign currency contracts do not represent amounts exchanged by the parties and, therefore, are not a measure of the Company’s risk. The amounts exchanged are calculated on the basis of the notional amounts and other terms of the contracts. The credit and market risks under these contracts are not considered to be significant. The Company’s interest expense is, in part, sensitive to the general level of interest rates, and the Company manages its exposure to interest rate risk through the mix of floating rate and fixed rate debt. From time to time, the Company enters into interest rate swap agreements in order to manage the Company’s exposure to interest rate fluctuations. The Company uses non-derivative and, periodically, derivative instruments to hedge a portion of the Company’s net investment in foreign operations against adverse movements in exchange rates. The Company’s gross profit is sensitive to the cost of steel and other raw materials. From time to time, the Company enters into derivative instruments to hedge a portion of its commodity purchases against adverse movements in commodity prices. The Company’s hedging policy prohibits it from entering into any foreign currency contracts for speculative trading purposes. See Note 11 for additional information regarding the Company’s derivative instruments and hedging activities. |
Recent Accounting Pronouncements and New Accounting Pronouncements to be Adopted | Recent Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848).” The amendments in this update provide optional expedients and exceptions for applying Generally Accepted Accounting Principles (“GAAP”) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. In January 2021, the FASB issued ASU 2021-01, which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The amendments in these updates are effective for all entities as of March 12, 2020 through December 31, 2022. The Company has adopted this guidance and the adoption did not have a material impact on the Company's results of operations, financial condition and cash flows. The Company adopted the following pronouncements, none of which had a material impact to the Company’s results of operations, financial condition and cash flows. • ASU 2019-12 – “Simplifying the Accounting for Income Taxes” was adopted as of January 1, 2021. • ASU 2020-01 – “Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)” was adopted as of January 1, 2021. • ASU 2020-08 – “Codification Improvements to Subtopic 310-20, Receivables—Nonrefundable Fees and Other Costs” was adopted as of January 1, 2021. New Accounting Pronouncements to be Adopted In June 2016, the FASB issued ASU 2016-13, which requires measurement and recognition of expected versus incurred credit losses for financial assets held. In November 2019, the FASB issued ASU 2019-10, “Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates,” which delays the effective date of ASU 2016-13 for smaller reporting companies and other non-SEC reporting entities. This applies to the Company’s equity method finance joint ventures who are now required to adopt ASU 2016-13 for annual periods beginning after December 15, 2022 and interim periods within those annual periods. The standard, and its subsequent modification, will likely impact the results of operations and financial condition of the Company’s finance joint ventures. Therefore, adoption of the standard by the Company’s finance joint ventures will likely impact the Company’s “Investment in affiliates” and “Equity in net earnings of affiliates.” The Company’s finance joint ventures are currently evaluating the impact of ASU 2016-13 to their results of operations and financial condition. In November 2021, the FASB issued ASU 2021-10, “Government Assistance (Topic 832): Disclosure by Business Entities about Government Assistance,” which improves the transparency of government assistance received by most business entities by requiring the disclosure of: (1) the types of government assistance received; (2) the accounting for such assistance; and (3) the effect of the assistance on a business entity's financial statements. This guidance will be effective for annual periods beginning after December 15, 2021. Early adoption is permitted. The Company is currently evaluating the impact of the new guidance on the Company's results of operations, financial condition and cash flows. Additionally, the Company will adopt the following pronouncement, which is not expected to have a material impact the Company's results of operations, financial condition and cash flows. • ASU 2021-08 – “Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” |
Operations and Summary of Sig_3
Operations and Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Schedule of Cash and Cash Equivalents | Cash and cash equivalents reported in the Consolidated Balance Sheets as of December 31, 2021, 2020 and 2019 and cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows for the years ended December 31, 2021, 2020 and 2019 are as follows (in millions): December 31, 2021 December 31, 2020 December 31, 2019 Cash (1) $ 833.0 $ 1,022.0 $ 412.3 Cash equivalents (2) 49.2 89.7 17.3 Restricted cash (3) 6.9 7.4 3.2 Total $ 889.1 $ 1,119.1 $ 432.8 ____________________________________ (1) Consisted primarily of cash on hand and bank deposits. (2) Consisted primarily of money market deposits, certificates of deposits and overnight investments. The Company considers all investments with an original maturity of three months or less to be cash equivalents. (3) Consisted primarily of cash in escrow or held as guarantee to support specific requirements. |
Accounts Receivable Outstanding as a Percent of Net Sales | The following summarizes by geographic region, as a percentage of the Company’s consolidated net sales, amounts with maximum interest-free periods as presented below (in millions): Year Ended December 31, 2021 North South Europe/ Asia/ Consolidated 0 to 6 months $ 1,909.7 $ 1,307.7 $ 6,217.6 $ 949.7 $ 10,384.7 93.2 % 7 to 12 months 739.7 — 4.1 — 743.8 6.7 % 13 to 24 months 9.8 — — — 9.8 0.1 % $ 2,659.2 $ 1,307.7 $ 6,221.7 $ 949.7 $ 11,138.3 100.0 % |
Trade Allowances and Sales Incentive Discounts | Accounts and notes receivable allowances at December 31, 2021 and 2020 were as follows (in millions): 2021 2020 Sales incentive discounts $ 8.0 $ 12.9 Doubtful accounts 32.6 36.4 $ 40.6 $ 49.3 |
Schedule of Inventory, Current | Inventories, net at December 31, 2021 and 2020 were as follows (in millions): 2021 2020 Finished goods $ 718.2 $ 641.3 Repair and replacement parts 697.8 652.3 Work in process 282.8 175.1 Raw materials 894.9 505.7 Inventories, net $ 2,593.7 $ 1,974.4 |
Property, Plant and Equipment | Property, plant and equipment, net at December 31, 2021 and 2020 consisted of the following (in millions): 2021 2020 Land $ 141.0 $ 147.2 Buildings and improvements 875.9 899.7 Machinery and equipment 2,702.3 2,772.0 Furniture and fixtures 171.1 168.0 Gross property, plant and equipment 3,890.3 3,986.9 Accumulated depreciation and amortization (2,425.5) (2,478.4) Property, plant and equipment, net $ 1,464.8 $ 1,508.5 |
Schedule of Goodwill | Changes in the carrying amount of goodwill during the years ended December 31, 2021, 2020 and 2019 are summarized as follows (in millions): North South Europe/ Asia/ Consolidated Balance as of December 31, 2018 $ 611.1 $ 116.7 $ 649.6 $ 118.1 $ 1,495.5 Impairment charge — — (173.6) — (173.6) Sale of a joint venture (5.1) — — — (5.1) Foreign currency translation — (4.5) (12.7) (1.3) (18.5) Balance as of December 31, 2019 606.0 112.2 463.3 116.8 1,298.3 Acquisition 7.2 — — — 7.2 Impairment charge (20.0) — — — (20.0) Foreign currency translation 0.2 (24.7) 38.0 7.5 21.0 Balance as of December 31, 2020 593.4 87.5 501.3 124.3 1,306.5 Acquisitions 16.2 — 0.6 — 16.8 Foreign currency translation — (5.8) (32.4) (4.3) (42.5) Balance as of December 31, 2021 $ 609.6 $ 81.7 $ 469.5 $ 120.0 $ 1,280.8 |
Schedule of Acquired Finite-Lived Intangible Assets by Major Class | The acquired intangible assets have a weighted average useful life as follows: Intangible Assets Weighted-Average Useful Life Patents and technology 11 years Customer relationships 13 years Trademarks and trade names 20 years Land use rights 45 years Trademarks and Customer Patents and Land Use Total Gross carrying amounts: Balance as of December 31, 2019 $ 199.3 $ 579.0 $ 151.1 $ 8.5 $ 937.9 Foreign currency translation 6.7 6.4 6.9 0.6 20.6 Balance as of December 31, 2020 206.0 585.4 158.0 9.1 958.5 Acquisitions 0.7 3.2 6.1 — 10.0 Sale of business (1.3) (4.4) (17.1) — (22.8) Foreign currency translation (5.5) (10.8) (6.3) 0.2 (22.4) Balance as of December 31, 2021 $ 199.9 $ 573.4 $ 140.7 $ 9.3 $ 923.3 Accumulated Amortization Trademarks and Customer Patents and Land Use Total Balance as of December 31, 2019 $ 83.3 $ 347.4 $ 88.7 $ 3.1 $ 522.5 Amortization expense 10.1 39.9 9.4 0.1 59.5 Foreign currency translation 2.0 3.0 5.1 0.2 10.3 Balance as of December 31, 2020 95.4 390.3 103.2 3.4 592.3 Amortization expense 10.8 37.4 12.5 0.2 60.9 Sale of business (1.3) (4.4) (15.2) — (20.9) Foreign currency translation (1.7) (8.0) (5.0) 0.2 (14.5) Balance as of December 31, 2021 $ 103.2 $ 415.3 $ 95.5 $ 3.8 $ 617.8 |
Schedule of Indefinite-lived Intangible Assets by Major Class | Indefinite-Lived Intangible Assets Trademarks and Balance as of December 31, 2019 $ 86.3 Foreign currency translation 3.1 Balance as of December 31, 2020 89.4 Foreign currency translation (2.7) Balance as of December 31, 2021 $ 86.7 |
Schedule of Accrued Liabilities | Accrued expenses at December 31, 2021 and 2020 consisted of the following (in millions): 2021 2020 Reserve for volume discounts and sales incentives $ 602.3 $ 582.9 Warranty reserves 492.7 431.6 Accrued employee compensation and benefits 322.3 329.2 Accrued taxes 282.5 249.6 Other 362.4 323.4 Balance at the end of the year $ 2,062.2 $ 1,916.7 |
Schedule of Product Warranty Liability | The warranty reserve activity for the years ended December 31, 2021, 2020 and 2019 consisted of the following (in millions): 2021 2020 2019 Balance at beginning of the year $ 521.8 $ 392.8 $ 360.9 Acquisitions — 0.2 — Accruals for warranties issued during the year 344.9 310.2 234.1 Settlements made (in cash or in kind) during the year (241.8) (204.3) (198.7) Foreign currency translation (32.4) 22.9 (3.5) Balance at the end of the year $ 592.5 $ 521.8 $ 392.8 |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | Stock compensation expense was recorded as follows (in millions). Refer to Note 10 for additional information regarding the Company’s stock incentive plans during 2021, 2020 and 2019: Years Ended December 31, 2021 2020 2019 Cost of goods sold $ 1.0 $ 1.1 $ 1.7 Selling, general and administrative expenses 26.6 36.8 40.0 Total stock compensation expense $ 27.6 $ 37.9 $ 41.7 |
Schedule of Components of Interest Expense, Net | Interest expense, net for the years ended December 31, 2021, 2020 and 2019 consisted of the following (in millions): 2021 2020 2019 Interest expense $ 25.4 $ 24.9 $ 28.8 Interest income (18.7) (9.9) (8.9) $ 6.7 $ 15.0 $ 19.9 |
Schedule of Earnings Per Share, Basic and Diluted | A reconciliation of net income attributable to AGCO Corporation and subsidiaries and weighted average common shares outstanding for purposes of calculating basic and diluted net income per share during the years ended December 31, 2021, 2020 and 2019 is as follows (in millions, except per share data): 2021 2020 2019 Basic net income per share: Net income attributable to AGCO Corporation and subsidiaries $ 897.0 $ 427.1 $ 125.2 Weighted average number of common shares outstanding 75.2 75.0 76.2 Basic net income per share attributable to AGCO Corporation and subsidiaries $ 11.93 $ 5.69 $ 1.64 Diluted net income per share: Net income attributable to AGCO Corporation and subsidiaries $ 897.0 $ 427.1 $ 125.2 Weighted average number of common shares outstanding 75.2 75.0 76.2 Dilutive SSARs, performance share awards and restricted stock units 0.5 0.6 0.8 Weighted average number of common shares and common share equivalents outstanding for purposes of computing diluted net income per share 75.7 75.6 77.0 Diluted net income per share attributable to AGCO Corporation and subsidiaries $ 11.85 $ 5.65 $ 1.63 |
Schedule of Comprehensive Income (Loss) | The components of other comprehensive income (loss) and the related tax effects for the years ended December 31, 2021, 2020 and 2019 are as follows (in millions): AGCO Corporation and Subsidiaries Noncontrolling Interests 2021 2021 Before-tax Income After-tax After-tax Defined benefit pension plans $ 110.1 $ (27.2) $ 82.9 $ — Net gain on derivatives 2.5 (0.4) 2.1 — Foreign currency translation adjustments (45.1) — (45.1) (0.4) Total components of other comprehensive income $ 67.5 $ (27.6) $ 39.9 $ (0.4) AGCO Corporation and Subsidiaries Noncontrolling Interests 2020 2020 Before-tax Income After-tax After-tax Defined benefit pension plans $ (19.3) $ 2.4 $ (16.9) $ — Net loss on derivatives (1.5) 0.3 (1.2) — Foreign currency translation adjustments (197.5) — (197.5) (4.3) Total components of other comprehensive loss $ (218.3) $ 2.7 $ (215.6) $ (4.3) AGCO Corporation and Subsidiaries Noncontrolling Interests 2019 2019 Before-tax Income After-tax After-tax Defined benefit pension plans $ (13.4) $ (0.6) $ (14.0) $ — Net loss on derivatives (3.1) 0.4 (2.7) — Foreign currency translation adjustments (23.1) — (23.1) 2.5 Total components of other comprehensive loss $ (39.6) $ (0.2) $ (39.8) $ 2.5 |
Business Combinations and Ass_2
Business Combinations and Asset Acquisitions (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] | The acquired identifiable intangible assets of Headsight and Faromatics as of the date of their respective acquisitions during 2021 are summarized in the following table (in millions): Intangible Asset Amount Weighted-Average Useful Life Customer relationships $ 3.2 7 years Technology 6.1 10 - 15 years Trademarks 0.7 7 years $ 10.0 |
Restructuring Expenses (Tables)
Restructuring Expenses (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Restructuring Reserve by Type of Cost | The components of the restructuring expenses are summarized as follows (in millions): Employee Severance Facility Closure Costs Write-down of Property, Plant Other Related Loss on Sale of Total Balance as of December 31, 2018 $ 7.1 $ — $ — $ — $ — $ 7.1 2019 provision 5.6 0.5 1.5 — 2.1 9.7 Less: Non-cash expense — — (1.5) — (2.1) (3.6) Cash expense 5.6 0.5 — — — 6.1 2019 provision reversal (0.7) — — — — (0.7) 2019 cash activity (6.8) (0.5) — — — (7.3) Foreign currency translation (0.4) — — — — (0.4) Balance as of December 31, 2019 4.8 — — — — 4.8 2020 provision 11.3 4.5 2.5 1.8 — 20.1 Less: Non-cash expense — — (2.5) — — (2.5) Cash expense 11.3 4.5 — 1.8 — 17.6 2020 provision reversal (0.4) — — — — (0.4) 2020 cash activity (4.5) (0.6) — — — (5.1) Foreign currency translation (0.1) — — — — (0.1) Balance as of December 31, 2020 11.1 3.9 — 1.8 — 16.8 2021 provision 18.4 — 0.2 1.5 — 20.1 Less: Non-cash expense — — (0.2) — — (0.2) Cash expense 18.4 — — 1.5 — 19.9 2021 provision reversal (2.2) — — (0.1) (2.5) (4.8) 2021 cash activity (12.3) (3.9) — (2.9) 2.5 (16.6) Foreign currency translation (0.5) — — (0.1) — (0.6) Balance as of December 31, 2021 $ 14.5 $ — $ — $ 0.2 $ — $ 14.7 |
Investments in Affiliates (Tabl
Investments in Affiliates (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Investments in and Advances to Affiliates | Investments in affiliates as of December 31, 2021 and 2020 were as follows (in millions): 2021 2020 Finance joint ventures $ 359.2 $ 395.3 Manufacturing joint ventures 31.0 31.8 Other affiliates 23.3 15.6 $ 413.5 $ 442.7 |
Schedule of Equity Method Investments | The Company’s equity in net earnings of affiliates for the years ended December 31, 2021, 2020 and 2019 were as follows (in millions): 2021 2020 2019 Finance joint ventures $ 64.4 $ 45.0 $ 41.5 Manufacturing and other joint ventures 1.2 0.5 1.0 $ 65.6 $ 45.5 $ 42.5 As of December 31, 2021 2020 Total assets $ 7,863.6 $ 8,033.4 Total liabilities 7,130.5 7,226.7 Partners’ equity 733.1 806.7 For the Years Ended December 31, 2021 2020 2019 Revenues $ 411.1 $ 402.2 $ 417.6 Costs 228.1 274.0 299.9 Income before income taxes $ 183.0 $ 128.2 $ 117.7 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income before Income Tax, Domestic and Foreign | The sources of income before income taxes and equity in net earnings of affiliates were as follows for the years ended December 31, 2021, 2020 and 2019 (in millions): 2021 2020 2019 United States $ 46.8 $ (73.4) $ (53.1) Foreign 897.5 635.4 314.2 Income before income taxes and equity in net earnings of affiliates $ 944.3 $ 562.0 $ 261.1 |
Schedule of Components of Income Tax Expense (Benefit) | The provision for income taxes by location of the taxing jurisdiction for the years ended December 31, 2021, 2020 and 2019 consisted of the following (in millions): 2021 2020 2019 Current: United States $ 3.4 $ 4.1 $ (4.4) Foreign 222.9 180.2 170.1 226.3 184.3 165.7 Deferred: United States (70.0) 1.3 1.3 Foreign (47.9) 2.1 13.8 (117.9) 3.4 15.1 $ 108.4 $ 187.7 $ 180.8 |
Schedule of Effective Income Tax Rate Reconciliation | A reconciliation of income taxes computed at the United States federal statutory income tax rate (21% for 2021, 2020, and 2019) to the provision for income taxes reflected in the Company’s Consolidated Statements of Operations for the years ended December 31, 2021, 2020 and 2019 is as follows (in millions): 2021 2020 2019 Provision for income taxes at United States federal statutory rate $ 198.3 $ 118.0 $ 54.8 State and local income taxes, net of federal income tax effects 2.2 (3.5) (2.5) Taxes on foreign income which differ from the United States statutory rate 16.2 13.9 6.7 Tax effect of permanent differences (6.4) 13.4 63.9 Change in valuation allowance (130.8) 16.3 84.6 Change in tax contingency reserves 36.6 37.2 3.2 Research and development tax credits (7.4) (9.0) (7.1) Impacts related to changes in tax laws — — (21.8) Other (0.3) 1.4 (1.0) $ 108.4 $ 187.7 $ 180.8 |
Schedule of Deferred Tax Assets and Liabilities | The significant components of the deferred tax assets and liabilities at December 31, 2021 and 2020 were as follows (in millions): 2021 2020 Deferred Tax Assets: Net operating loss carryforwards $ 69.5 $ 62.9 Sales incentive discounts 40.1 50.8 Inventory valuation reserves 33.6 35.9 Pensions and postretirement health care benefits 18.5 55.8 Warranty and other reserves 102.9 126.3 Research and development tax credits 3.8 12.9 Foreign tax credits 9.4 5.9 Other 14.0 10.4 Total gross deferred tax assets 291.8 360.9 Valuation allowance (47.4) (181.0) Total deferred tax assets 244.4 179.9 Deferred Tax Liabilities: Tax over book depreciation and amortization 159.3 167.5 Investment in affiliates 24.4 33.1 Other 8.3 14.1 Total deferred tax liabilities 192.0 214.7 Net deferred tax assets (liabilities) $ 52.4 $ (34.8) Amounts recognized in Consolidated Balance Sheets: Deferred tax assets - noncurrent $ 169.3 $ 77.6 Deferred tax liabilities - noncurrent (116.9) (112.4) $ 52.4 $ (34.8) |
Summary of Income Tax Contingencies | A reconciliation of the beginning and ending balances of the total amounts of gross unrecognized tax benefits as of and during the years ended December 31, 2021 and 2020 is as follows (in millions): 2021 2020 Gross unrecognized income tax benefits at the beginning of the year $ 227.9 $ 210.7 Additions for tax positions of the current year 43.0 32.0 Additions for tax positions of prior years 8.4 9.4 Reductions for tax positions of prior years for: Changes in judgments 3.2 9.1 Settlements during the year (19.1) (52.9) Lapses of applicable statute of limitations (0.6) (0.2) Foreign currency translation and other (16.4) 19.8 Gross unrecognized income tax benefits at the end of the year $ 246.4 $ 227.9 |
Indebtedness (Tables)
Indebtedness (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Components of Indebtedness | Long-term debt consisted of the following at December 31, 2021 and 2020 (in millions): December 31, 2021 December 31, 2020 Senior term loan due 2022 $ — $ 184.0 Credit facility, expires 2023 — 277.9 1.002% Senior term loan due 2025 283.7 306.7 Senior term loans due between 2023 and 2028 (1) 445.9 806.0 0.800% Senior Notes Due 2028 680.8 — Other long-term debt 7.7 10.5 Debt issuance costs (4.8) (2.5) 1,413.3 1,582.6 Less: Senior term loans due 2021, net of debt issuance costs — (323.6) Current portion of other long-term debt (2.1) (2.3) Total long-term indebtedness, less current portion $ 1,411.2 $ 1,256.7 |
Maturities of Long-term Debt | At December 31, 2021, the aggregate scheduled maturities of long-term debt, excluding the current portion of long-term debt, are as follows (in millions): 2023 $ 281.7 2024 2.3 2025 355.1 2026 59.7 Thereafter 712.4 $ 1,411.2 |
Employee Benefit Plans (Tables)
Employee Benefit Plans (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |
Net Pension and Postretirement Cost | As of December 31, 2021 and 2020, the net prior service cost related to the Company’s Brazilian postretirement health care benefit plans was as follows (in millions): 2021 2020 Net prior service cost $ 3.2 $ 2.9 |
Reconciliation of Changes in Benefit Obligations, Plan Assets and Funded Status | The following tables set forth reconciliations of the changes in benefit obligation, plan assets and funded status as of December 31, 2021 and 2020 (in millions): Pension and ENPP Benefits Postretirement Benefits Change in benefit obligation 2021 2020 2021 2020 Benefit obligation at beginning of year $ 1,033.7 $ 917.3 $ 26.4 $ 29.4 Service cost 15.0 16.2 0.1 0.1 Interest cost 12.6 16.5 0.9 1.2 Plan participants’ contributions 1.4 1.3 — — Actuarial losses (gains) (70.7) 86.8 (3.7) (1.1) Amendments (13.6) (0.3) 0.4 — Curtailment (9.7) — — — Settlements (0.2) (0.3) — — Benefits paid (47.2) (44.6) (1.3) (1.5) Foreign currency exchange rate changes (16.5) 40.8 (0.2) (1.7) Benefit obligation at end of year $ 904.8 $ 1,033.7 $ 22.6 $ 26.4 Pension and ENPP Benefits Postretirement Benefits Change in plan assets 2021 2020 2021 2020 Fair value of plan assets at beginning of year $ 808.6 $ 711.0 $ — $ — Actual return on plan assets 27.7 76.6 — — Employer contributions 36.0 32.4 1.3 1.5 Plan participants’ contributions 1.4 1.3 — — Benefits paid (47.2) (44.6) (1.3) (1.5) Settlements (0.2) (0.3) — — Foreign currency exchange rate changes (10.7) 32.2 — — Fair value of plan assets at end of year $ 815.6 $ 808.6 $ — $ — Funded status $ (89.2) $ (225.1) $ (22.6) $ (26.4) Unrecognized net actuarial losses (gains) 291.7 385.1 (1.1) 2.6 Unrecognized prior service cost 7.1 20.1 3.2 2.9 Accumulated other comprehensive loss (298.8) (405.2) (2.1) (5.5) Net amount recognized $ (89.2) $ (225.1) $ (22.6) $ (26.4) Amounts recognized in Consolidated Other long-term asset $ 109.4 $ 13.2 $ — $ — Other current liabilities (7.1) (6.7) (1.5) (1.4) Accrued expenses (3.6) (3.2) — — Pensions and postretirement health care benefits (noncurrent) (187.9) (228.4) (21.1) (25.0) Net amount recognized $ (89.2) $ (225.1) $ (22.6) $ (26.4) |
Schedule of Accumulated Other Comprehensive Income (Loss) | The Company’s accumulated comprehensive loss as of December 31, 2021 and 2020 reflects a reduction in equity related to the following items (in millions): 2021 2020 All plans: (1) Reduction in equity, net of taxes of $72.0 and $98.6 at December 31, 2021 and 2020, respectively $ 300.9 $ 410.8 GIMA joint venture: (2) Reduction in equity, net of taxes of $0.5 and $0.6 at December 31, 2021 and 2020, respectively 1.5 1.7 ______________________________________ (1) Primarily related to the Company’s U.K. pension plan. (2) These amounts represented 50% of GIMA’s unrecognized net actuarial losses and unrecognized prior service cost associated with its pension plan. In addition, GIMA recognized a net actuarial loss due to settlements of approximately $0.1 million in 2020. Defined Benefit Pension Plans Cumulative Translation Adjustment Deferred Net Gains (Losses) on Derivatives Total Accumulated other comprehensive loss, December 31, 2019 $ (296.4) $ (1,297.5) $ (1.3) $ (1,595.2) Other comprehensive (loss) income before reclassifications (32.1) (197.5) 5.1 (224.5) Net losses (gains) reclassified from accumulated other comprehensive loss 15.2 — (6.3) 8.9 Other comprehensive loss, net of reclassification adjustments (16.9) (197.5) (1.2) (215.6) Accumulated other comprehensive loss, December 31, 2020 (313.3) (1,495.0) (2.5) (1,810.8) Other comprehensive income (loss) before reclassifications 70.0 (45.1) 5.1 30.0 Net losses (gains) reclassified from accumulated other comprehensive income (loss) 12.9 — (3.0) 9.9 Other comprehensive income (loss), net of reclassification adjustments 82.9 (45.1) 2.1 39.9 Accumulated other comprehensive loss, December 31, 2021 $ (230.4) $ (1,540.1) $ (0.4) $ (1,770.9) |
Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) | The unrecognized net actuarial losses included in accumulated other comprehensive loss related to the Company’s defined benefit pension plans and ENPP as of December 31, 2021 and 2020 are set forth below (in millions): 2021 2020 Unrecognized net actuarial losses $ 291.7 $ 385.1 2021 2020 Unrecognized prior service cost $ 7.1 $ 20.1 |
Schedule of Defined Benefit Plan Amortization Losses | As of December 31, 2021, the average amortization periods were as follows: ENPP U.S. Plans U.K. Plan Average amortization period of losses related to defined benefit pension plans 7 years 14 years 19 years |
Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year | The following table summarizes the unrecognized net actuarial (gains) losses included in the Company’s accumulated other comprehensive loss related to the Company’s U.S. and Brazilian postretirement health care benefit plans as of December 31, 2021 and 2020 (in millions): 2021 2020 Unrecognized net actuarial (gains) losses (1) $ (1.1) $ 2.6 ___________________________________ (1) Includes a gain of approximately $0.2 million and a loss of $1.0 million, respectively, related to the Company’s U.S. postretirement benefit plans. |
Defined Benefit Plan, Plan Assets, Category | The following table summarizes the fair value of plan assets, aggregate projected benefit obligation and accumulated benefit obligation as of December 31, 2021 and 2020 for defined benefit pension plans, ENPP and other postretirement plans with accumulated benefit obligations in excess of plan assets (in millions): 2021 2020 All plans: Fair value of plan assets $ 43.4 $ 41.6 Projected benefit obligation 264.1 306.2 Accumulated benefit obligation 246.6 269.4 U.S.-based plans and ENPP: Fair value of plan assets $ 4.9 $ 5.1 Projected benefit obligation 130.9 157.4 Accumulated benefit obligation 125.4 135.4 |
Allocation of Plan Assets | The fair value of the Company’s pension assets as of December 31, 2020 is as follows (in millions): Total Level 1 Level 2 Level 3 Equity securities: Global equities $ 235.3 $ 156.5 $ 78.8 $ — Non-U.S. equities 4.7 4.7 — — U.K. equities 65.2 65.2 — — U.S. large cap equities 5.2 5.2 — — U.S. small cap equities 3.9 3.9 — — Total equity securities 314.3 235.5 78.8 — Fixed income: Aggregate fixed income 162.9 162.9 — — International fixed income 249.5 249.5 — — Total fixed income share (1) 412.4 412.4 — — Alternative investments: Private equity fund 2.1 — — 2.1 Hedge funds measured at net asset value (4) 38.5 — — — Total alternative investments (2) 40.6 — — 2.1 Miscellaneous funds (3) 36.6 — — 36.6 Cash and equivalents measured at net asset value (4) 4.7 — — — Total assets $ 808.6 $ 647.9 $ 78.8 $ 38.7 _______________________________________ (1) 44% of “fixed income” securities are in investment-grade corporate bonds; 20% are in government treasuries; 11% are in high-yield securities; 10% are in foreign securities; 6% are in asset-backed and mortgage-backed securities; and 9% are in other various fixed income securities. (2) 42% of “alternative investments” are in relative value funds; 25% are in long-short equity funds; 14% are in event-driven funds; 5% are distributed in hedged and non-hedged funds; and 14% are in credit funds. (3) “Miscellaneous funds” is comprised of insurance contracts in Finland, Norway and Switzerland. (4) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. U.S. Pension Plans Non-U.S. Pension Plans (1) Overall investment strategies: (2) Assets for the near-term benefit payments 80.0 % 82.5 % Assets for longer-term growth 20.0 % 17.5 % Total 100.0 % 100.0 % Target allocations: Equity securities 17.0 % 12.5 % Fixed income securities 75.0 % 82.5 % Alternative investments 3.0 % 5.0 % Cash and cash equivalents 5.0 % — % Total 100.0 % 100.0 % _______________________________________ (1) The majority of the Company’s non-U.S. pension fund investments are related to the Company’s pension plan in the United Kingdom. (2) The overall U.S. and non-U.S. pension funds invest in a broad diversification of asset types. |
Reconciliation of Significant Unobservable Inputs, Changes in Plan Assets | The following is a reconciliation of Level 3 assets as of December 31, 2020 (in millions): Total Alternative Investments Miscellaneous Funds Beginning balance as of December 31, 2019 $ 33.1 $ 2.3 $ 30.8 Actual return on plan assets: (a) Relating to assets still held at reporting date 0.1 (0.2) 0.3 (b) Relating to assets sold during period — — — Purchases, sales and /or settlements 2.4 — 2.4 Foreign currency exchange rate changes 3.1 — 3.1 Ending balance as of December 31, 2020 $ 38.7 $ 2.1 $ 36.6 |
Pension plan | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |
Net Pension and Postretirement Cost | Net annual pension costs for the years ended December 31, 2021, 2020 and 2019 for the Company’s defined benefit pension plans and ENPP are set forth below (in millions): Pension benefits 2021 2020 2019 Service cost $ 15.0 $ 16.2 $ 15.5 Interest cost 12.6 16.5 20.7 Expected return on plan assets (31.3) (28.4) (28.1) Amortization of net actuarial losses 16.5 15.5 14.3 Amortization of prior service cost 0.7 2.1 1.6 Net loss recognized due to settlement 0.1 0.2 0.5 Curtailment gain (1) (1.2) — — Net annual pension cost $ 12.4 $ 22.1 $ 24.5 ___________________________________ (1) During 2021, the Company amended its Executive Nonqualified Pension Plan (“ENPP”) to freeze the plan as of December 31, 2024 to future salary benefit accruals, and to eliminate a lifetime annuity feature for participants reaching age 65 subsequent to December 31, 2022. This amendment resulted in a curtailment gain as well as a net prior service credit. |
Assumptions Used | The weighted average assumptions used to determine the net annual pension costs for the Company’s defined benefit pension plans and ENPP for the years ended December 31, 2021, 2020 and 2019 are as follows: 2021 2020 2019 All plans: Weighted average discount rate 1.5 % 2.0 % 2.8 % Weighted average expected long-term rate of return on plan assets 3.9 % 4.1 % 4.6 % Rate of increase in future compensation 1.5%-5.0% 1.8%-5.0% 1.8%-5.0% U.S.-based plans: Weighted average discount rate 2.75 % 3.45 % 4.35 % Weighted average expected long-term rate of return on plan assets (1) 5.0 % 5.0 % 5.5 % Rate of increase in future compensation (2) 5.0 % 5.0 % 5.0 % ___________________________________ (1) Applicable for U.S. funded, qualified plans. (2) Applicable for U.S. unfunded, nonqualified plan. 2021 2020 All plans: Weighted average discount rate 1.9 % 1.5 % Rate of increase in future compensation 1.50%-5.0% 1.50%-5.0% U.S.-based plans: Weighted average discount rate 3.05 % 2.75 % Rate of increase in future compensation (1) 4.25 % 5.0 % ____________________________________ (1) Applicable for U.S. unfunded, nonqualified plan. |
Schedule of Accumulated Other Comprehensive Income (Loss) | The following table summarizes the activity in accumulated other comprehensive loss related to the Company’s ENPP and defined pension and postretirement benefit plans during the years ended December 31, 2021 and 2020 (in millions): Before-Tax Income After-Tax Accumulated other comprehensive loss as of December 31, 2019 $ (393.2) $ (96.8) $ (296.4) Prior service credit arising during the year 0.3 — 0.3 Net loss recognized due to settlement 0.3 — 0.3 Net actuarial loss arising during the year (37.8) (5.1) (32.7) Amortization of prior service cost 2.2 0.1 2.1 Amortization of net actuarial losses 15.7 2.6 13.1 Accumulated other comprehensive loss as of December 31, 2020 $ (412.5) $ (99.2) $ (313.3) Prior service credit arising during the year 13.1 3.1 10.0 Net loss recognized due to settlement 0.1 — 0.1 Net loss recognized due to curtailment 8.5 2.2 6.3 Net actuarial gain arising during the year 71.0 17.4 53.6 Amortization of prior service cost 0.8 0.2 0.6 Amortization of net actuarial losses 16.6 4.3 12.3 Accumulated other comprehensive loss as of December 31, 2021 $ (302.4) $ (72.0) $ (230.4) |
Expected Benefit Payments | At December 31, 2021, the aggregate expected benefit payments for the Company’s defined benefit pension plans and ENPP are as follows (in millions): 2022 $ 53.2 2023 51.6 2024 51.8 2025 52.2 2026 52.5 2027 through 2031 279.1 $ 540.4 |
Allocation of Plan Assets | The fair value of the Company’s pension assets as of December 31, 2021 is as follows (in millions): Total Level 1 Level 2 Level 3 Equity securities: Global equities $ 102.5 $ 18.2 $ 84.3 $ — U.S. large cap equities 5.6 5.6 — — Total equity securities 108.1 23.8 84.3 — Fixed income: Aggregate fixed income 615.9 615.9 — — Total fixed income share (1) 615.9 615.9 — — Alternative investments: Private equity fund 3.5 — — 3.5 Hedge funds measured at net asset value (4) 41.7 — — — Total alternative investments (2) 45.2 — — 3.5 Miscellaneous funds (3) 40.2 — — 40.2 Cash and equivalents measured at net asset value (4) 6.2 — — — Total assets $ 815.6 $ 639.7 $ 84.3 $ 43.7 ______________________________________ (1) 50% of "fixed income" securities are in government treasuries; 20% are in foreign securities; 13% are in investment-grade corporate bonds; 8% are in high-yield securities; 6% are in other various fixed income securities and 3% are in asset-backed and mortgage-backed securities. (2) 42% of “alternative investments” are in relative value funds; 28% are in long-short equity funds; 14% are in event-driven funds; 8% are in credit funds; and 8% are distributed in hedged and non-hedged funds. (3) “Miscellaneous funds” is comprised of insurance contracts in Finland, Norway and Switzerland. (4) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
Reconciliation of Significant Unobservable Inputs, Changes in Plan Assets | The following is a reconciliation of Level 3 assets as of December 31, 2021 (in millions): Total Alternative Investments Miscellaneous Funds Beginning balance as of December 31, 2020 $ 38.7 $ 2.1 $ 36.6 Actual return on plan assets: (a) Relating to assets still held at reporting date 3.3 1.4 1.9 (b) Relating to assets sold during period — — — Purchases, sales and /or settlements 4.7 — 4.7 Foreign currency exchange rate changes (3.0) — (3.0) Ending balance as of December 31, 2021 $ 43.7 $ 3.5 $ 40.2 |
Postretirement benefits | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |
Net Pension and Postretirement Cost | Net annual postretirement benefit costs, and the weighted average discount rate used to determine them, for the years ended December 31, 2021, 2020 and 2019 are set forth below (in millions, except percentages): Postretirement benefits 2021 2020 2019 Service cost $ 0.1 $ 0.1 $ 0.1 Interest cost 0.9 1.2 1.3 Amortization of net actuarial losses 0.1 0.1 — Amortization of prior service cost 0.1 0.1 0.1 Net annual postretirement benefit cost $ 1.2 $ 1.5 $ 1.5 Weighted average discount rate 3.8 % 4.5 % 5.2 % |
Expected Benefit Payments | At December 31, 2021, the aggregate expected benefit payments for the Company’s U.S. and Brazilian postretirement benefit plans are as follows (in millions): 2022 $ 1.5 2023 1.6 2024 1.6 2025 1.6 2026 1.6 2027 through 2031 7.5 $ 15.4 |
U.S. | Pension plan | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |
Allocation of Plan Assets | The weighted average asset allocation of the Company’s U.S. pension benefit plans as of December 31, 2021 and 2020 are as follows: Asset Category 2021 2020 Equity securities 14 % 36 % Fixed income securities 75 % 57 % Other investments 11 % 7 % Total 100 % 100 % |
Non-U.S. | Pension plan | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |
Allocation of Plan Assets | The weighted average asset allocation of the Company’s non-U.S. pension benefit plans as of December 31, 2021 and 2020 are as follows: Asset Category 2021 2020 Equity securities 14 % 41 % Fixed income securities 80 % 53 % Other investments 6 % 6 % Total 100 % 100 % |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Equity [Abstract] | |
Schedule of Accumulated Other Comprehensive Income (Loss) | The Company’s accumulated comprehensive loss as of December 31, 2021 and 2020 reflects a reduction in equity related to the following items (in millions): 2021 2020 All plans: (1) Reduction in equity, net of taxes of $72.0 and $98.6 at December 31, 2021 and 2020, respectively $ 300.9 $ 410.8 GIMA joint venture: (2) Reduction in equity, net of taxes of $0.5 and $0.6 at December 31, 2021 and 2020, respectively 1.5 1.7 ______________________________________ (1) Primarily related to the Company’s U.K. pension plan. (2) These amounts represented 50% of GIMA’s unrecognized net actuarial losses and unrecognized prior service cost associated with its pension plan. In addition, GIMA recognized a net actuarial loss due to settlements of approximately $0.1 million in 2020. Defined Benefit Pension Plans Cumulative Translation Adjustment Deferred Net Gains (Losses) on Derivatives Total Accumulated other comprehensive loss, December 31, 2019 $ (296.4) $ (1,297.5) $ (1.3) $ (1,595.2) Other comprehensive (loss) income before reclassifications (32.1) (197.5) 5.1 (224.5) Net losses (gains) reclassified from accumulated other comprehensive loss 15.2 — (6.3) 8.9 Other comprehensive loss, net of reclassification adjustments (16.9) (197.5) (1.2) (215.6) Accumulated other comprehensive loss, December 31, 2020 (313.3) (1,495.0) (2.5) (1,810.8) Other comprehensive income (loss) before reclassifications 70.0 (45.1) 5.1 30.0 Net losses (gains) reclassified from accumulated other comprehensive income (loss) 12.9 — (3.0) 9.9 Other comprehensive income (loss), net of reclassification adjustments 82.9 (45.1) 2.1 39.9 Accumulated other comprehensive loss, December 31, 2021 $ (230.4) $ (1,540.1) $ (0.4) $ (1,770.9) |
Schedule of Reclassifications Out of AOCI | The following table sets forth reclassification adjustments out of accumulated other comprehensive loss by component attributed to AGCO Corporation and its subsidiaries for the years ended December 31, 2021 and 2020 (in millions): Details about Accumulated Other Comprehensive Loss Components Amount Reclassified from Accumulated Other Comprehensive Loss Affected Line Item within the Consolidated Year ended December 31, 2021 (1) Year ended December 31, 2020 (1) Derivatives: Net losses (gains) on foreign currency contracts $ 11.4 $ (6.4) Cost of goods sold Net gains on commodity contracts (17.2) — Cost of goods sold Reclassification before tax (5.8) (6.4) 2.8 0.1 Income tax provision Reclassification net of tax $ (3.0) $ (6.3) Defined benefit pension plans: Amortization of net actuarial losses $ 16.6 $ 15.7 Other expense, net (2) Amortization of prior service cost 0.8 2.2 Other expense, net (2) Reclassification before tax 17.4 17.9 (4.5) (2.7) Income tax provision Reclassification net of tax $ 12.9 $ 15.2 Net losses reclassified from accumulated other comprehensive loss $ 9.9 $ 8.9 ____________________________________ (1) (Gains) losses included within the Consolidated Statements of Operations for the years ended December 31, 2021 and 2020, respectively. (2) These accumulated other comprehensive loss components are included in the computation of net periodic pension and postretirement benefit cost. See Note 8 to the Company’s Consolidated Financial Statements. |
Dividends Declared | The Company’s Board of Directors has declared and the Company has paid cash dividends per common share during the following years: 2021 (1)(2) 2020 (2) 2019 (2) Dividends declared and paid per common share $ 4.74 $ 0.63 $ 0.63 ____________________________________ (1) The Company’s Board of Directors declared and the Company has paid quarterly cash dividends of $0.20 per common share beginning in the second quarter of 2021, from $0.16 per common share in the first quarter of 2021. On January 20, 2022, the Company's Board of Directors approved a quarterly dividend of $0.20 per common share outstanding commencing in the first quarter of 2022. In addition, the Company's Board of Directors also declared and the Company paid a special cash dividend of $4.00 per common share during 2021 totaling approximately $301.5 million. (2) The Company’s Board of Directors declared and the Company has paid quarterly cash dividends of $0.16 per common share beginning in the second quarter of 2019, from $0.15 per common share in the first quarter of 2019, through the first quarter of 2021. |
Stock Incentive Plan (Tables)
Stock Incentive Plan (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average grant-date fair value of performance awards granted under the Plan during 2021, 2020 and 2019 was as follows: Years Ended December 31, 2021 2020 2019 Weighted average grant-date fair value $ 123.33 $ 70.84 $ 61.01 |
Performance Award Transactions | Performance award transactions during 2021 were as follows and are presented as if the Company were to achieve its maximum levels of performance under the plan: Shares awarded but not earned at January 1 582,952 Shares awarded 281,310 Shares forfeited (40,350) Shares earned (309,198) Shares awarded but not earned at December 31 514,714 |
Restricted Stock Unit Award Transactions | RSU transactions during the year ended December 31, 2021 were as follows: Shares awarded but not vested at January 1 143,287 Shares awarded 92,848 Shares forfeited (9,797) Shares vested (67,110) Shares awarded but not vested at December 31 159,228 |
Weighted Average Grant-Date Fair Value Of SSARS And Assumptions Under Black-Scholes Option Model | The weighted average grant-date fair value of SSAR awards granted under the Plan and the weighted average assumptions under the Black-Scholes option model were as follows for the years ended December 31, 2020 and 2019: 2020 2019 Weighted average grant-date fair value $ 12.31 $ 11.34 Weighted average assumptions under Black-Scholes option model: Expected life of awards (years) 3.0 3.0 Risk-free interest rate 1.5 % 2.6 % Expected volatility 24.1 % 24.2 % Expected dividend yield 0.9 % 1.0 % |
SSAR Activity | SSAR transactions during the year ended December 31, 2021 were as follows: SSARs outstanding at January 1 403,150 SSARs granted — SSARs exercised (194,661) SSARs canceled or forfeited (13,878) SSARs outstanding at December 31 194,611 SSAR price ranges per share: Granted $ — Exercised 43.88 - 73.14 Canceled or forfeited 46.58 - 73.14 Weighted average SSAR exercise prices per share: Granted $ — Exercised 64.41 Canceled or forfeited 68.51 Outstanding at December 31 68.33 |
Schedule Of SSAR Exercise Price Range, Number Of Shares, Weighted Average Exercise Price And Remaining Contractual Lives | The following table sets forth the exercise price range, number of shares, weighted average exercise price, and remaining contractual lives by groups of similar price as of December 31, 2021: SSARs Outstanding SSARs Exercisable Range of Exercise Prices Number of Weighted Average Weighted Average Exercisable as of December 31, 2021 Weighted Average $46.58 - $63.47 80,523 3.51 $ 61.91 38,923 $ 60.91 $72.74 - $73.14 114,088 4.41 $ 72.86 35,013 $ 72.99 194,611 73,936 $ 66.63 |
Derivative Instruments and He_2
Derivative Instruments and Hedging Activities (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] | The following table summarizes the after-tax impact that changes in the fair value of derivatives designated as cash flow hedges had on accumulated other comprehensive loss and net income during 2021, 2020 and 2019 (in millions): Recognized in Net Income Gain (Loss) Recognized in Accumulated Classification of Gain (Loss) Gain (Loss) Reclassified from Accumulated Total Amount of the Line Item in the Consolidated Statements of Operations Containing Hedge Gains (Losses) 2021 Foreign currency contracts $ (7.4) Cost of goods sold $ (10.2) $ 8,566.0 Commodity contracts (1) 12.5 Cost of goods sold 13.2 $ 8,566.0 Total $ 5.1 $ 3.0 2020 Foreign currency contracts $ 4.6 Cost of goods sold $ 6.3 $ 7,092.2 Commodity contracts (1) 0.5 Cost of goods sold — $ 7,092.2 Total $ 5.1 $ 6.3 2019 Foreign currency contracts $ (2.6) Cost of goods sold $ 0.1 $ 7,057.1 (1) The outstanding contracts as of December 31, 2021 range in maturity through July 2022. |
Summary Of Accumulated Other Comprehensive Loss Related To Derivatives | The following table summarizes the activity in accumulated other comprehensive loss related to the derivatives held by the Company during the years ended December 31, 2021, 2020 and 2019 (in millions): Before-Tax Income After-Tax Accumulated derivative net gains as of December 31, 2018 $ 1.6 $ 0.2 $ 1.4 Net changes in fair value of derivatives (3.0) (0.4) (2.6) Net gains reclassified from accumulated other comprehensive loss into income (0.1) — (0.1) Accumulated derivative net losses as of December 31, 2019 $ (1.5) $ (0.2) $ (1.3) Net changes in fair value of derivatives 4.9 (0.2) 5.1 Net gains reclassified from accumulated other comprehensive loss into income (6.4) (0.1) (6.3) Accumulated derivative net losses as of December 31, 2020 $ (3.0) $ (0.5) $ (2.5) Net changes in fair value of derivatives 8.3 3.2 5.1 Net gains reclassified from accumulated other comprehensive loss into income (5.8) (2.8) (3.0) Accumulated derivative net losses as of December 31, 2021 (1) $ (0.5) $ (0.1) $ (0.4) (1) As of December 31, 2021, approximately $0.2 million of derivative realized net losses and approximately $1.5 million of derivative realized net gains, before taxes, remain in accumulated other comprehensive loss related to foreign currency contracts and commodity contracts, respectively, associated with inventory that had not yet been sold. |
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] | The following table summarizes the notional values of the instrument designated as a net investment hedge (in millions): Notional Amount as of December 31, 2021 December 31, 2020 Cross currency swap contract $ 300.0 $ 300.0 |
Schedule of Derivative Instruments [Table Text Block] | The following table summarizes the after-tax impact of changes in the fair value of the instrument designated as a net investment hedge (in millions): Gain (Loss) Recognized in Accumulated Other Comprehensive Loss for the Years Ended December 31, 2021 December 31, 2020 December 31, 2019 Foreign currency denominated debt $ — $ 1.7 $ 2.5 Cross currency swap contract 11.0 (25.5) 9.3 |
Derivatives Not Designated as Hedging Instruments [Table Text Block] | The following table summarizes the impact that changes in the fair value of derivatives not designated as hedging instruments had on net income (in millions): For the Years Ended Classification of December 31, 2021 December 31, 2020 December 31, 2019 Foreign currency contracts Other expense, net $ 54.8 $ 3.7 $ 20.4 |
Fair Value Of Derivative Instruments | The table below sets forth the fair value of derivative instruments as of December 31, 2021 (in millions): Asset Derivatives as of Liability Derivatives as of Balance Sheet Fair Balance Sheet Fair Derivative instruments designated as hedging instruments: Foreign currency contracts Other current assets $ — Other current liabilities $ — Commodity contracts Other current assets 0.2 Other current liabilities 2.0 Cross currency swap contract Other noncurrent assets 12.5 Other noncurrent liabilities — Derivative instruments not designated as hedging instruments: Foreign currency contracts (1) Other current assets 15.1 Other current liabilities 5.1 Total derivative instruments $ 27.8 $ 7.1 (1) The outstanding contracts as of December 31, 2021 range in maturity through October 2022. The table below sets forth the fair value of derivative instruments as of December 31, 2020 (in millions): Asset Derivatives as of Liability Derivatives as of Balance Sheet Fair Balance Sheet Fair Derivative instruments designated as hedging instruments: Foreign currency contracts Other current assets $ 1.0 Other current liabilities $ 4.5 Commodity contracts Other current assets 0.5 Other current liabilities — Cross currency swap contract Other noncurrent assets 1.5 Other noncurrent liabilities — Derivative instruments not designated as hedging instruments: Foreign currency contracts Other current assets 12.3 Other current liabilities 22.2 Total derivative instruments $ 15.3 $ 26.7 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets and Liabilities Measured at Fair Value | Assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 and 2020 are summarized below (in millions): As of December 31, 2021 Level 1 Level 2 Level 3 Total Derivative assets $ — $ 27.8 $ — $ 27.8 Derivative liabilities — 7.1 — 7.1 As of December 31, 2020 Level 1 Level 2 Level 3 Total Derivative assets $ — $ 15.3 $ — $ 15.3 Derivative liabilities — 26.7 — 26.7 |
Segment Reporting (Tables)
Segment Reporting (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Segment Results By Reportable Segments | Segment results for the years ended December 31, 2021, 2020 and 2019 based on the Company’s reportable segments are as follows (in millions): Years Ended December 31, North America South America Europe/Middle East Asia/Pacific/Africa Consolidated 2021 Net sales $ 2,659.2 $ 1,307.7 $ 6,221.7 $ 949.7 $ 11,138.3 Income from operations 238.1 132.2 755.4 113.9 1,239.6 Depreciation 60.8 26.5 116.5 16.9 220.7 Assets 1,328.1 922.7 2,348.7 610.6 5,210.1 Capital expenditures 41.2 32.5 184.6 11.5 269.8 2020 Net sales $ 2,175.0 $ 873.8 $ 5,366.9 $ 734.0 $ 9,149.7 Income from operations 193.7 29.3 585.3 62.1 870.4 Depreciation 61.3 25.8 110.5 14.9 212.5 Assets 1,051.9 687.6 2,238.7 536.2 4,514.4 Capital expenditures 42.2 18.8 201.8 7.1 269.9 2019 Net sales $ 2,191.8 $ 802.2 $ 5,328.8 $ 718.6 $ 9,041.4 Income (loss) from operations 121.6 (39.4) 638.2 43.4 763.8 Depreciation 61.6 32.4 102.7 14.2 210.9 Assets 1,125.6 758.0 2,187.7 430.2 4,501.5 Capital expenditures 52.1 32.9 173.5 14.9 273.4 |
Income From Operations And Total Assets | A reconciliation from the segment information to the consolidated balances for income from operations and total assets is set forth below (in millions): 2021 2020 2019 Segment income from operations $ 1,239.6 $ 870.4 $ 763.8 Corporate expenses (135.2) (134.7) (129.0) Amortization of intangibles (61.1) (59.5) (61.1) Stock compensation expense (26.6) (36.8) (40.0) Impairment charges — (20.0) (176.6) Restructuring expenses (15.3) (19.7) (9.0) Consolidated income from operations $ 1,001.4 $ 599.7 $ 348.1 Segment assets $ 5,210.1 $ 4,514.4 $ 4,501.5 Cash and cash equivalents 889.1 1,119.1 432.8 Investments in affiliates 413.5 442.7 380.2 Deferred tax assets, other current and noncurrent assets 996.4 665.9 645.2 Intangible assets, net 392.2 455.6 501.7 Goodwill 1,280.8 1,306.5 1,298.3 Consolidated total assets $ 9,182.1 $ 8,504.2 $ 7,759.7 |
Schedule of Segment Reporting Information, Property, Plant And Equipment and Amortizable Intangible Assets By Country | Property, plant and equipment, right-of-use lease assets and amortizable intangible assets by country as of December 31, 2021 and 2020 was as follows (in millions): 2021 2020 United States $ 499.1 $ 541.2 Germany 446.7 456.6 Finland 189.5 191.4 Brazil 144.9 150.4 France 133.2 137.6 Italy 112.7 129.0 China 91.6 98.9 Denmark 84.7 101.9 Other 222.0 232.8 $ 1,924.4 $ 2,039.8 |
Revenue (Tables)
Revenue (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Significant Changes in Contract Assets and Liabilities | Significant changes in the balance of contract liabilities for the years ended December 31, 2021 and 2020 were as follows (in millions): Year Ended December 31, 2021 Year Ended December 31, 2020 Balance at beginning of period $ 172.0 $ 104.0 Advance consideration received 227.8 192.7 Revenue recognized during the period for extended warranty contracts, maintenance services and technology services (64.0) (46.6) Revenue recognized during the period related to grain storage and protein production systems (103.5) (85.6) Foreign currency translation (6.1) 7.5 Balance as of December 31 $ 226.2 $ 172.0 |
Disaggregation of Revenue | Net sales for the year ended December 31, 2021 disaggregated by primary geographical markets and major products consisted of the following (in millions): North America South Europe/ Asia/ Consolidated Primary geographical markets: United States $ 2,116.2 $ — $ — $ — $ 2,116.2 Canada 436.7 — — — 436.7 Germany — — 1,332.0 — 1,332.0 France — — 1,129.1 — 1,129.1 United Kingdom and Ireland — — 635.3 — 635.3 Finland and Scandinavia — — 836.3 — 836.3 Other Europe — — 2,104.6 — 2,104.6 South America — 1,294.8 — — 1,294.8 Middle East and Algeria — — 184.4 — 184.4 Africa — — — 152.3 152.3 Asia — — — 436.5 436.5 Australia and New Zealand — — — 360.9 360.9 Mexico, Central America and Caribbean 106.3 12.9 — — 119.2 $ 2,659.2 $ 1,307.7 $ 6,221.7 $ 949.7 $ 11,138.3 Major products: Tractors $ 940.4 $ 664.6 $ 4,338.2 $ 443.7 $ 6,386.9 Replacement parts 379.1 131.8 1,070.5 106.5 1,687.9 Grain storage and protein production systems 534.9 140.1 174.0 227.1 1,076.1 Combines, application equipment and other machinery 804.8 371.2 639.0 172.4 1,987.4 $ 2,659.2 $ 1,307.7 $ 6,221.7 $ 949.7 $ 11,138.3 Net sales for the year ended December 31, 2020 disaggregated by primary geographical markets and major products consisted of the following (in millions): North South Europe/ Asia/ Consolidated Primary geographical markets: United States $ 1,763.2 $ — $ — $ — $ 1,763.2 Canada 325.9 — — — 325.9 Germany — — 1,280.6 — 1,280.6 France — — 1,080.2 — 1,080.2 United Kingdom and Ireland — — 557.8 — 557.8 Finland and Scandinavia — — 698.5 — 698.5 Other Europe — — 1,613.1 — 1,613.1 South America — 865.4 — — 865.4 Middle East and Algeria — — 136.7 — 136.7 Africa — — — 58.3 58.3 Asia — — — 373.1 373.1 Australia and New Zealand — — — 302.6 302.6 Mexico, Central America and Caribbean 85.9 8.4 — — 94.3 $ 2,175.0 $ 873.8 $ 5,366.9 $ 734.0 $ 9,149.7 Major products: Tractors $ 692.0 $ 469.8 $ 3,814.3 $ 296.1 $ 5,272.2 Replacement parts 338.4 84.0 936.1 87.2 1,445.7 Grain storage and protein production systems 471.0 82.8 122.2 226.0 902.0 Combines, application equipment and other machinery 673.6 237.2 494.3 124.7 1,529.8 $ 2,175.0 $ 873.8 $ 5,366.9 $ 734.0 $ 9,149.7 Net sales for the year ended December 31, 2019 disaggregated by primary geographical markets and major products consisted of the following (in millions): North America South Europe/ Asia/ Consolidated Primary geographical markets: United States $ 1,787.4 $ — $ — $ — $ 1,787.4 Canada 302.0 — — — 302.0 Germany — — 1,194.3 — 1,194.3 France — — 1,097.6 — 1,097.6 United Kingdom and Ireland — — 561.9 — 561.9 Finland and Scandinavia — — 772.8 — 772.8 Other Europe — — 1,629.0 — 1,629.0 South America — 789.7 — — 789.7 Middle East and Algeria — — 73.2 — 73.2 Africa — — — 116.2 116.2 Asia — — — 344.7 344.7 Australia and New Zealand — — — 257.7 257.7 Mexico, Central America and Caribbean 102.4 12.5 — — 114.9 $ 2,191.8 $ 802.2 $ 5,328.8 $ 718.6 $ 9,041.4 Major products: Tractors $ 662.4 $ 447.7 $ 3,772.0 $ 300.6 $ 5,182.7 Replacement parts 310.2 88.2 874.8 74.6 1,347.8 Grain storage and protein production systems 547.9 79.5 172.8 234.6 1,034.8 Combines, application equipment and other machinery 671.3 186.8 509.2 108.8 1,476.1 $ 2,191.8 $ 802.2 $ 5,328.8 $ 718.6 $ 9,041.4 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Leases [Abstract] | |
Assets and Liabilities, Lessee | Total lease assets and liabilities at December 31, 2021 and 2020 were as follows (in millions): Lease Assets Classification As of December 31, 2021 As of December 31, 2020 Operating ROU assets Right-of-use lease assets $ 154.1 $ 165.1 Finance lease assets Property, plant and equipment, net (1) 10.6 15.1 Total lease assets $ 164.7 $ 180.2 Lease Liabilities Classification As of December 31, 2021 As of December 31, 2020 Current: Operating Accrued expenses $ 42.3 $ 43.5 Finance Other current liabilities 3.8 3.0 Noncurrent: Operating Operating lease liabilities 115.5 125.9 Finance Other noncurrent liabilities 6.0 9.8 Total lease liabilities $ 167.6 $ 182.2 ____________________________________ (1) Finance lease assets are recorded net of accumulated depreciation of $7.8 million and $15.6 million as of December 31, 2021 and 2020, respectively. |
Lease, Cost | Total lease costs for 2021 and 2020 are set forth below (in millions): Classification Year Ended Year Ended Operating lease cost Selling, general and administrative expenses $ 59.0 $ 54.0 Variable lease cost Selling, general and administrative expenses 1.0 1.7 Short-term lease cost Selling, general and administrative expenses 18.7 11.0 Finance lease cost: Amortization of lease assets Depreciation expense (1) 2.4 3.7 Interest on lease liabilities Interest expense, net 0.3 0.6 Total lease cost $ 81.4 $ 71.0 ____________________________________ (1) Depreciation expense was included in both cost of goods sold and selling, general and administrative expenses. As of December 31, 2021 As of December 31, 2020 Weighted-average remaining lease term: Operating leases 7 years 7 years Finance leases 12 years 15 years Weighted-average discount rate: Operating leases 3.1 % 3.5 % Finance leases 2.4 % 2.7 % Year Ended December 31, 2021 Year Ended December 31, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 59.8 $ 54.1 Operating cash flows from finance leases 0.2 0.4 Financing cash flows from finance leases 2.6 3.8 Leased assets obtained in exchange for lease obligations: Operating leases $ 50.6 $ 30.8 Finance leases 0.9 0.9 |
Lessee, Operating Lease, Liability, Maturity | Lease payment amounts for operating and finance leases with remaining terms greater than one year as of December 31, 2021 were as follows (in millions): December 31, 2021 Operating Leases Finance Leases 2022 $ 45.7 $ 4.0 2023 36.2 0.9 2024 24.5 0.6 2025 17.3 0.4 2026 12.3 0.2 Thereafter 39.1 6.3 Total lease payments 175.1 12.4 Less: imputed interest (1) (17.3) (2.5) Present value of lease liabilities $ 157.8 $ 9.9 ____________________________________ (1) Calculated using the implicit interest rate for each lease. Lease payment amounts for operating and finance leases with remaining terms greater than one year as of December 31, 2020 were as follows (in millions): December 31, 2020 Operating Leases Finance Leases 2021 $ 47.6 $ 3.3 2022 37.7 1.4 2023 28.6 1.1 2024 18.9 0.8 2025 13.6 0.6 Thereafter 44.5 9.1 Total lease payments 190.9 16.3 Less: imputed interest (1) (21.5) (3.5) Present value of lease liabilities $ 169.4 $ 12.8 ____________________________________ (1) Calculated using the implicit interest rate for each lease. |
Finance Lease, Liability, Maturity | Lease payment amounts for operating and finance leases with remaining terms greater than one year as of December 31, 2021 were as follows (in millions): December 31, 2021 Operating Leases Finance Leases 2022 $ 45.7 $ 4.0 2023 36.2 0.9 2024 24.5 0.6 2025 17.3 0.4 2026 12.3 0.2 Thereafter 39.1 6.3 Total lease payments 175.1 12.4 Less: imputed interest (1) (17.3) (2.5) Present value of lease liabilities $ 157.8 $ 9.9 ____________________________________ (1) Calculated using the implicit interest rate for each lease. Lease payment amounts for operating and finance leases with remaining terms greater than one year as of December 31, 2020 were as follows (in millions): December 31, 2020 Operating Leases Finance Leases 2021 $ 47.6 $ 3.3 2022 37.7 1.4 2023 28.6 1.1 2024 18.9 0.8 2025 13.6 0.6 Thereafter 44.5 9.1 Total lease payments 190.9 16.3 Less: imputed interest (1) (21.5) (3.5) Present value of lease liabilities $ 169.4 $ 12.8 ____________________________________ (1) Calculated using the implicit interest rate for each lease. |
Operations and Summary of Sig_4
Operations and Summary of Significant Accounting Policies (Business) (Details) | Dec. 31, 2021Independent_Dealers_Distributors |
Accounting Policies [Abstract] | |
Number of independent dealers and distributors | 3,200 |
Operations and Summary of Sig_5
Operations and Summary of Significant Accounting Policies (Basis of Presentation and Consolidation) (Details) | Dec. 31, 2021 |
Minimum | |
Schedule of Equity Method Investments [Line Items] | |
Ownership percentage | 20.00% |
Operations and Summary of Sig_6
Operations and Summary of Significant Accounting Policies (Cash and Cash Equivalents and Restricted Cash) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Accounting Policies [Abstract] | ||||
Cash | $ 833 | $ 1,022 | $ 412.3 | |
Cash Equivalents | 49.2 | 89.7 | 17.3 | |
Restricted Cash | 6.9 | 7.4 | 3.2 | |
Total | $ 889.1 | $ 1,119.1 | $ 432.8 | $ 326.1 |
Operations and Summary of Sig_7
Operations and Summary of Significant Accounting Policies (Accounts and Notes Receivable) (Details) | 12 Months Ended |
Dec. 31, 2021 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Time period in which remaining installment balance is generally due | 12 months |
Interest free period on receivables | 12 months |
Equipment sales | United States and Canada | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Payment period on product sales | 12 months |
Replacement parts | United States and Canada | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Payment period on product sales | 30 days |
Grain storage and protein production systems | United States and Canada | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Payment period on product sales | 30 days |
Maximum | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Interest free period on receivables | 12 months |
Payment period on product sales | 6 months |
Maximum | Large seasonal products | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Interest free period on receivables | 24 months |
Maximum | Large seasonal products | International | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Payment period on product sales | 6 months |
Maximum | Equipment sales | International | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Payment period on product sales | 180 days |
Maximum | Replacement parts | International | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Payment period on product sales | 90 days |
Minimum | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Interest free period on receivables | 1 month |
Minimum | Equipment sales | International | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Payment period on product sales | 30 days |
Minimum | Replacement parts | International | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Payment period on product sales | 30 days |
Operations and Summary of Sig_8
Operations and Summary of Significant Accounting Policies (Summary of Geographic Region) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
0 to 6 months | $ 10,384.7 | ||
0 to 6 months, percent | 93.20% | ||
7 to 12 months | $ 743.8 | ||
7 to 12 months, percent | 6.70% | ||
13 to 24 months | $ 9.8 | ||
13 to 24 months, percent | 0.10% | ||
Net sales | $ 11,138.3 | $ 9,149.7 | $ 9,041.4 |
Net sales, percent | 100.00% | ||
North America | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
0 to 6 months | $ 1,909.7 | ||
7 to 12 months | 739.7 | ||
13 to 24 months | 9.8 | ||
Net sales | 2,659.2 | ||
South America | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
0 to 6 months | 1,307.7 | ||
7 to 12 months | 0 | ||
13 to 24 months | 0 | ||
Net sales | 1,307.7 | ||
Europe/ Middle East | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
0 to 6 months | 6,217.6 | ||
7 to 12 months | 4.1 | ||
13 to 24 months | 0 | ||
Net sales | 6,221.7 | ||
Asia/ Pacific/Africa | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
0 to 6 months | 949.7 | ||
7 to 12 months | 0 | ||
13 to 24 months | 0 | ||
Net sales | $ 949.7 |
Operations and Summary of Sig_9
Operations and Summary of Significant Accounting Policies (Summary of Accounts and Notes Receivable Allowances) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Doubtful accounts | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Allowances | $ 32.6 | $ 36.4 | $ 28.8 | $ 31.7 |
Accounts receivable | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Allowances | 40.6 | 49.3 | ||
Accounts receivable | Sales incentive discounts | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Allowances | 8 | 12.9 | ||
Accounts receivable | Doubtful accounts | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Allowances | $ 32.6 | $ 36.4 |
Operations and Summary of Si_10
Operations and Summary of Significant Accounting Policies (Inventories Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Accounting Policies [Abstract] | ||
Adjustment for surplus and obsolete inventories | $ 202.6 | $ 209.2 |
Operations and Summary of Si_11
Operations and Summary of Significant Accounting Policies (Summary of Inventory) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Accounting Policies [Abstract] | ||
Finished goods | $ 718.2 | $ 641.3 |
Repair and replacement parts | 697.8 | 652.3 |
Work in process | 282.8 | 175.1 |
Raw materials | 894.9 | 505.7 |
Inventories, net | $ 2,593.7 | $ 1,974.4 |
Operations and Summary of Si_12
Operations and Summary of Significant Accounting Policies (Recoverable Indirect Taxes) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Accounting Policies [Abstract] | ||
VAT tax credits | $ 114.4 | $ 91.2 |
Operations and Summary of Si_13
Operations and Summary of Significant Accounting Policies (Property Plant and Equipment Narrative) (Details) | 12 Months Ended |
Dec. 31, 2021 | |
Minimum | Buildings and improvements | |
Property, Plant and Equipment [Line Items] | |
Property, plant and equipment useful life | 2 years |
Minimum | Machinery and equipment | |
Property, Plant and Equipment [Line Items] | |
Property, plant and equipment useful life | 3 years |
Minimum | Furniture and fixtures | |
Property, Plant and Equipment [Line Items] | |
Property, plant and equipment useful life | 3 years |
Maximum | Buildings and improvements | |
Property, Plant and Equipment [Line Items] | |
Property, plant and equipment useful life | 40 years |
Maximum | Machinery and equipment | |
Property, Plant and Equipment [Line Items] | |
Property, plant and equipment useful life | 15 years |
Maximum | Furniture and fixtures | |
Property, Plant and Equipment [Line Items] | |
Property, plant and equipment useful life | 10 years |
Operations and Summary of Si_14
Operations and Summary of Significant Accounting Policies (Summary of Property Plant and Equipment) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Property, Plant and Equipment [Abstract] | ||
Gross property, plant and equipment | $ 3,890.3 | $ 3,986.9 |
Accumulated depreciation and amortization | (2,425.5) | (2,478.4) |
Property, plant and equipment, net | 1,464.8 | 1,508.5 |
Land | ||
Property, Plant and Equipment [Abstract] | ||
Gross property, plant and equipment | 141 | 147.2 |
Buildings and improvements | ||
Property, Plant and Equipment [Abstract] | ||
Gross property, plant and equipment | 875.9 | 899.7 |
Machinery and equipment | ||
Property, Plant and Equipment [Abstract] | ||
Gross property, plant and equipment | 2,702.3 | 2,772 |
Furniture and fixtures | ||
Property, Plant and Equipment [Abstract] | ||
Gross property, plant and equipment | $ 171.1 | $ 168 |
Operations and Summary of Si_15
Operations and Summary of Significant Accounting Policies (Goodwill and Other Intangible Assets and Long-Lived Assets Narrative) (Details) $ in Millions | Oct. 01, 2019USD ($) | Jun. 30, 2021 | Jun. 30, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2021USD ($)country | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) |
Goodwill [Line Items] | |||||||
Ownership percentage in joint venture | 50.00% | ||||||
Goodwill impairment charge | $ 20 | $ 173.6 | |||||
Long-lived assets impairment charge | $ 3 | ||||||
Amortization of intangibles | $ 61.1 | 59.5 | 61.1 | ||||
Sale of business | (20.9) | ||||||
2022 | 57.5 | ||||||
2023 | 53.8 | ||||||
2024 | 52.5 | ||||||
2025 | 48.4 | ||||||
2026 | $ 19.7 | ||||||
Ownership Percentage In Joint Venture Sold | 50.00% | ||||||
Intellectual Property | |||||||
Goodwill [Line Items] | |||||||
Intangible assets useful life | 5 years | ||||||
Amortization of intangibles | $ 0.2 | ||||||
Finite-Lived Intangible Assets, Net | $ 16.1 | ||||||
North America | |||||||
Goodwill [Line Items] | |||||||
Goodwill impairment charge | $ 20 | ||||||
Europe/ Middle East | |||||||
Goodwill [Line Items] | |||||||
Goodwill impairment charge | $ 173.6 | ||||||
Massey Ferguson | |||||||
Goodwill [Line Items] | |||||||
Number of countries where products are sold | country | 110 | ||||||
Valtra Brand | |||||||
Goodwill [Line Items] | |||||||
Number of countries where products are sold | country | 60 | ||||||
Minimum | |||||||
Goodwill [Line Items] | |||||||
Intangible assets useful life | 5 years | ||||||
Maximum | |||||||
Goodwill [Line Items] | |||||||
Intangible assets useful life | 50 years | ||||||
Impairment charges | |||||||
Goodwill [Line Items] | |||||||
Goodwill impairment charge | $ 173.6 | $ 20 | |||||
Accumulated goodwill impairment | $ 354.1 | ||||||
Net loss attributable to noncontrolling interests | |||||||
Goodwill [Line Items] | |||||||
Goodwill impairment charge | $ 10 |
Operations and Summary of Si_16
Operations and Summary of Significant Accounting Policies (Summary of Changes in Carrying Amount of Goodwill) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Goodwill [Roll Forward] | |||
Goodwill beginning of period | $ 1,306.5 | $ 1,298.3 | $ 1,495.5 |
Impairment charge | (20) | (173.6) | |
Sale of a joint venture | (5.1) | ||
Foreign currency translation | (42.5) | 21 | (18.5) |
Acquisitions | 16.8 | 7.2 | |
Goodwill end of period | 1,280.8 | 1,306.5 | 1,298.3 |
North America | |||
Goodwill [Roll Forward] | |||
Goodwill beginning of period | 593.4 | 606 | 611.1 |
Impairment charge | (20) | ||
Sale of a joint venture | (5.1) | ||
Foreign currency translation | 0.2 | ||
Acquisitions | 16.2 | 7.2 | |
Goodwill end of period | 609.6 | 593.4 | 606 |
South America | |||
Goodwill [Roll Forward] | |||
Goodwill beginning of period | 87.5 | 112.2 | 116.7 |
Foreign currency translation | (5.8) | (24.7) | (4.5) |
Goodwill end of period | 81.7 | 87.5 | 112.2 |
Europe/ Middle East | |||
Goodwill [Roll Forward] | |||
Goodwill beginning of period | 501.3 | 463.3 | 649.6 |
Impairment charge | (173.6) | ||
Foreign currency translation | (32.4) | 38 | (12.7) |
Acquisitions | 0.6 | ||
Goodwill end of period | 469.5 | 501.3 | 463.3 |
Asia/ Pacific/Africa | |||
Goodwill [Roll Forward] | |||
Goodwill beginning of period | 124.3 | 116.8 | 118.1 |
Foreign currency translation | (4.3) | 7.5 | (1.3) |
Goodwill end of period | $ 120 | $ 124.3 | $ 116.8 |
Operations and Summary of Si_17
Operations and Summary of Significant Accounting Policies (Acquired Intangible Assets Useful Life) (Details) | 12 Months Ended |
Dec. 31, 2021 | |
Patents and technology | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Weighted-Average Useful Life | 11 years |
Customer relationships | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Weighted-Average Useful Life | 13 years |
Trademarks and trade names | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Weighted-Average Useful Life | 20 years |
Land use rights | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Weighted-Average Useful Life | 45 years |
Operations and Summary of Si_18
Operations and Summary of Significant Accounting Policies (Summary of Changes in Carrying Amount of Acquired Intangible Assets) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Finite-lived Intangible Assets [Roll Forward] | ||
Finite-lived intangible assets, beginning of period | $ 958.5 | $ 937.9 |
Foreign currency translation | (22.4) | 20.6 |
Acquisitions | 10 | |
Sale of business | 22.8 | |
Finite-lived intangible assets, end of period | 923.3 | 958.5 |
Trademarks and Trade Names | ||
Finite-lived Intangible Assets [Roll Forward] | ||
Finite-lived intangible assets, beginning of period | 206 | 199.3 |
Foreign currency translation | (5.5) | 6.7 |
Acquisitions | 0.7 | |
Sale of business | 1.3 | |
Finite-lived intangible assets, end of period | 199.9 | 206 |
Customer Relationships | ||
Finite-lived Intangible Assets [Roll Forward] | ||
Finite-lived intangible assets, beginning of period | 585.4 | 579 |
Foreign currency translation | (10.8) | 6.4 |
Acquisitions | 3.2 | |
Sale of business | 4.4 | |
Finite-lived intangible assets, end of period | 573.4 | 585.4 |
Patents and Technology | ||
Finite-lived Intangible Assets [Roll Forward] | ||
Finite-lived intangible assets, beginning of period | 158 | 151.1 |
Foreign currency translation | (6.3) | 6.9 |
Acquisitions | 6.1 | |
Sale of business | 17.1 | |
Finite-lived intangible assets, end of period | 140.7 | 158 |
Land Use Rights | ||
Finite-lived Intangible Assets [Roll Forward] | ||
Finite-lived intangible assets, beginning of period | 9.1 | 8.5 |
Foreign currency translation | 0.2 | 0.6 |
Acquisitions | 0 | |
Sale of business | 0 | |
Finite-lived intangible assets, end of period | 9.3 | $ 9.1 |
Intellectual Property | ||
Finite-lived Intangible Assets [Roll Forward] | ||
Acquisitions | $ 16.3 |
Operations and Summary of Si_19
Operations and Summary of Significant Accounting Policies (Summary of Changes in Accumulated Amortization of Acquired Intangible Assets) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Finite-lived Intangible Assets [Roll Forward] | |||
Finite-lived intangible assets, accumulated amortization, beginning of period | $ 592.3 | $ 522.5 | |
Amortization of intangibles | 61.1 | 59.5 | $ 61.1 |
Sale of business | (20.9) | ||
Foreign currency translation | (14.5) | 10.3 | |
Finite-lived intangible assets, accumulated amortization, end of period | 617.8 | 592.3 | 522.5 |
Trademarks and Trade Names | |||
Finite-lived Intangible Assets [Roll Forward] | |||
Finite-lived intangible assets, accumulated amortization, beginning of period | 95.4 | 83.3 | |
Amortization of intangibles | 10.8 | 10.1 | |
Sale of business | (1.3) | ||
Foreign currency translation | (1.7) | 2 | |
Finite-lived intangible assets, accumulated amortization, end of period | 103.2 | 95.4 | 83.3 |
Customer Relationships | |||
Finite-lived Intangible Assets [Roll Forward] | |||
Finite-lived intangible assets, accumulated amortization, beginning of period | 390.3 | 347.4 | |
Amortization of intangibles | 37.4 | 39.9 | |
Sale of business | (4.4) | ||
Foreign currency translation | (8) | 3 | |
Finite-lived intangible assets, accumulated amortization, end of period | 415.3 | 390.3 | 347.4 |
Patents and Technology | |||
Finite-lived Intangible Assets [Roll Forward] | |||
Finite-lived intangible assets, accumulated amortization, beginning of period | 103.2 | 88.7 | |
Amortization of intangibles | 12.5 | 9.4 | |
Sale of business | (15.2) | ||
Foreign currency translation | (5) | 5.1 | |
Finite-lived intangible assets, accumulated amortization, end of period | 95.5 | 103.2 | 88.7 |
Land Use Rights | |||
Finite-lived Intangible Assets [Roll Forward] | |||
Finite-lived intangible assets, accumulated amortization, beginning of period | 3.4 | 3.1 | |
Amortization of intangibles | 0.2 | 0.1 | |
Sale of business | 0 | ||
Foreign currency translation | 0.2 | 0.2 | |
Finite-lived intangible assets, accumulated amortization, end of period | 3.8 | 3.4 | 3.1 |
Intangible Assets Excluding Intellectual Property | |||
Finite-lived Intangible Assets [Roll Forward] | |||
Amortization of intangibles | $ 60.9 | $ 59.5 | $ 61.1 |
Operations and Summary of Si_20
Operations and Summary of Significant Accounting Policies (Indefinite-Lived Intangible Assets) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Indefinite-lived Intangible Assets [Roll Forward] | |||
Amortization of intangibles | $ 61.1 | $ 59.5 | $ 61.1 |
Trademarks and Trade Names | |||
Indefinite-lived Intangible Assets [Roll Forward] | |||
Indefinite-lived intangible assets, beginning of period | 89.4 | 86.3 | |
Foreign currency translation | (2.7) | 3.1 | |
Indefinite-lived intangible assets, end of period | $ 86.7 | $ 89.4 | $ 86.3 |
Operations and Summary of Si_21
Operations and Summary of Significant Accounting Policies (Accrued Expense and Reserves) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Accounting Policies [Abstract] | ||
Reserve for volume discounts and sales incentives | $ 602.3 | $ 582.9 |
Warranty reserves | 492.7 | 431.6 |
Accrued employee compensation and benefits | 322.3 | 329.2 |
Accrued taxes | 282.5 | 249.6 |
Other | 362.4 | 323.4 |
Accrued expenses | $ 2,062.2 | $ 1,916.7 |
Operations and Summary of Si_22
Operations and Summary of Significant Accounting Policies (Warranty Reserves Activity) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] | |||
Warranty reserves, beginning of period | $ 521.8 | $ 392.8 | $ 360.9 |
Acquisitions | 0 | 0.2 | 0 |
Accruals for warranties issued during the year | 344.9 | 310.2 | 234.1 |
Settlements made (in cash or in kind) during the year | (241.8) | (204.3) | (198.7) |
Foreign currency translation | (32.4) | 22.9 | (3.5) |
Warranty reserves, end of period | $ 592.5 | $ 521.8 | $ 392.8 |
Operations and Summary of Si_23
Operations and Summary of Significant Accounting Policies (Warranty Reserves Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
Minimum product warranty period | 1 year | |
Maximum product warranty period | 4 years | |
Warranty reserves included in other noncurrent liabilities | $ 99.8 | $ 90.2 |
Operations and Summary of Si_24
Operations and Summary of Significant Accounting Policies (Revenue Narrative) (Details) | 12 Months Ended |
Dec. 31, 2021 | |
Minimum | |
Accounting Policies [Line Items] | |
Extended product warrant, period | 1 year |
Maximum | |
Accounting Policies [Line Items] | |
Extended product warrant, period | 5 years |
Operations and Summary of Si_25
Operations and Summary of Significant Accounting Policies (Stock Incentive Plans) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total stock compensation expense | $ 27.6 | $ 37.9 | $ 41.7 |
Cost of goods sold | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total stock compensation expense | 1 | 1.1 | 1.7 |
Selling, general and administrative expenses | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total stock compensation expense | $ 26.6 | $ 36.8 | $ 40 |
Operations and Summary of Si_26
Operations and Summary of Significant Accounting Policies (Advertising Costs) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accounting Policies [Abstract] | |||
Advertising expense | $ 54.2 | $ 45.3 | $ 42.3 |
Operations and Summary of Si_27
Operations and Summary of Significant Accounting Policies (Shipping and Handling Expenses) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Selling, general and administrative expenses | |||
Accounting Policies [Line Items] | |||
Shipping and handling costs | $ 43.6 | $ 38 | $ 38.9 |
Operations and Summary of Si_28
Operations and Summary of Significant Accounting Policies (Summary of Interest Expense, Net) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accounting Policies [Abstract] | |||
Interest expense | $ 25.4 | $ 24.9 | $ 28.8 |
Interest income | (18.7) | (9.9) | (8.9) |
Interest expense, net | $ 6.7 | $ 15 | $ 19.9 |
Operations and Summary of Si_29
Operations and Summary of Significant Accounting Policies (Summary of Net Income Per Common Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Basic net income per share: | |||
Net income attributable to AGCO Corporation and subsidiaries | $ 897 | $ 427.1 | $ 125.2 |
Weighted average number of common shares outstanding (in shares) | 75.2 | 75 | 76.2 |
Basic net income per share attributable to AGCO Corporation and subsidiaries (in dollars per share) | $ 11.93 | $ 5.69 | $ 1.64 |
Diluted net income per share: | |||
Net income attributable to AGCO Corporation and subsidiaries | $ 897 | $ 427.1 | $ 125.2 |
Weighted average number of common shares outstanding (in shares) | 75.2 | 75 | 76.2 |
Dilutive SSARs, performance share awards and restricted stock units (in shares) | 0.5 | 0.6 | 0.8 |
Weighted average number of common shares and common share equivalents outstanding for purposes of computing diluted net income per share (in shares) | 75.7 | 75.6 | 77 |
Diluted net income per share attributable to AGCO Corporation and subsidiaries (in dollars per share) | $ 11.85 | $ 5.65 | $ 1.63 |
Operations and Summary of Si_30
Operations and Summary of Significant Accounting Policies (Net Income Per Common Share Narrative) (Details) - shares shares in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Stock Appreciation Rights (SSARs) | |||
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 0 | 0.3 | 0.2 |
Operations and Summary of Si_31
Operations and Summary of Significant Accounting Policies (Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive gain (loss), net of reclassification adjustments | $ 39.5 | $ (219.9) | $ (37.3) |
AOCI Attributable To Parent | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive income (loss), before tax amount | 67.5 | (218.3) | (39.6) |
Other comprehensive income (loss), income taxes | (27.6) | 2.7 | (0.2) |
Other comprehensive gain (loss), net of reclassification adjustments | 39.9 | (215.6) | (39.8) |
Defined Benefit Pension Plans | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive income (loss), before tax amount | 110.1 | (19.3) | (13.4) |
Other comprehensive income (loss), income taxes | (27.2) | 2.4 | (0.6) |
Other comprehensive gain (loss), net of reclassification adjustments | 82.9 | (16.9) | (14) |
Net gain on derivatives | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive income (loss), before tax amount | 2.5 | (1.5) | (3.1) |
Other comprehensive income (loss), income taxes | (0.4) | 0.3 | 0.4 |
Other comprehensive gain (loss), net of reclassification adjustments | 2.1 | (1.2) | (2.7) |
Foreign currency translation adjustments | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive income (loss), before tax amount | (45.1) | (197.5) | (23.1) |
Other comprehensive income (loss), income taxes | 0 | 0 | 0 |
Other comprehensive gain (loss), net of reclassification adjustments | (45.1) | (197.5) | (23.1) |
AOCI Attributable to Noncontrolling Interest | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive gain (loss), net of reclassification adjustments | (0.4) | (4.3) | 2.5 |
Defined benefit pension plans | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive gain (loss), net of reclassification adjustments | 0 | 0 | 0 |
Net loss on derivatives | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive gain (loss), net of reclassification adjustments | 0 | 0 | 0 |
Foreign currency translation adjustments | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Other comprehensive gain (loss), net of reclassification adjustments | $ (0.4) | $ (4.3) | $ 2.5 |
Business Combinations and Ass_3
Business Combinations and Asset Acquisitions (Details) € in Millions, $ in Millions | Jan. 01, 2022USD ($) | Dec. 01, 2021USD ($) | Sep. 10, 2021USD ($) | Sep. 10, 2021EUR (€) | Aug. 13, 2021USD ($) | Sep. 10, 2020USD ($) | Jun. 30, 2020 | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2021USD ($) | Sep. 10, 2021EUR (€) | Dec. 31, 2018USD ($) |
Business Acquisition [Line Items] | |||||||||||||
Purchase of businesses, net of cash acquired | $ 22.6 | $ 2.8 | $ 0 | ||||||||||
Ownership percentage in joint venture | 50.00% | ||||||||||||
Goodwill | 1,280.8 | 1,306.5 | 1,298.3 | $ 1,280.8 | $ 1,495.5 | ||||||||
Restricted Cash | 6.9 | $ 7.4 | $ 3.2 | 6.9 | |||||||||
Reversal of contingent consideration liability | 3.3 | ||||||||||||
Appareo | Subsequent event | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Purchase of businesses, net of cash acquired | $ 61.4 | ||||||||||||
Cash acquired from acquisition | $ 0.5 | ||||||||||||
Ownership percentage in joint venture | 50.00% | ||||||||||||
Indebtedness payable | $ 0.9 | ||||||||||||
Creatives Sites Media | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Purchase of businesses, net of cash acquired | $ 5.7 | ||||||||||||
Goodwill | $ 5.7 | ||||||||||||
Faromatics | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Purchase of businesses, net of cash acquired | $ 5.5 | € 4.6 | |||||||||||
Cash acquired from acquisition | 0.1 | € 0.1 | |||||||||||
Goodwill | 2.2 | € 1.8 | |||||||||||
Restricted Cash | $ 0.9 | € 0.8 | |||||||||||
Number of months in which remaining payment is due for the acquisition | 18 months | 18 months | |||||||||||
Faromatics | Technology | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Finite-lived intangible assets acquired | $ 5.2 | € 4.4 | |||||||||||
Headsight | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Purchase of businesses, net of cash acquired | $ 16.8 | ||||||||||||
Goodwill | 8.9 | ||||||||||||
Finite-lived intangible assets acquired | 4.8 | ||||||||||||
151 Research | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Purchase of businesses, net of cash acquired | $ 2.8 | ||||||||||||
Goodwill | 7.2 | ||||||||||||
Contingent consideration liability | $ 4.4 | 0.8 | 0.8 | ||||||||||
Payment for contingent consideration | 0.5 | ||||||||||||
Foreign currency impact included in contingent consideration liability | (0.2) | ||||||||||||
Headsight and Faromatics | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Finite-lived intangible assets acquired | $ 10 | ||||||||||||
Headsight and Faromatics | Technology | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Finite-lived intangible assets acquired | $ 6.1 | $ 6.1 | |||||||||||
Intangible assets useful life | 15 years | 15 years | 10 years | ||||||||||
Headsight and Faromatics | Customer relationships | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Finite-lived intangible assets acquired | $ 3.2 | ||||||||||||
Intangible assets useful life | 7 years | ||||||||||||
Headsight and Faromatics | Trademarks | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Finite-lived intangible assets acquired | $ 0.7 | ||||||||||||
Intangible assets useful life | 7 years |
Restructuring Expenses (Narrati
Restructuring Expenses (Narrative) (Details) $ in Millions | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2019USD ($) | Dec. 31, 2021USD ($)employees | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | |
Restructuring Cost and Reserve [Line Items] | ||||
Number of employees terminated | employees | 150 | |||
Controlling interest ownership percentage | 50.00% | |||
Proceeds from divestiture of interest in joint venture | $ 5.1 | |||
Restructuring expenses | $ 20.1 | $ 20.1 | $ 9.7 | |
Provision reversal | (4.8) | (0.4) | (0.7) | |
Loss on Sale of Joint Venture | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring expenses | 0 | 0 | 2.1 | |
Provision reversal | (2.5) | $ 0 | $ 0 | |
Gain On Sale of Joint Venture | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Provision reversal | $ 2.5 |
Restructuring Expenses (Details
Restructuring Expenses (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | $ 16.8 | $ 4.8 | $ 7.1 |
Provision | 20.1 | 20.1 | 9.7 |
Less: Non-cash expense | (0.2) | (2.5) | (3.6) |
Cash expense | 19.9 | 17.6 | 6.1 |
Provision reversal | (4.8) | (0.4) | (0.7) |
Cash activity | (5.1) | (7.3) | |
Cash activity | (16.6) | ||
Foreign currency translation | (0.6) | (0.1) | (0.4) |
Restructuring Reserve, Ending Balance | 14.7 | 16.8 | 4.8 |
Employee Severance | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 11.1 | 4.8 | 7.1 |
Provision | 18.4 | 11.3 | 5.6 |
Less: Non-cash expense | 0 | 0 | 0 |
Cash expense | 18.4 | 11.3 | 5.6 |
Provision reversal | (2.2) | (0.4) | (0.7) |
Cash activity | (4.5) | (6.8) | |
Cash activity | (12.3) | ||
Foreign currency translation | (0.5) | (0.1) | (0.4) |
Restructuring Reserve, Ending Balance | 14.5 | 11.1 | 4.8 |
Facility Closure Costs | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 3.9 | 0 | 0 |
Provision | 0 | 4.5 | 0.5 |
Less: Non-cash expense | 0 | 0 | 0 |
Cash expense | 0 | 4.5 | 0.5 |
Provision reversal | 0 | 0 | 0 |
Cash activity | (0.6) | (0.5) | |
Cash activity | (3.9) | ||
Foreign currency translation | 0 | 0 | 0 |
Restructuring Reserve, Ending Balance | 0 | 3.9 | 0 |
Write-down of Property, Plant and Equipment | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 0 | 0 | 0 |
Provision | 0.2 | 2.5 | 1.5 |
Less: Non-cash expense | (0.2) | (2.5) | (1.5) |
Cash expense | 0 | 0 | 0 |
Provision reversal | 0 | 0 | 0 |
Cash activity | 0 | 0 | |
Cash activity | 0 | ||
Foreign currency translation | 0 | 0 | 0 |
Restructuring Reserve, Ending Balance | 0 | 0 | 0 |
Other Related Closure Costs | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 1.8 | 0 | 0 |
Provision | 1.5 | 1.8 | 0 |
Less: Non-cash expense | 0 | 0 | 0 |
Cash expense | 1.5 | 1.8 | 0 |
Provision reversal | (0.1) | 0 | 0 |
Cash activity | 0 | 0 | |
Cash activity | (2.9) | ||
Foreign currency translation | (0.1) | 0 | 0 |
Restructuring Reserve, Ending Balance | 0.2 | 1.8 | 0 |
Loss on Sale of Joint Venture | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 0 | 0 | 0 |
Provision | 0 | 0 | 2.1 |
Less: Non-cash expense | 0 | 0 | (2.1) |
Cash expense | 0 | 0 | 0 |
Provision reversal | (2.5) | 0 | 0 |
Cash activity | 0 | 0 | |
Cash activity | 2.5 | ||
Foreign currency translation | 0 | 0 | 0 |
Restructuring Reserve, Ending Balance | $ 0 | $ 0 | $ 0 |
Accounts Receivable Sales Agr_2
Accounts Receivable Sales Agreements (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Resale Agreement Counterparty [Line Items] | |||
Outstanding accounts receivable securitization | $ 82.1 | $ 85.2 | |
Trade Receivables | |||
Resale Agreement Counterparty [Line Items] | |||
Cash received from receivables sold | 215.4 | 199.9 | |
Other expense, net | |||
Resale Agreement Counterparty [Line Items] | |||
Loss on sales of receivables | 24.5 | 24.1 | $ 42.4 |
United States, Canada, Europe, and Brazil | |||
Resale Agreement Counterparty [Line Items] | |||
Cash received from receivables sold | $ 1,300 | $ 1,500 |
Investments in Affiliates (Inve
Investments in Affiliates (Investment in Affiliates) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Schedule of Equity Method Investments [Line Items] | ||
Investments in affiliates | $ 413.5 | $ 442.7 |
Finance joint ventures | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in affiliates | 359.2 | 395.3 |
Manufacturing joint ventures | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in affiliates | 31 | 31.8 |
Other affiliates | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in affiliates | $ 23.3 | $ 15.6 |
Investments in Affiliates (Narr
Investments in Affiliates (Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Noncontrolling Interest [Line Items] | ||
Receivables from affiliates | $ 55.1 | $ 47.5 |
Undistributed earnings | 365.6 | $ 375.5 |
Dividends from joint ventures | 84.4 | |
Return of investment in excess of earnings | $ 22.7 | |
Finance Joint Ventures | ||
Noncontrolling Interest [Line Items] | ||
Noncontrolling interest, ownership percentage by parent | 49.00% |
Investments in Affiliates (Equi
Investments in Affiliates (Equity in Net Earnings of Affiliates) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Schedule of Equity Method Investments [Line Items] | |||
Equity in net earnings of affiliates | $ 65.6 | $ 45.5 | $ 42.5 |
Finance joint ventures | |||
Schedule of Equity Method Investments [Line Items] | |||
Equity in net earnings of affiliates | 64.4 | 45 | 41.5 |
Manufacturing and other joint ventures | |||
Schedule of Equity Method Investments [Line Items] | |||
Equity in net earnings of affiliates | $ 1.2 | $ 0.5 | $ 1 |
Investments in Affiliates (Summ
Investments in Affiliates (Summarized Financial Information of Finance Joint Ventures) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Schedule of Equity Method Investments [Line Items] | |||
Total assets | $ 9,182.1 | $ 8,504.2 | $ 7,759.7 |
Total liabilities | 5,738.3 | 5,486.2 | |
Partners’ equity | 3,415.9 | 2,980 | |
Income before income taxes | 183 | 128.2 | 117.7 |
Equity Method Investment, Nonconsolidated Investee or Group of Investees | |||
Schedule of Equity Method Investments [Line Items] | |||
Total assets | 7,863.6 | 8,033.4 | |
Total liabilities | 7,130.5 | 7,226.7 | |
Partners’ equity | 733.1 | 806.7 | |
Revenues | 411.1 | 402.2 | 417.6 |
Costs | $ 228.1 | $ 274 | $ 299.9 |
Income Taxes (Schedule of Incom
Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Sources of income (loss) before income taxes and equity in net earnings of affiliates | |||
United States | $ 46.8 | $ (73.4) | $ (53.1) |
Foreign | 897.5 | 635.4 | 314.2 |
Income before income taxes and equity in net earnings of affiliates | $ 944.3 | $ 562 | $ 261.1 |
Income Taxes (Schedule of Compo
Income Taxes (Schedule of Components of Income Tax Expense (Benefit)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Current: | |||
United States | $ 3.4 | $ 4.1 | $ (4.4) |
Foreign | 222.9 | 180.2 | 170.1 |
Current income tax expense (benefit) | 226.3 | 184.3 | 165.7 |
Deferred: | |||
United States | (70) | 1.3 | 1.3 |
Foreign | (47.9) | 2.1 | 13.8 |
Deferred income tax expense (benefit) | (117.9) | 3.4 | 15.1 |
Income tax provision | $ 108.4 | $ 187.7 | $ 180.8 |
Income Taxes (Narrative) (Detai
Income Taxes (Narrative) (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | 24 Months Ended | |||
Dec. 31, 2019 | Sep. 30, 2019 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2021 | |
Income Taxes [Line Items] | ||||||
Foreign currency transaction gain | $ 21.8 | |||||
Tax Cuts and Jobs Act income tax benefit | $ 0 | $ 0 | $ 21.8 | |||
Deferred tax liability | 34.8 | |||||
Valuation allowance | 47.4 | 181 | $ 47.4 | |||
Non-cash deferred income tax charge | $ 53.7 | |||||
Net operating loss carryforwards | 235.6 | 235.6 | ||||
Net operating loss carryforwards not subject to expiration | 146.5 | 146.5 | ||||
Income taxes paid | 247.3 | 181.4 | 144.4 | |||
Unrecognized income tax benefits that would affect effective tax rate | 246.4 | 227.9 | 246.4 | |||
Accrued or deferred taxes relating to uncertain income tax positions | 40.1 | 57.1 | 40.1 | |||
Interest and penalties related to unrecognized tax benefits | 4.8 | 7.1 | ||||
Accrued interest and penalties related to unrecognized tax benefits | 32.7 | 39.4 | 32.7 | |||
Indirect favorable effects relating to other tax jurisdictions | 70.2 | 64.1 | ||||
Income tax examination, penalties and interest accrued | 40.1 | 40.1 | ||||
Cash | $ 412.3 | 833 | $ 1,022 | $ 412.3 | 833 | |
Net deferred tax assets (liabilities) | 52.4 | 52.4 | ||||
United States | ||||||
Income Taxes [Line Items] | ||||||
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | 67.8 | |||||
BRAZIL | ||||||
Income Taxes [Line Items] | ||||||
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | 55.6 | |||||
Change in tax positions, judgements, and lapses of statutes of limitations | ||||||
Income Taxes [Line Items] | ||||||
Indirect favorable effects relating to other tax jurisdictions | 9.9 | |||||
Foreign | ||||||
Income Taxes [Line Items] | ||||||
Net operating loss carryforwards | 235.6 | 235.6 | ||||
Cash | 6.7 | 6.7 | ||||
2022 | ||||||
Income Taxes [Line Items] | ||||||
Net operating loss carryforwards, subject to expiration | 14.2 | 14.2 | ||||
2023 | ||||||
Income Taxes [Line Items] | ||||||
Net operating loss carryforwards, subject to expiration | 23.9 | 23.9 | ||||
2024 | ||||||
Income Taxes [Line Items] | ||||||
Net operating loss carryforwards, subject to expiration | $ 51 | $ 51 |
Income Taxes (Schedule of Effec
Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract] | |||
Provision for income taxes at United States federal statutory rate | $ 198.3 | $ 118 | $ 54.8 |
State and local income taxes, net of federal income tax effects | 2.2 | (3.5) | (2.5) |
Taxes on foreign income which differ from the United States statutory rate | 16.2 | 13.9 | 6.7 |
Tax effect of permanent differences | (6.4) | 13.4 | 63.9 |
Change in valuation allowance | (130.8) | 16.3 | 84.6 |
Change in tax contingency reserves | 36.6 | 37.2 | 3.2 |
Research and development tax credits | (7.4) | (9) | (7.1) |
Impacts related to changes in tax laws | 0 | 0 | (21.8) |
Other | (0.3) | 1.4 | (1) |
Income tax provision | $ 108.4 | $ 187.7 | $ 180.8 |
Income Taxes (Schedule of Defer
Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Deferred Tax Assets: | ||
Net operating loss carryforwards | $ 69.5 | $ 62.9 |
Sales incentive discounts | 40.1 | 50.8 |
Inventory valuation reserves | 33.6 | 35.9 |
Pensions and postretirement health care benefits | 18.5 | 55.8 |
Warranty and other reserves | 102.9 | 126.3 |
Research and development tax credits | 3.8 | 12.9 |
Foreign tax credits | 9.4 | 5.9 |
Other | 14 | 10.4 |
Total gross deferred tax assets | 291.8 | 360.9 |
Valuation allowance | (47.4) | (181) |
Total deferred tax assets | 244.4 | 179.9 |
Deferred Tax Liabilities: | ||
Tax over book depreciation and amortization | 159.3 | 167.5 |
Investment in affiliates | 24.4 | 33.1 |
Other | 8.3 | 14.1 |
Total deferred tax liabilities | 192 | 214.7 |
Net deferred tax assets (liabilities) | 52.4 | |
Net deferred tax assets (liabilities) | (34.8) | |
Amounts recognized in Consolidated Balance Sheets: | ||
Deferred tax assets - noncurrent | 169.3 | 77.6 |
Deferred tax liabilities - noncurrent | (116.9) | (112.4) |
Net deferred tax assets (liabilities) | $ 52.4 | |
Net deferred tax assets (liabilities) | $ (34.8) |
Income Taxes (Summary of Income
Income Taxes (Summary of Income Tax Contingencies) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Gross unrecognized tax benefits: | ||
Gross unrecognized income tax benefits, beginning of period | $ 227.9 | $ 210.7 |
Additions for tax positions of the current year | 43 | 32 |
Additions for tax positions of prior years | 8.4 | 9.4 |
Reductions for tax positions of prior years for: | ||
Changes in judgments | 3.2 | 9.1 |
Settlements during the year | (19.1) | (52.9) |
Lapses of applicable statute of limitations | (0.6) | (0.2) |
Foreign currency translation and other | (16.4) | 19.8 |
Gross unrecognized income tax benefits, end of period | $ 246.4 | $ 227.9 |
Indebtedness (Components Of Ind
Indebtedness (Components Of Indebtedness) (Details) € in Millions, $ in Millions | Dec. 31, 2021USD ($) | Dec. 31, 2021EUR (€) | Oct. 06, 2021 | Dec. 31, 2020USD ($) |
Debt Instrument [Line Items] | ||||
Other long-term debt | $ 7.7 | $ 10.5 | ||
Debt issuance costs | (4.8) | (2.5) | ||
Total indebtedness | 1,413.3 | 1,582.6 | ||
Less: Senior term loans due 2021, net of debt issuance costs | (2.1) | (325.9) | ||
Current portion of other long-term debt | (2.1) | (2.3) | ||
Total long-term indebtedness, less current portion | 1,411.2 | 1,256.7 | ||
Senior Notes due 2022 | ||||
Debt Instrument [Line Items] | ||||
Senior notes | 0 | 184 | ||
Credit facility, expires 2023 | ||||
Debt Instrument [Line Items] | ||||
Senior notes | $ 0 | 277.9 | ||
1.002% Senior term loan due 2025 | ||||
Debt Instrument [Line Items] | ||||
Debt interest rate | 1.002% | 1.002% | ||
1.002% Senior term loan due 2025 | ||||
Debt Instrument [Line Items] | ||||
Senior notes | $ 283.7 | 306.7 | ||
Senior term loans due between 2021 and 2028 | ||||
Debt Instrument [Line Items] | ||||
Senior notes | 445.9 | 806 | ||
Less: Senior term loans due 2021, net of debt issuance costs | 0 | (323.6) | ||
0.800% Senior Notes Due 2028 | ||||
Debt Instrument [Line Items] | ||||
Senior notes | $ 680.8 | € 600 | $ 0 | |
Debt interest rate | 0.80% | 0.80% | 0.80% |
Indebtedness (Maturities of Lon
Indebtedness (Maturities of Long-term Debt) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Debt Disclosure [Abstract] | ||
2023 | $ 281.7 | |
2024 | 2.3 | |
2025 | 355.1 | |
2026 | 59.7 | |
Thereafter | 712.4 | |
Total indebtedness, less current portion | $ 1,411.2 | $ 1,256.7 |
Indebtedness (Narrative) (Detai
Indebtedness (Narrative) (Details) | Feb. 01, 2022USD ($) | Feb. 01, 2022EUR (€) | Oct. 19, 2021USD ($) | Oct. 19, 2021EUR (€) | Oct. 15, 2021USD ($) | Oct. 08, 2021USD ($) | Oct. 08, 2021EUR (€) | Oct. 06, 2021USD ($) | Aug. 01, 2021USD ($) | Aug. 01, 2021EUR (€) | Feb. 16, 2021USD ($) | Feb. 16, 2021EUR (€) | Apr. 15, 2020USD ($) | Apr. 15, 2020EUR (€) | Apr. 09, 2020USD ($) | Oct. 31, 2019USD ($) | Oct. 31, 2019EUR (€) | Aug. 31, 2018EUR (€)loan_agreement | Oct. 31, 2018USD ($) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Feb. 01, 2022EUR (€) | Dec. 31, 2021EUR (€) | Oct. 06, 2021EUR (€) | Apr. 15, 2020EUR (€) | Apr. 09, 2020EUR (€) | Jan. 25, 2019EUR (€) | Oct. 31, 2018EUR (€) | Oct. 31, 2016EUR (€)loan_agreement |
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Interest paid | $ 23,800,000 | $ 23,600,000 | $ 26,300,000 | |||||||||||||||||||||||||||
Repayments of indebtedness | 2,501,400,000 | 1,045,600,000 | $ 2,191,100,000 | |||||||||||||||||||||||||||
Current portion of long-term debt | 2,100,000 | 325,900,000 | ||||||||||||||||||||||||||||
Outstanding letters of credit | 14,600,000 | 14,400,000 | ||||||||||||||||||||||||||||
Short term borrowings | 90,800,000 | 33,800,000 | ||||||||||||||||||||||||||||
Debt Instrument, Face Amount, Issue Price, Percentage | 99.993% | |||||||||||||||||||||||||||||
Number of term loan agreements | loan_agreement | 7 | 7 | ||||||||||||||||||||||||||||
U.S. dollars | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Long-term line of credit | 283,700,000 | |||||||||||||||||||||||||||||
Euro | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Long-term line of credit | € | € 250,000,000 | |||||||||||||||||||||||||||||
Term loan due 2022 | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Senior notes | € | € 150,000,000 | |||||||||||||||||||||||||||||
Repayments of indebtedness | $ 173,400,000 | € 150,000,000 | ||||||||||||||||||||||||||||
Senior Notes due 2022 | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Senior notes | 0 | 184,000,000 | ||||||||||||||||||||||||||||
Line of credit | Revolving credit facility | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Maximum borrowing capacity | $ 800,000,000 | $ 800,000,000 | ||||||||||||||||||||||||||||
Line of credit outstanding | 0 | 0 | ||||||||||||||||||||||||||||
Remaining borrowing capacity | $ 800,000,000 | 800,000,000 | ||||||||||||||||||||||||||||
Line of credit | Interest accrual, option three | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 1.00% | |||||||||||||||||||||||||||||
Line of credit | Interest accrual, option two | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 0.50% | |||||||||||||||||||||||||||||
Line of credit | Variable basis, additional margin | Interest accrual, option three | Minimum | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 0.00% | 0.90% | ||||||||||||||||||||||||||||
Line of credit | Variable basis, additional margin | Interest accrual, option three | Minimum | LIBOR | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 0.875% | |||||||||||||||||||||||||||||
Line of credit | Variable basis, additional margin | Interest accrual, option three | Minimum | EURIBOR | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 0.90% | |||||||||||||||||||||||||||||
Line of credit | Variable basis, additional margin | Interest accrual, option three | Maximum | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 0.875% | 2.26% | ||||||||||||||||||||||||||||
Line of credit | Variable basis, additional margin | Interest accrual, option three | Maximum | LIBOR | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 1.875% | |||||||||||||||||||||||||||||
Line of credit | Variable basis, additional margin | Interest accrual, option three | Maximum | EURIBOR | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 1.25% | |||||||||||||||||||||||||||||
Term loan | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Remaining borrowing capacity | $ 267,000,000 | € 117,500,000 | ||||||||||||||||||||||||||||
Repayments of indebtedness | $ 276,000,000 | $ 108,700,000 | € 100,000,000 | |||||||||||||||||||||||||||
Term loan | Multi-currency loan, EUR | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Face amount | € | € 235,000,000 | |||||||||||||||||||||||||||||
Long-term line of credit | € | € 117,500,000 | |||||||||||||||||||||||||||||
Repayments of indebtedness | € | € 117,500,000 | |||||||||||||||||||||||||||||
Term loan | Multi-currency loan, USD | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Remaining borrowing capacity | 133,700,000 | |||||||||||||||||||||||||||||
Face amount | 267,500,000 | |||||||||||||||||||||||||||||
Long-term line of credit | $ 133,800,000 | |||||||||||||||||||||||||||||
Repayments of indebtedness | $ 133,800,000 | |||||||||||||||||||||||||||||
Term loan | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Face amount | $ 534,100,000 | |||||||||||||||||||||||||||||
Draw down, minimum principal amount | 100,000,000 | |||||||||||||||||||||||||||||
Draw down, minimum integral multiple limit | $ 50,000,000 | |||||||||||||||||||||||||||||
Term loan | Minimum | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 1.125% | |||||||||||||||||||||||||||||
Term loan | Maximum | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 2.125% | |||||||||||||||||||||||||||||
Term loan | Interest accrual, option three | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 1.00% | |||||||||||||||||||||||||||||
Term loan | Interest accrual, option three | Minimum | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 0.125% | |||||||||||||||||||||||||||||
Term loan | Interest accrual, option three | Maximum | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 1.375% | |||||||||||||||||||||||||||||
Term loan | Interest accrual, option two | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 0.50% | |||||||||||||||||||||||||||||
Term loan | Interest accrual, option one, thereafter | Minimum | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 1.375% | |||||||||||||||||||||||||||||
Term loan | Interest accrual, option one, thereafter | Maximum | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 2.375% | |||||||||||||||||||||||||||||
Term loan | Interest accrual, option three, thereafter | Minimum | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 0.375% | |||||||||||||||||||||||||||||
Term loan | Interest accrual, option three, thereafter | Maximum | Incremental term loans | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Variable rate | 1.375% | |||||||||||||||||||||||||||||
1.002% Senior term loan due 2025 | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Debt interest rate | 1.002% | 1.002% | ||||||||||||||||||||||||||||
Senior term loans due between 2021 and 2028 | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Senior notes | $ 445,900,000 | 806,000,000 | ||||||||||||||||||||||||||||
Face amount | € | € 375,000,000 | |||||||||||||||||||||||||||||
Repayments of senior debt | $ 61,100,000 | € 56,000,000 | ||||||||||||||||||||||||||||
Current portion of long-term debt | 0 | 323,600,000 | ||||||||||||||||||||||||||||
Credit facility, expires 2023 | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Senior notes | 0 | 277,900,000 | ||||||||||||||||||||||||||||
Proceeds from issuance of debt | € | € 338,000,000 | |||||||||||||||||||||||||||||
Credit facility, expires 2023 | Senior term loans due between 2021 and 2028 | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Senior notes | 445,900,000 | € 393,000,000 | ||||||||||||||||||||||||||||
Credit facility, expires 2023 | Senior term loans due between 2021 and 2028 | Subsequent event | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Senior notes | $ 361,000,000 | € 320,500,000 | ||||||||||||||||||||||||||||
Revolving credit facility | Revolving credit facility | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Repayments of indebtedness | $ 370,000,000 | |||||||||||||||||||||||||||||
0.800% Senior Notes Due 2028 | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Senior notes | $ 680,800,000 | $ 0 | € 600,000,000 | |||||||||||||||||||||||||||
Face amount | $ 680,800,000 | € 600,000,000 | ||||||||||||||||||||||||||||
Debt interest rate | 0.80% | 0.80% | 0.80% | 0.80% | ||||||||||||||||||||||||||
Term Loans Due Between 2021 and 2028 | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Repayments of indebtedness | $ 223,800,000 | € 192,000,000 | $ 85,500,000 | € 72,000,000 | ||||||||||||||||||||||||||
Term Loans Due Between 2021 and 2028 | Subsequent event | ||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||
Repayments of indebtedness | $ 81,700,000 | € 72,500,000 |
Employee Benefit Plans (Narrati
Employee Benefit Plans (Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, weighted-average interest crediting rate | 1.00% | 1.00% | |
Defined benefit plan, weighted-average interest crediting rate above minimum government rate | 0.25% | 0.00% | |
Defined benefit plan, minimum contributions in the next fiscal year | $ 37.8 | ||
Defined benefit plan, expected return next fiscal year | 4.25% | ||
Company contributions | $ 16.9 | $ 15.4 | $ 15.8 |
ENPP | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, retirement income, maximum period over which benefits are paid | 15 years | ||
Defined benefit plan, minimum vesting age | 50 years | ||
Defined benefit plan, minimum service period to qualify | 10 years | ||
Defined benefit plan, minimum service period for vesting | 5 years | ||
Defined benefit plan, minimum age to receive benefits | 65 years | ||
Defined benefit plan, average amortization period | 7 years | ||
Postretirement benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, average amortization period | 10 years | ||
Defined benefit plan, weighted average discount rate used to determine the benefit obligation | 4.10% | 3.80% | |
Estimated benefit payments in the next fiscal year | $ 1.5 | ||
Benefits paid | $ 1.3 | $ 1.5 | |
U.S postretirement health care and life insurance benefit plans | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Health care cost trend rate assumed | 6.80% | 7.00% | |
Ultimate health care cost trend rate | 5.00% | 5.00% | |
Estimated benefit payments in the next fiscal year | $ 1.5 | ||
Brazilian postretirement benefit plan | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Health care cost trend rate assumed | 9.96% | 9.96% | |
Ultimate health care cost trend rate | 4.28% | 4.28% | |
Estimated benefit payments in the next fiscal year | $ 0.1 | ||
Pension plan | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, weighted average discount rate used to determine the benefit obligation | 1.90% | 1.50% | |
Estimated benefit payments in the next fiscal year | $ 53.2 | ||
Benefit payments made to defined benefit pension plans and ENPP | 47.4 | ||
Benefits paid | $ 47.2 | $ 44.6 | |
Pension plan | U.S. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, average amortization period | 14 years | ||
Defined benefit plan, weighted average discount rate used to determine the benefit obligation | 3.05% | 2.75% | |
Defined benefit plan, minimum contributions in the next fiscal year | $ 5 | ||
Defined benefit plan, historical average return on asset mix | 4.87% | ||
Target allocations | 100.00% | ||
Pension plan | Foreign Plan [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Target allocations | 100.00% | ||
Pension plan | U.K | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, average amortization period | 19 years | ||
Defined benefit plan, minimum contributions in the next fiscal year | $ 31.3 | ||
Pension plan | Non-U.S. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, historical average return on asset mix | 2.50% | ||
U.K. pension plan | Foreign Plan [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, minimum contributions in the next fiscal year | $ 21.1 | ||
U.K. pension plan | Non-U.S. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, expected return next fiscal year | 2.25% |
Employee Benefit Plans (Net Pen
Employee Benefit Plans (Net Pension And Postretirement Cost) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Pension plan | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | $ 15 | $ 16.2 | $ 15.5 |
Interest cost | 12.6 | 16.5 | 20.7 |
Expected return on plan assets | (31.3) | (28.4) | (28.1) |
Amortization of net actuarial losses | 16.5 | 15.5 | 14.3 |
Amortization of prior service cost | 0.7 | 2.1 | 1.6 |
Net loss recognized due to settlement | 0.1 | 0.2 | 0.5 |
Curtailment gain | (1.2) | 0 | 0 |
Net annual cost | $ 12.4 | $ 22.1 | $ 24.5 |
Weighted average discount rate | 1.50% | 2.00% | 2.80% |
Postretirement benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | $ 0.1 | $ 0.1 | $ 0.1 |
Interest cost | 0.9 | 1.2 | 1.3 |
Amortization of net actuarial losses | 0.1 | 0.1 | 0 |
Amortization of prior service cost | 0.1 | 0.1 | 0.1 |
Net annual cost | $ 1.2 | $ 1.5 | $ 1.5 |
Weighted average discount rate | 3.80% | 4.50% | 5.20% |
ENPP | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit plan, minimum age to receive benefits | 65 years |
Employee Benefit Plans (Assumpt
Employee Benefit Plans (Assumptions for Pension and Postretirement Cost) (Details) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Minimum | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Rate of increase in future compensation | 1.50% | 1.80% | 1.80% |
Maximum | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Rate of increase in future compensation | 5.00% | 5.00% | 5.00% |
Pension plan | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Weighted average discount rate | 1.50% | 2.00% | 2.80% |
Weighted average expected long-term rate of return on plan assets | 3.90% | 4.10% | 4.60% |
Pension plan | U.S. | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Weighted average discount rate | 2.75% | 3.45% | 4.35% |
Weighted average expected long-term rate of return on plan assets | 5.00% | 5.00% | 5.50% |
Rate of increase in future compensation | 5.00% | 5.00% | 5.00% |
Employee Benefit Plans (Net Fun
Employee Benefit Plans (Net Funded Status) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Amounts recognized in Consolidated Balance Sheets: | |||
Pensions and postretirement health care benefits (noncurrent) | $ (209) | $ (253.4) | |
Pension and ENPP Benefits | |||
Change in benefit obligation | |||
Benefit obligation at beginning of year | 1,033.7 | 917.3 | |
Service cost | 15 | 16.2 | $ 15.5 |
Interest cost | 12.6 | 16.5 | 20.7 |
Plan participants’ contributions | 1.4 | 1.3 | |
Actuarial losses (gains) | (70.7) | 86.8 | |
Amendments | (13.6) | (0.3) | |
Curtailment | (9.7) | 0 | |
Settlements | (0.2) | (0.3) | |
Benefits paid | (47.2) | (44.6) | |
Foreign currency exchange rate changes | (16.5) | 40.8 | |
Benefit obligation at end of year | 904.8 | 1,033.7 | 917.3 |
Change in plan assets | |||
Fair value of plan assets at beginning of year | 808.6 | 711 | |
Actual return on plan assets | 27.7 | 76.6 | |
Employer contributions | 36 | 32.4 | |
Plan participants’ contributions | 1.4 | 1.3 | |
Benefits paid | (47.2) | (44.6) | |
Settlements | (0.2) | (0.3) | |
Foreign currency exchange rate changes | (10.7) | 32.2 | |
Fair value of plan assets at end of year | 815.6 | 808.6 | 711 |
Funded status | (89.2) | (225.1) | |
Unrecognized net actuarial losses (gains) | 291.7 | 385.1 | |
Unrecognized prior service cost | 7.1 | 20.1 | |
Accumulated other comprehensive loss | (298.8) | (405.2) | |
Net amount recognized | (89.2) | (225.1) | |
Amounts recognized in Consolidated Balance Sheets: | |||
Other long-term asset | 109.4 | 13.2 | |
Other current liabilities | (7.1) | (6.7) | |
Accrued expenses | (3.6) | (3.2) | |
Pensions and postretirement health care benefits (noncurrent) | (187.9) | (228.4) | |
Postretirement Benefits | |||
Change in benefit obligation | |||
Benefit obligation at beginning of year | 26.4 | 29.4 | |
Service cost | 0.1 | 0.1 | 0.1 |
Interest cost | 0.9 | 1.2 | 1.3 |
Plan participants’ contributions | 0 | 0 | |
Actuarial losses (gains) | (3.7) | (1.1) | |
Amendments | 0.4 | 0 | |
Curtailment | 0 | 0 | |
Settlements | 0 | 0 | |
Benefits paid | (1.3) | (1.5) | |
Foreign currency exchange rate changes | (0.2) | (1.7) | |
Benefit obligation at end of year | 22.6 | 26.4 | 29.4 |
Change in plan assets | |||
Fair value of plan assets at beginning of year | 0 | 0 | |
Actual return on plan assets | 0 | 0 | |
Employer contributions | 1.3 | 1.5 | |
Plan participants’ contributions | 0 | 0 | |
Benefits paid | (1.3) | (1.5) | |
Settlements | 0 | 0 | |
Foreign currency exchange rate changes | 0 | 0 | |
Fair value of plan assets at end of year | 0 | 0 | $ 0 |
Funded status | (22.6) | (26.4) | |
Unrecognized net actuarial losses (gains) | (1.1) | 2.6 | |
Unrecognized prior service cost | 3.2 | 2.9 | |
Accumulated other comprehensive loss | (2.1) | (5.5) | |
Net amount recognized | (22.6) | (26.4) | |
Amounts recognized in Consolidated Balance Sheets: | |||
Other long-term asset | 0 | 0 | |
Other current liabilities | (1.5) | (1.4) | |
Accrued expenses | 0 | 0 | |
Pensions and postretirement health care benefits (noncurrent) | $ (21.1) | $ (25) |
Employee Benefit Plans (Net Per
Employee Benefit Plans (Net Periodic Pension Costs Included in Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
After-Tax Amount | |||
Prior service credit (cost) arising during the year | $ 10 | $ 0.3 | $ (4.7) |
Net loss recognized due to settlement | 0.1 | 0.3 | 0.6 |
Net loss recognized due to curtailment | 6.3 | 0 | 0 |
Net actuarial loss arising during the year | 53.6 | (32.7) | (23.3) |
Amortization of prior service cost | 0.6 | 2.1 | 1.6 |
Amortization of net actuarial losses | 12.3 | 13.1 | 11.8 |
Defined Benefit Pension Plans | |||
After-Tax Amount | |||
Prior service credit (cost) arising during the year | 10 | 0.3 | (4.7) |
Net loss recognized due to settlement | 0.1 | 0.3 | 0.6 |
Net loss recognized due to curtailment | 6.3 | ||
Net actuarial loss arising during the year | 53.6 | (32.7) | (23.3) |
Amortization of prior service cost | 0.6 | 2.1 | 1.6 |
Amortization of net actuarial losses | 12.3 | 13.1 | 11.8 |
Postretirement benefits | |||
Before-Tax Amount | |||
Accumulated other comprehensive loss, beginning of period | (5.5) | ||
Accumulated other comprehensive loss, end of period | (2.1) | (5.5) | |
Postretirement benefits | Defined Benefit Pension Plans | |||
Before-Tax Amount | |||
Accumulated other comprehensive loss, beginning of period | (412.5) | (393.2) | |
Prior service credit arising during the year | 13.1 | 0.3 | |
Net loss recognized due to settlement | 0.1 | 0.3 | |
Net loss recognized due to curtailment | 8.5 | ||
Net actuarial loss arising during the year | 71 | (37.8) | |
Amortization of prior service cost | 0.8 | 2.2 | |
Amortization of net actuarial losses | 16.6 | 15.7 | |
Accumulated other comprehensive loss, end of period | (302.4) | (412.5) | (393.2) |
Income Tax | |||
Accumulated other comprehensive loss, beginning of period | (99.2) | (96.8) | |
Prior service credit arising during the year | 3.1 | 0 | |
Net loss recognized due to settlement | 0 | 0 | |
Net loss recognized due to curtailment | 2.2 | ||
Net actuarial loss arising during the year | 17.4 | (5.1) | |
Amortization of prior service cost | 0.2 | 0.1 | |
Amortization of net actuarial losses | 4.3 | 2.6 | |
Accumulated other comprehensive loss, end of period | (72) | (99.2) | (96.8) |
After-Tax Amount | |||
Accumulated other comprehensive loss, , beginning of period | (313.3) | (296.4) | |
Prior service credit (cost) arising during the year | 10 | 0.3 | |
Net loss recognized due to settlement | 0.1 | 0.3 | |
Net loss recognized due to curtailment | 6.3 | ||
Net actuarial loss arising during the year | 53.6 | (32.7) | |
Amortization of prior service cost | 0.6 | 2.1 | |
Amortization of net actuarial losses | 12.3 | 13.1 | |
Accumulated other comprehensive loss, end of period | $ (230.4) | $ (313.3) | $ (296.4) |
Employee Benefit Plans (Various
Employee Benefit Plans (Various Tables) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Pension plan | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Unrecognized net actuarial (gains) losses | $ 291.7 | $ 385.1 |
Prior service cost | $ 7.1 | 20.1 |
Pension plan | U.S. | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Average amortization period of losses related to defined benefit pension plans | 14 years | |
Fair value of plan assets, aggregate projected benefit obligation and accumulated benefit obligation | ||
Fair value of plan assets | $ 4.9 | 5.1 |
Projected benefit obligation | 130.9 | 157.4 |
Accumulated benefit obligation | $ 125.4 | 135.4 |
Pension plan | U.K | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Average amortization period of losses related to defined benefit pension plans | 19 years | |
ENPP | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Average amortization period of losses related to defined benefit pension plans | 7 years | |
Postretirement benefits | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Unrecognized net actuarial (gains) losses | $ (1.1) | 2.6 |
Average amortization period of losses related to defined benefit pension plans | 10 years | |
Prior service cost | $ 3.2 | 2.9 |
Postretirement benefits | U.S. and Brazil | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Unrecognized net actuarial (gains) losses | (1.1) | 2.6 |
Postretirement benefits | U.S. | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Unrecognized net actuarial (gains) losses | (0.2) | 1 |
All plans | ||
Fair value of plan assets, aggregate projected benefit obligation and accumulated benefit obligation | ||
Fair value of plan assets | 43.4 | 41.6 |
Projected benefit obligation | 264.1 | 306.2 |
Accumulated benefit obligation | $ 246.6 | $ 269.4 |
Employee Benefit Plans (Accumul
Employee Benefit Plans (Accumulated Comprehensive Loss) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
GIMA | Corporate joint venture | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Reduction in equity, taxes | $ 0.5 | $ 0.6 |
Reduction in equity, net of taxes | $ 1.5 | 1.7 |
Ownership percentage | 50.00% | |
Net loss recognized due to settlement | 0.1 | |
All plans | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Reduction in equity, taxes | $ 72 | 98.6 |
Reduction in equity, net of taxes | $ 300.9 | $ 410.8 |
Employee Benefit Plans (Assum_2
Employee Benefit Plans (Assumptions for Benefit Obligation) (Details) | Dec. 31, 2021 | Dec. 31, 2020 |
Minimum | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Rate of increase in future compensation | 1.50% | 1.50% |
Maximum | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Rate of increase in future compensation | 5.00% | 5.00% |
Pension plan | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Weighted average discount rate | 1.90% | 1.50% |
Pension plan | U.S. | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Weighted average discount rate | 3.05% | 2.75% |
Rate of increase in future compensation | 4.25% | 5.00% |
Employee Benefit Plans (Expecte
Employee Benefit Plans (Expected Future Minimum Payments) (Details) $ in Millions | Dec. 31, 2021USD ($) |
Pension plan | |
Defined Benefit Plan Disclosure [Line Items] | |
2022 | $ 53.2 |
2023 | 51.6 |
2024 | 51.8 |
2025 | 52.2 |
2026 | 52.5 |
2027 through 2031 | 279.1 |
Total | 540.4 |
Postretirement benefits | |
Defined Benefit Plan Disclosure [Line Items] | |
2022 | 1.5 |
2023 | 1.6 |
2024 | 1.6 |
2025 | 1.6 |
2026 | 1.6 |
2027 through 2031 | 7.5 |
Total | $ 15.4 |
Employee Benefit Plans (Weighte
Employee Benefit Plans (Weighted Average Asset Allocation) (Details) - Pension plan | Dec. 31, 2021 | Dec. 31, 2020 |
U.S. | ||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||
Equity Securities | 100.00% | 100.00% |
U.S. | Equity securities | ||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||
Equity Securities | 14.00% | 36.00% |
U.S. | Fixed income securities | ||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||
Equity Securities | 75.00% | 57.00% |
U.S. | Other investments | ||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||
Equity Securities | 11.00% | 7.00% |
Non-U.S. | ||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||
Equity Securities | 100.00% | 100.00% |
Non-U.S. | Equity securities | ||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||
Equity Securities | 14.00% | 41.00% |
Non-U.S. | Fixed income securities | ||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||
Equity Securities | 80.00% | 53.00% |
Non-U.S. | Other investments | ||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||
Equity Securities | 6.00% | 6.00% |
Employee Benefit Plans (Fair Va
Employee Benefit Plans (Fair Value Pension Assets) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Percentage of fixed income securities in asset-backed and mortgage-backed securities | 3.00% | ||
Pension plan | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | $ 815.6 | $ 808.6 | $ 711 |
Percentage of fixed income securities in investment-grade corporate bonds | 13.00% | 44.00% | |
Percentage of fixed income securities in government treasuries | 50.00% | 20.00% | |
Percentage of fixed income securities in high-yield securities | 8.00% | 11.00% | |
Percentage of fixed income securities in foreign securities | 20.00% | 10.00% | |
Percentage of fixed income securities in asset-backed and mortgage-backed securities | 6.00% | ||
Percentage of fixed income securities in other various fixed income securities | 6.00% | 9.00% | |
Percentage of alternative investments in relative value funds | 42.00% | 42.00% | |
Percentage of alternative investments in long-short equity funds | 28.00% | 25.00% | |
Percentage of alternative investments in event-driven funds | 14.00% | 14.00% | |
Percentage of alternative investments in credit funds | 8.00% | 14.00% | |
Percentage of alternative investments in hedged and non-hedged funds | 8.00% | 5.00% | |
Pension plan | Total equity securities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | $ 108.1 | $ 314.3 | |
Pension plan | Global equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 102.5 | 235.3 | |
Pension plan | Non-U.S. equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 4.7 | ||
Pension plan | U.K. equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 65.2 | ||
Pension plan | U.S. large cap equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 5.6 | 5.2 | |
Pension plan | U.S. small cap equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 3.9 | ||
Pension plan | Total fixed income share | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 615.9 | 412.4 | |
Pension plan | Aggregate fixed income | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 615.9 | 162.9 | |
Pension plan | International fixed income | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 249.5 | ||
Pension plan | Total alternative investments | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 45.2 | 40.6 | |
Pension plan | Private equity fund | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 3.5 | 2.1 | |
Pension plan | Hedge funds measured at net asset value | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 41.7 | 38.5 | |
Pension plan | Miscellaneous funds | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 40.2 | 36.6 | |
Pension plan | Cash and equivalents measured at net asset value | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 6.2 | 4.7 | |
Total | Pension plan | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 815.6 | 808.6 | |
Level 1 | Pension plan | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 639.7 | 647.9 | |
Level 1 | Pension plan | Total equity securities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 23.8 | 235.5 | |
Level 1 | Pension plan | Global equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 18.2 | 156.5 | |
Level 1 | Pension plan | Non-U.S. equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 4.7 | ||
Level 1 | Pension plan | U.K. equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 65.2 | ||
Level 1 | Pension plan | U.S. large cap equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 5.6 | 5.2 | |
Level 1 | Pension plan | U.S. small cap equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 3.9 | ||
Level 1 | Pension plan | Total fixed income share | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 615.9 | 412.4 | |
Level 1 | Pension plan | Aggregate fixed income | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 615.9 | 162.9 | |
Level 1 | Pension plan | International fixed income | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 249.5 | ||
Level 1 | Pension plan | Total alternative investments | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 1 | Pension plan | Private equity fund | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 1 | Pension plan | Hedge funds measured at net asset value | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 1 | Pension plan | Miscellaneous funds | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 1 | Pension plan | Cash and equivalents measured at net asset value | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 2 | Pension plan | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 84.3 | 78.8 | |
Level 2 | Pension plan | Total equity securities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 84.3 | 78.8 | |
Level 2 | Pension plan | Global equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 84.3 | 78.8 | |
Level 2 | Pension plan | Non-U.S. equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | ||
Level 2 | Pension plan | U.K. equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | ||
Level 2 | Pension plan | U.S. large cap equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 2 | Pension plan | U.S. small cap equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | ||
Level 2 | Pension plan | Total fixed income share | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 2 | Pension plan | Aggregate fixed income | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 2 | Pension plan | International fixed income | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | ||
Level 2 | Pension plan | Total alternative investments | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 2 | Pension plan | Private equity fund | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 2 | Pension plan | Hedge funds measured at net asset value | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 2 | Pension plan | Miscellaneous funds | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 2 | Pension plan | Cash and equivalents measured at net asset value | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 3 | Pension plan | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 43.7 | 38.7 | 33.1 |
Level 3 | Pension plan | Total equity securities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 3 | Pension plan | Global equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 3 | Pension plan | Non-U.S. equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | ||
Level 3 | Pension plan | U.K. equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | ||
Level 3 | Pension plan | U.S. large cap equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 3 | Pension plan | U.S. small cap equities | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | ||
Level 3 | Pension plan | Total fixed income share | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 3 | Pension plan | Aggregate fixed income | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 3 | Pension plan | International fixed income | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | ||
Level 3 | Pension plan | Total alternative investments | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 3.5 | 2.1 | 2.3 |
Level 3 | Pension plan | Private equity fund | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 3.5 | 2.1 | |
Level 3 | Pension plan | Hedge funds measured at net asset value | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 0 | 0 | |
Level 3 | Pension plan | Miscellaneous funds | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | 40.2 | 36.6 | $ 30.8 |
Level 3 | Pension plan | Cash and equivalents measured at net asset value | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Total assets | $ 0 | $ 0 |
Employee Benefit Plans (Reconci
Employee Benefit Plans (Reconciliation of Level 3 Assets) (Details) - Pension plan - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ||
Fair value of plan assets at beginning of year | $ 808.6 | $ 711 |
Foreign currency exchange rate changes | (10.7) | 32.2 |
Fair value of plan assets at end of year | 815.6 | 808.6 |
Alternative Investments | ||
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ||
Fair value of plan assets at beginning of year | 40.6 | |
Fair value of plan assets at end of year | 45.2 | 40.6 |
Miscellaneous Funds | ||
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ||
Fair value of plan assets at beginning of year | 36.6 | |
Fair value of plan assets at end of year | 40.2 | 36.6 |
Level 3 | ||
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ||
Fair value of plan assets at beginning of year | 38.7 | 33.1 |
Related to assets still held at reporting | 3.3 | 0.1 |
Relating to assets sold during period | 0 | 0 |
Purchases, sales and /or settlements | 4.7 | 2.4 |
Foreign currency exchange rate changes | (3) | 3.1 |
Fair value of plan assets at end of year | 43.7 | 38.7 |
Level 3 | Alternative Investments | ||
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ||
Fair value of plan assets at beginning of year | 2.1 | 2.3 |
Related to assets still held at reporting | 1.4 | (0.2) |
Relating to assets sold during period | 0 | 0 |
Purchases, sales and /or settlements | 0 | 0 |
Foreign currency exchange rate changes | 0 | 0 |
Fair value of plan assets at end of year | 3.5 | 2.1 |
Level 3 | Miscellaneous Funds | ||
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ||
Fair value of plan assets at beginning of year | 36.6 | 30.8 |
Related to assets still held at reporting | 1.9 | 0.3 |
Relating to assets sold during period | 0 | 0 |
Purchases, sales and /or settlements | 4.7 | 2.4 |
Foreign currency exchange rate changes | (3) | 3.1 |
Fair value of plan assets at end of year | $ 40.2 | $ 36.6 |
Employee Benefit Plans (Investm
Employee Benefit Plans (Investment Strategies and Target Allocation) (Details) - Pension plan | 12 Months Ended |
Dec. 31, 2021 | |
U.S. | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Assets for the near-term benefit payments | 80.00% |
Assets for longer-term growth | 20.00% |
Target allocations | 100.00% |
U.S. | Equity securities | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Target allocations | 17.00% |
U.S. | Fixed income securities | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Target allocations | 75.00% |
U.S. | Alternative Investments | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Target allocations | 3.00% |
U.S. | Cash and cash equivalents | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Target allocations | 5.00% |
Non-U.S. | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Assets for the near-term benefit payments | 82.50% |
Assets for longer-term growth | 17.50% |
Target allocations | 100.00% |
Non-U.S. | Equity securities | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Target allocations | 12.50% |
Non-U.S. | Fixed Income Investments | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Target allocations | 82.50% |
Non-U.S. | Alternative Investments | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Target allocations | 5.00% |
Non-U.S. | Cash and cash equivalents | |
Defined Benefit Plan, Plan Assets, Allocation [Line Items] | |
Target allocations | 0.00% |
Stockholders' Equity (Narrative
Stockholders' Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions | Jan. 19, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Accelerated Share Repurchases [Line Items] | ||||
Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
Common stock, shares outstanding (in shares) | 74,441,312 | 74,962,231 | ||
Shares available for grant (in shares) | 4,000,968 | |||
Purchases and retirement of common stock | $ 135 | $ 55 | $ 130 | |
Remaining authorized repurchase amount | $ 110 | |||
Accelerated share repurchase | ||||
Accelerated Share Repurchases [Line Items] | ||||
Purchases and retirement of common stock (in shares) | 952,204 | 970,141 | ||
Purchases and retirement of common stock | $ 135 | $ 55 | ||
Accelerated share repurchase | Subsequent event | ||||
Accelerated Share Repurchases [Line Items] | ||||
Purchases and retirement of common stock (in shares) | 113,824 |
Stockholders' Equity (Dividends
Stockholders' Equity (Dividends Declared and Paid) (Details) - USD ($) $ / shares in Units, $ in Millions | Jan. 20, 2022 | Mar. 31, 2021 | Mar. 31, 2019 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2021 |
Subsequent Event [Line Items] | ||||||||
Cash dividends declared and paid per common share (in dollars per share) | $ 0.16 | $ 0.15 | $ 0.20 | $ 4.74 | $ 0.63 | $ 0.63 | $ 0.16 | |
Common Stock, Dividends, Per Share, Declared | $ 0.16 | $ 0.15 | $ 0.20 | $ 0.16 | ||||
Special Dividends | ||||||||
Subsequent Event [Line Items] | ||||||||
Cash dividends declared and paid per common share (in dollars per share) | 4 | |||||||
Common Stock, Dividends, Per Share, Declared | $ 4 | |||||||
Payments of Dividends | $ 301.5 | |||||||
Subsequent event | ||||||||
Subsequent Event [Line Items] | ||||||||
Common Stock, Dividends, Per Share, Declared | $ 0.20 |
Stockholders' Equity (Changes i
Stockholders' Equity (Changes in Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Stockholders' equity, beginning of period | $ 3,018 | $ 2,907 | $ 2,993.5 |
Net losses (gains) reclassified from accumulated other comprehensive income (loss) | 9.9 | 8.9 | |
Other comprehensive gain (loss), net of reclassification adjustments | 39.5 | (219.9) | (37.3) |
Stockholders' equity, end of period | 3,443.8 | 3,018 | 2,907 |
Accumulated Other Comprehensive Loss | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Stockholders' equity, beginning of period | (1,810.8) | (1,595.2) | (1,555.4) |
Other comprehensive income (loss) before reclassifications | 30 | (224.5) | |
Net losses (gains) reclassified from accumulated other comprehensive income (loss) | 9.9 | 8.9 | |
Other comprehensive gain (loss), net of reclassification adjustments | 39.9 | (215.6) | (39.8) |
Stockholders' equity, end of period | (1,770.9) | (1,810.8) | (1,595.2) |
Defined Benefit Pension Plans | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Stockholders' equity, beginning of period | (313.3) | (296.4) | (282.4) |
Other comprehensive income (loss) before reclassifications | 70 | (32.1) | |
Net losses (gains) reclassified from accumulated other comprehensive income (loss) | 12.9 | 15.2 | |
Other comprehensive gain (loss), net of reclassification adjustments | 82.9 | (16.9) | (14) |
Stockholders' equity, end of period | (230.4) | (313.3) | (296.4) |
Cumulative Translation Adjustment | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Stockholders' equity, beginning of period | (1,495) | (1,297.5) | (1,274.4) |
Other comprehensive income (loss) before reclassifications | (45.1) | (197.5) | |
Net losses (gains) reclassified from accumulated other comprehensive income (loss) | 0 | 0 | |
Other comprehensive gain (loss), net of reclassification adjustments | (45.1) | (197.5) | (23.1) |
Stockholders' equity, end of period | (1,540.1) | (1,495) | (1,297.5) |
Deferred Net Gains (Losses) on Derivatives | |||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | |||
Stockholders' equity, beginning of period | (2.5) | (1.3) | 1.4 |
Other comprehensive income (loss) before reclassifications | 5.1 | 5.1 | (2.6) |
Net losses (gains) reclassified from accumulated other comprehensive income (loss) | (3) | (6.3) | (0.1) |
Other comprehensive gain (loss), net of reclassification adjustments | 2.1 | (1.2) | (2.7) |
Stockholders' equity, end of period | $ (0.4) | $ (2.5) | $ (1.3) |
Stockholders' Equity (Reclassif
Stockholders' Equity (Reclassification Out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Cost of goods sold | $ 8,566 | $ 7,092.2 | $ 7,057.1 |
Reclassification before tax | (944.3) | (562) | (261.1) |
Income tax provision | 108.4 | 187.7 | 180.8 |
Reclassification net of tax | (897) | (427.1) | (125.2) |
Net losses reclassified from accumulated other comprehensive loss | 9.9 | 8.9 | |
Deferred Net Gains (Losses) on Derivatives | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Reclassification before tax | (5.8) | (6.4) | (0.1) |
Income tax provision | 2.8 | 0.1 | 0 |
Net losses reclassified from accumulated other comprehensive loss | (3) | (6.3) | $ (0.1) |
Amortization of net actuarial losses | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Reclassification before tax | 16.6 | 15.7 | |
Amortization of prior service cost | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Reclassification before tax | 0.8 | 2.2 | |
Defined Benefit Pension Plans | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Reclassification before tax | 17.4 | 17.9 | |
Income tax provision | (4.5) | (2.7) | |
Net losses reclassified from accumulated other comprehensive loss | 12.9 | 15.2 | |
Reclassification out of Accumulated Other Comprehensive Income | Deferred Net Gains (Losses) on Derivatives | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Reclassification before tax | (5.8) | (6.4) | |
Income tax provision | 2.8 | 0.1 | |
Reclassification net of tax | (3) | (6.3) | |
Foreign currency contracts | Reclassification out of Accumulated Other Comprehensive Income | Deferred Net Gains (Losses) on Derivatives | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Cost of goods sold | 11.4 | (6.4) | |
Commodity contracts | Reclassification out of Accumulated Other Comprehensive Income | Deferred Net Gains (Losses) on Derivatives | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
Cost of goods sold | $ (17.2) | $ 0 |
Stock Incentive Plan (Narrative
Stock Incentive Plan (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions | Jan. 20, 2022 | Dec. 31, 2021 | Apr. 22, 2021 | Feb. 25, 2022 | Jan. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Common stock, shares issuable (in shares) | 150,000,000 | 150,000,000 | 150,000,000 | |||||
Shares available for grant (in shares) | 4,000,968 | 4,000,968 | ||||||
Compensation cost related to unearned performance awards | $ 20.6 | $ 20.6 | ||||||
Stock compensation expense | 27.6 | $ 37.9 | $ 41.7 | |||||
Excess tax benefit of stock awards | $ 3.3 | $ 2.5 | $ 2.7 | |||||
Certain retirees and other individuals | ||||||||
Shares earned (in shares) | 59,182 | |||||||
Subsequent event | ||||||||
Shares issued (in shares) | 330,174 | |||||||
Shares withheld for taxes (in shares) | 125,363 | |||||||
Performance Shares | ||||||||
Shares awarded (in shares) | 281,310 | |||||||
Shares earned (in share) | 330,174 | 330,174 | ||||||
Shares earned (in shares) | 309,198 | |||||||
Recognition period | 1 year 6 months | |||||||
Weighted average grant-date fair value (in dollars per share) | $ 123.33 | $ 70.84 | $ 61.01 | |||||
Number of shares not vested (in shares) | 514,714 | 514,714 | 582,952 | |||||
Performance Shares | Certain retirees and other individuals | ||||||||
Shares earned (in share) | 97,818 | |||||||
Performance Shares | Subsequent event | ||||||||
Shares awarded (in shares) | 137,283 | |||||||
Restricted Stock Units (RSUs) | ||||||||
Performance period | 3 years | |||||||
Shares awarded (in shares) | 92,848 | |||||||
Shares earned (in shares) | 67,110 | |||||||
Compensation cost related to unearned performance awards | $ 8.5 | $ 8.5 | ||||||
Recognition period | 1 year 6 months | |||||||
Award vesting rights, share conversion ratio | 1 | |||||||
Weighted average grant-date fair value (in dollars per share) | $ 113.91 | $ 70.83 | 61.01 | |||||
Number of shares not vested (in shares) | 159,228 | 159,228 | 143,287 | |||||
Restricted Stock Units (RSUs) | Certain Retirees | ||||||||
Shares earned (in shares) | 3,830 | |||||||
Restricted Stock Units (RSUs) | Certain Executives | 2020 Grants | ||||||||
Vesting period | 3 years | |||||||
Restricted Stock Units (RSUs) | Tranche one | ||||||||
Award vesting percentage | 33.33% | |||||||
Restricted Stock Units (RSUs) | Tranche two | ||||||||
Award vesting percentage | 33.33% | |||||||
Restricted Stock Units (RSUs) | Tranche three | ||||||||
Award vesting percentage | 33.33% | |||||||
Restricted Stock Units (RSUs) | Subsequent event | ||||||||
Shares awarded (in shares) | 91,583 | |||||||
Issuance of stock awards (in shares) | 44,991 | |||||||
Shares withheld for taxes (in shares) | 23,726 | |||||||
Stock Appreciation Rights (SSARs) | ||||||||
Compensation cost related to unearned performance awards | $ 0.8 | $ 0.8 | ||||||
Recognition period | 1 year 6 months | |||||||
Weighted average grant-date fair value (in dollars per share) | $ 12.31 | $ 11.34 | ||||||
SSAR expiration period | 7 years | |||||||
Vesting period | 4 years | |||||||
Stock compensation expense | $ 0.8 | $ 1.9 | $ 2.4 | |||||
Weighted average remaining contractual life of SSARs outstanding | 4 years | |||||||
Total fair value of SSARs vested | $ 1.5 | |||||||
Number of shares not vested (in shares) | 120,675 | 120,675 | ||||||
Total intrinsic value of outstanding SSARs | $ 9.3 | $ 9.3 | ||||||
Total intrinsic value of exercisable of SSARs | $ 3.7 | 3.7 | ||||||
Total intrinsic value of SSARs exercised | 13.6 | |||||||
Restricted Stock | ||||||||
Stock compensation expense | $ 1.4 | |||||||
Weighted-average period for compensation cost expected to be recognized | 1 year | |||||||
Restricted common stocks issued (in shares) | 9,117 | |||||||
Restricted common stocks issued after shares withheld for taxes (in shares) | 7,899 | |||||||
Minimum | Long Term Incentive Plan | ||||||||
Target award percentages | 33.00% | |||||||
Maximum | Long Term Incentive Plan | ||||||||
Target award percentages | 200.00% | |||||||
2006 Plan | ||||||||
Common stock, shares issuable (in shares) | 10,000,000 | 10,000,000 | ||||||
Long Term Incentive Plan | ||||||||
Performance period | 3 years |
Stock Incentive Plan (Performan
Stock Incentive Plan (Performance Award Transactions) (Details) - Performance Shares | 12 Months Ended |
Dec. 31, 2021shares | |
Share Activity | |
Shares awarded but not earned/vested at January 1 (in shares) | 582,952 |
Shares awarded (in shares) | 281,310 |
Shares forfeited or unearned (in shares) | (40,350) |
Shares earned (in shares) | (309,198) |
Shares awarded but not earned/vested at December 31 (in shares) | 514,714 |
Stock Incentive Plan (Restricte
Stock Incentive Plan (Restricted Stock Units) (Details) - Restricted Stock Units (RSUs) | 12 Months Ended |
Dec. 31, 2021shares | |
Share Activity | |
Shares awarded but not earned/vested at January 1 (in shares) | 143,287 |
Shares awarded (in shares) | 92,848 |
Shares forfeited (in shares) | (9,797) |
Shares earned (in shares) | (67,110) |
Shares awarded but not earned/vested at December 31 (in shares) | 159,228 |
Stock Incentive Plan (Weighted
Stock Incentive Plan (Weighted Average Grant-Date Fair Value Of SSARS And Assumptions Under Black-Scholes Option Model) (Details) - Stock Appreciation Rights (SSARs) - $ / shares | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted average grant-date fair value (in dollars per share) | $ 12.31 | $ 11.34 |
Expected life of awards (years) | 3 years | 3 years |
Risk-free interest rate | 1.50% | 2.60% |
Expected volatility | 24.10% | 24.20% |
Expected dividend yield | 0.90% | 1.00% |
Stock Incentive Plan (SSAR Acti
Stock Incentive Plan (SSAR Activity) (Details) - Stock Appreciation Rights (SSARs) | 12 Months Ended |
Dec. 31, 2021$ / sharesshares | |
Share Activity | |
SSARs outstanding, beginning of period (in shares) | shares | 403,150 |
SSARs granted (in shares) | shares | 0 |
SSARs exercised (in shares) | shares | (194,661) |
SSARs canceled or forfeited (in shares) | shares | (13,878) |
SSARs outstanding, end of period (in shares) | shares | 194,611 |
Weighted average SSAR exercise prices per share, Granted (in dollars per share) | $ 0 |
Weighted average SSAR exercise prices per share, Exercised (in dollars per share) | 64.41 |
Weighted average SSAR exercise prices per share, Canceled or forfeited (in dollars per share) | 68.51 |
Weighted average SSAR exercise prices per share Outstanding at December 31 (in dollars per share) | $ 68.33 |
Minimum | |
Share Activity | |
SSAR price ranges per share, Granted (in dollars per share) | 0 |
SSAR price ranges per share, Exercised (in dollars per share) | 43.88 |
SSAR price ranges per share, Canceled (in dollars per share) | 46.58 |
Maximum | |
Share Activity | |
SSAR price ranges per share, Granted (in dollars per share) | 0 |
SSAR price ranges per share, Exercised (in dollars per share) | 73.14 |
SSAR price ranges per share, Canceled (in dollars per share) | 73.14 |
Stock Incentive Plan (Schedule
Stock Incentive Plan (Schedule Of SSAR Exercise Price Range, Number Of Shares, Weighted Average Exercise Price And Remaining Contractual Lives) (Details) - Stock Appreciation Rights (SSARs) - $ / shares | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||
SSARs Outstanding (in shares) | 194,611 | 403,150 |
SSARs Exercisable (in shares) | 73,936 | |
SSARs Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 66.63 | |
$46.58 - $63.47 | ||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||
Range of Exercise Prices, lower limit (in dollars per share) | 46.58 | |
Range of Exercise Prices, upper limit (in dollars per share) | $ 63.47 | |
SSARs Outstanding (in shares) | 80,523 | |
SSAR Outstanding, Weighted Average Remaining Contractual Life (Years) | 3 years 6 months 3 days | |
SSARs Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 61.91 | |
SSARs Exercisable (in shares) | 38,923 | |
SSARs Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 60.91 | |
$72.74 - $73.14 | ||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||
Range of Exercise Prices, lower limit (in dollars per share) | 72.74 | |
Range of Exercise Prices, upper limit (in dollars per share) | $ 73.14 | |
SSARs Outstanding (in shares) | 114,088 | |
SSAR Outstanding, Weighted Average Remaining Contractual Life (Years) | 4 years 4 months 28 days | |
SSARs Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 72.86 | |
SSARs Exercisable (in shares) | 35,013 | |
SSARs Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 72.99 |
Derivative Instruments and He_3
Derivative Instruments and Hedging Activities (Narrative) (Details) € in Millions, $ in Millions | Jan. 19, 2021USD ($) | Jan. 29, 2028USD ($) | Jan. 29, 2028EUR (€) | Dec. 31, 2021USD ($) | Jan. 19, 2021EUR (€) | Dec. 31, 2020USD ($) |
Cash flow hedging | Derivative instruments designated as hedging instruments | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Notional amount | $ 3,681.9 | |||||
Foreign currency contracts | Derivative instruments not designated as hedging instruments | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Notional amount | 3,681.9 | $ 3,326.6 | ||||
Foreign currency contracts | Cash flow hedging | Derivative instruments designated as hedging instruments | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Notional amount | 0 | 395.8 | ||||
Commodity contracts | Cash flow hedging | Derivative instruments designated as hedging instruments | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Notional amount | 31.9 | $ 14.7 | ||||
Cross currency interest rate contract, payment | Net investment hedging | Derivative instruments designated as hedging instruments | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Derivative Liability | $ 297.1 | $ 281.3 | € 245.7 | |||
Cross currency interest rate contract, payment | Net investment hedging | Derivative instruments designated as hedging instruments | Forecast | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Derivative Liability | € | € 247.9 | |||||
Cross currency interest rate contract, receipt | Net investment hedging | Derivative instruments designated as hedging instruments | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Derivative Liability | 300 | |||||
Gain recognized in other comprehensive loss | $ 2.9 | |||||
Cross currency interest rate contract, receipt | Net investment hedging | Derivative instruments designated as hedging instruments | Forecast | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Derivative Liability | $ 300 |
Derivative Instruments and He_4
Derivative Instruments and Hedging Activities (Impact of Derivatives on Other Comprehensive Income) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Gain (Loss) Recognized in Accumulated Other Comprehensive Loss | $ 5.1 | $ 5.1 | $ (2.6) |
Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income | 3 | 6.3 | 0.1 |
Cost of goods sold | 8,566 | 7,092.2 | 7,057.1 |
Cash flow hedging | Derivative instruments designated as hedging instruments | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Gain (Loss) Recognized in Accumulated Other Comprehensive Loss | 5.1 | ||
Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income | 6.3 | ||
Cash flow hedging | Derivative instruments designated as hedging instruments | Cost of goods sold | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Gain (Loss) Recognized in Accumulated Other Comprehensive Loss | 5.1 | ||
Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income | 3 | ||
Foreign currency contracts | Cash flow hedging | Derivative instruments designated as hedging instruments | Cost of goods sold | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Gain (Loss) Recognized in Accumulated Other Comprehensive Loss | (7.4) | 4.6 | (2.6) |
Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income | (10.2) | 6.3 | $ 0.1 |
Commodity contracts | Cash flow hedging | Derivative instruments designated as hedging instruments | Cost of goods sold | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Gain (Loss) Recognized in Accumulated Other Comprehensive Loss | 12.5 | 0.5 | |
Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income | $ 13.2 | $ 0 |
Derivative Instruments and He_5
Derivative Instruments and Hedging Activities (Summary Of Accumulated Other Comprehensive Loss Related To Derivatives) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
After-Tax Amount | |||
Stockholders' equity, beginning of period | $ 3,018 | $ 2,907 | $ 2,993.5 |
Net losses (gains) reclassified from accumulated other comprehensive loss into income | 9.9 | 8.9 | |
Stockholders' equity, end of period | 3,443.8 | 3,018 | 2,907 |
Deferred Net Gains (Losses) on Derivatives | |||
Before-Tax Amount | |||
Accumulated derivative net gains (losses), beginning of period | (3) | (1.5) | 1.6 |
Net changes in fair value of derivatives | 8.3 | 4.9 | (3) |
Net losses (gains) reclassified from accumulated other comprehensive loss into income | (5.8) | (6.4) | (0.1) |
Accumulated derivative net gains (losses), end of period | (0.5) | (3) | (1.5) |
Income Tax | |||
Accumulated derivative net gains (losses), beginning of period | (0.5) | (0.2) | 0.2 |
Net changes in fair value of derivatives | 3.2 | (0.2) | (0.4) |
Net losses (gains) reclassified from accumulated other comprehensive loss into income | (2.8) | (0.1) | 0 |
Accumulated derivative net gains (losses), end of period | (0.1) | (0.5) | (0.2) |
After-Tax Amount | |||
Stockholders' equity, beginning of period | (2.5) | (1.3) | 1.4 |
Net changes in fair value of derivatives | 5.1 | 5.1 | (2.6) |
Net losses (gains) reclassified from accumulated other comprehensive loss into income | (3) | (6.3) | (0.1) |
Stockholders' equity, end of period | (0.4) | $ (2.5) | $ (1.3) |
Deferred Net Gains (Losses) on Derivatives | Foreign currency contracts | |||
Before-Tax Amount | |||
Accumulated derivative net gains (losses), end of period | (0.2) | ||
Deferred Net Gains (Losses) on Derivatives | Commodity contracts | |||
Before-Tax Amount | |||
Accumulated derivative net gains (losses), end of period | $ 1.5 |
Derivative Instruments and He_6
Derivative Instruments and Hedging Activities (Net Investment Hedges) (Details) - Derivative instruments designated as hedging instruments - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Net investment hedging | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Gain (Loss) Recognized in Accumulated Other Comprehensive Loss | $ 0 | $ 1.7 | $ 2.5 |
Currency swap | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Gain (Loss) Recognized in Accumulated Other Comprehensive Loss | 11 | (25.5) | $ 9.3 |
Cross currency swap contract | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Notional amount | $ 300 | $ 300 |
Derivative Instruments and He_7
Derivative Instruments and Hedging Activities (Derivatives not Designated as Hedging Instruments) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Foreign currency contracts | Derivative instruments not designated as hedging instruments | Other expense, net | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Gain (loss) on derivative instruments | $ 54.8 | $ 3.7 | $ 20.4 |
Derivative Instruments and He_8
Derivative Instruments and Hedging Activities (Fair Value Of Derivative Instruments) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Derivative assets | $ 27.8 | $ 15.3 |
Derivative liabilities | 7.1 | 26.7 |
Level 2 | ||
Derivative assets | 27.8 | 15.3 |
Derivative liabilities | 7.1 | 26.7 |
Foreign currency contracts | Derivative instruments designated as hedging instruments | Other current assets | ||
Derivative assets | 0 | 1 |
Foreign currency contracts | Derivative instruments designated as hedging instruments | Other current liabilities | ||
Derivative liabilities | 0 | 4.5 |
Foreign currency contracts | Derivative instruments not designated as hedging instruments | Other current assets | ||
Derivative assets | 15.1 | 12.3 |
Foreign currency contracts | Derivative instruments not designated as hedging instruments | Other current liabilities | ||
Derivative liabilities | 5.1 | 22.2 |
Commodity contracts | Derivative instruments designated as hedging instruments | Other current assets | ||
Derivative assets | 0.2 | 0.5 |
Commodity contracts | Derivative instruments designated as hedging instruments | Other current liabilities | ||
Derivative liabilities | 2 | 0 |
Cross currency swap contract | Derivative instruments designated as hedging instruments | Other noncurrent assets | ||
Derivative assets | 12.5 | 1.5 |
Cross currency swap contract | Derivative instruments designated as hedging instruments | Other noncurrent liabilities | ||
Derivative liabilities | $ 0 | $ 0 |
Commitments and Contingencies (
Commitments and Contingencies (Narrative) (Details) R$ in Millions | 12 Months Ended | ||
Dec. 31, 2021USD ($) | Dec. 31, 2021BRL (R$) | Dec. 31, 2020USD ($) | |
Guarantor Obligations [Line Items] | |||
Interest payments to be paid in the next fiscal year | $ 15,100,000 | ||
Unconditional purchase obligations to be paid in the next fiscal year | 131,100,000 | ||
Uncertain income tax provisions to be paid in the next fiscal year | 40,100,000 | $ 57,100,000 | |
Defined benefit plan, minimum contributions in the next fiscal year | 37,800,000 | ||
Guarantor obligations, maximum exposure, undiscounted | 160,700,000 | ||
Tax disallowance not including interest and penalties | 23,600,000 | R$ 131.5 | |
Deere & Company | |||
Guarantor Obligations [Line Items] | |||
Loss Contingency, Estimate of Possible Loss | 7,000,000 | ||
Cash flow hedging | Derivative instruments designated as hedging instruments | |||
Guarantor Obligations [Line Items] | |||
Notional amount | 3,681,900,000 | ||
Cash flow hedging | Derivative instruments designated as hedging instruments | Commodity contracts | |||
Guarantor Obligations [Line Items] | |||
Notional amount | 31,900,000 | $ 14,700,000 | |
Third-party payor | |||
Guarantor Obligations [Line Items] | |||
Guarantor obligations, current carrying value | 25,200,000 | ||
Other affiliates | |||
Guarantor Obligations [Line Items] | |||
Guarantor obligations, current carrying value | 23,300,000 | ||
U.S. finance joint venture | |||
Guarantor Obligations [Line Items] | |||
Guarantor obligations, maximum inventory exposure per calendar year, undiscounted | $ 6,000,000 |
Fair Value of Financial Instr_3
Fair Value of Financial Instrument (Details) € in Millions, $ in Millions | Dec. 31, 2021USD ($) | Dec. 31, 2021EUR (€) | Oct. 06, 2021 | Dec. 31, 2020USD ($) |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets | $ 27.8 | $ 15.3 | ||
Derivative liabilities | $ 7.1 | 26.7 | ||
1.002% Senior term loan due 2025 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Debt interest rate | 1.002% | 1.002% | ||
0.800% Senior Notes Due 2028 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Debt interest rate | 0.80% | 0.80% | 0.80% | |
Debt Instrument, Fair Value Disclosure | $ 675.2 | € 595.1 | ||
Senior notes | 680.8 | € 600 | 0 | |
Level 1 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets | 0 | 0 | ||
Derivative liabilities | 0 | 0 | ||
Level 2 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets | 27.8 | 15.3 | ||
Derivative liabilities | 7.1 | 26.7 | ||
Level 3 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets | 0 | 0 | ||
Derivative liabilities | $ 0 | $ 0 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | Oct. 15, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Related Party Transaction [Line Items] | ||||
Payments to acquire interest in joint venture | $ 0 | $ 1,900,000 | $ 0 | |
Dividends from related parties | $ 84,400,000 | 0 | 40,500,000 | |
Rabobank | AGCO | ||||
Related Party Transaction [Line Items] | ||||
Ownership percentage | 51.00% | |||
Tractors and Farm Equipment Limited | ||||
Related Party Transaction [Line Items] | ||||
Stock repurchased during period (in shares) | 461,000 | |||
Stock repurchased during period | $ 33,900,000 | |||
TAFE | ||||
Related Party Transaction [Line Items] | ||||
Dividends from related parties | $ 2,000,000 | 1,800,000 | 2,000,000 | |
Cost method investment, ownership percentage | 20.70% | |||
Beneficial ownership of related parties (in shares) | 12,150,152 | |||
Beneficial ownership of related parties, maximum shares allowed per letter agreement (in shares) | 12,150,152 | |||
Purchases from related party | $ 137,600,000 | 78,900,000 | 92,700,000 | |
Revenue from related parties | $ 1,400,000 | $ 1,300,000 | $ 1,500,000 |
Segment Reporting (Segment Resu
Segment Reporting (Segment Results By Reportable Segments) (Details) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021USD ($)segments | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | |
Number of reportable segments | segments | 4 | ||
Net sales | $ 11,138.3 | $ 9,149.7 | $ 9,041.4 |
Income from operations | 1,001.4 | 599.7 | 348.1 |
Depreciation | 220.7 | 212.5 | 210.9 |
Assets | 9,182.1 | 8,504.2 | 7,759.7 |
Capital expenditures | 269.8 | 269.9 | 273.4 |
Operating Segments | |||
Net sales | 11,138.3 | 9,149.7 | 9,041.4 |
Income from operations | 1,239.6 | 870.4 | 763.8 |
Depreciation | 220.7 | 212.5 | 210.9 |
Assets | 5,210.1 | 4,514.4 | 4,501.5 |
Capital expenditures | 269.8 | 269.9 | 273.4 |
North America | |||
Net sales | 2,659.2 | 2,175 | 2,191.8 |
Income from operations | 238.1 | 193.7 | 121.6 |
Depreciation | 60.8 | 61.3 | 61.6 |
Assets | 1,328.1 | 1,051.9 | 1,125.6 |
Capital expenditures | 41.2 | 42.2 | 52.1 |
South America | |||
Net sales | 1,307.7 | 873.8 | 802.2 |
Income from operations | 132.2 | 29.3 | (39.4) |
Depreciation | 26.5 | 25.8 | 32.4 |
Assets | 922.7 | 687.6 | 758 |
Capital expenditures | 32.5 | 18.8 | 32.9 |
Europe/ Middle East | |||
Net sales | 6,221.7 | 5,366.9 | 5,328.8 |
Income from operations | 755.4 | 585.3 | 638.2 |
Depreciation | 116.5 | 110.5 | 102.7 |
Assets | 2,348.7 | 2,238.7 | 2,187.7 |
Capital expenditures | 184.6 | 201.8 | 173.5 |
Asia/ Pacific/Africa | |||
Net sales | 949.7 | 734 | 718.6 |
Income from operations | 113.9 | 62.1 | 43.4 |
Depreciation | 16.9 | 14.9 | 14.2 |
Assets | 610.6 | 536.2 | 430.2 |
Capital expenditures | $ 11.5 | $ 7.1 | $ 14.9 |
Segment Reporting (Income From
Segment Reporting (Income From Operations And Total Assets) (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Income from operations | $ 1,001.4 | $ 599.7 | $ 348.1 | |
Amortization of intangibles | (61.1) | (59.5) | (61.1) | |
Impairment charges | 0 | (20) | (176.6) | |
Total assets | 9,182.1 | 8,504.2 | 7,759.7 | |
Cash and cash equivalents | 889.1 | 1,119.1 | ||
Investments in affiliates | 413.5 | 442.7 | ||
Intangible assets, net | 392.2 | 455.6 | ||
Goodwill | 1,280.8 | 1,306.5 | 1,298.3 | $ 1,495.5 |
Operating Segments | ||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Income from operations | 1,239.6 | 870.4 | 763.8 | |
Total assets | 5,210.1 | 4,514.4 | 4,501.5 | |
Segment Reconciling Items | ||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Corporate expenses | (135.2) | (134.7) | (129) | |
Amortization of intangibles | (61.1) | (59.5) | (61.1) | |
Stock compensation expense | (26.6) | (36.8) | (40) | |
Restructuring expenses | (15.3) | (19.7) | (9) | |
Cash and cash equivalents | 889.1 | 1,119.1 | 432.8 | |
Investments in affiliates | 413.5 | 442.7 | 380.2 | |
Deferred tax assets, other current and noncurrent assets | 996.4 | 665.9 | 645.2 | |
Intangible assets, net | 392.2 | 455.6 | 501.7 | |
Goodwill | $ 1,280.8 | $ 1,306.5 | $ 1,298.3 |
Segment Reporting (Schedule of
Segment Reporting (Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | $ 1,924.4 | $ 2,039.8 |
United States | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | 499.1 | 541.2 |
Germany | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | 446.7 | 456.6 |
Finland | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | 189.5 | 191.4 |
Brazil | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | 144.9 | 150.4 |
France | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | 133.2 | 137.6 |
Italy | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | 112.7 | 129 |
China | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | 91.6 | 98.9 |
Denmark | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | 84.7 | 101.9 |
Other Countries | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Property plant and equipment, right-of-use assets and amortizable intangible assets | $ 222 | $ 232.8 |
Revenue (Summary of Contract As
Revenue (Summary of Contract Assets and Liabilities) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Change in Contract with Customer, Liability [Roll Forward] | ||
Balance beginning of period | $ 172 | $ 104 |
Advance consideration received | 227.8 | 192.7 |
Foreign currency translation | (6.1) | 7.5 |
Balance end of period | 226.2 | 172 |
Revenue recognized during the period for extended warranty contracts, maintenance services and technology services | 80.7 | 44 |
Extended warranty contracts, maintenance services and technology services | ||
Change in Contract with Customer, Liability [Roll Forward] | ||
Revenue recognized during the period | (64) | (46.6) |
Grain storage and protein production systems | ||
Change in Contract with Customer, Liability [Roll Forward] | ||
Revenue recognized during the period | $ (103.5) | $ (85.6) |
Revenue (Performance Obligation
Revenue (Performance Obligation) (Details) $ in Millions | Dec. 31, 2021USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation | $ 73.2 |
Revenue, remaining performance obligation, expected timing of satisfaction | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation | $ 62.5 |
Revenue, remaining performance obligation, expected timing of satisfaction | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation | $ 35.4 |
Revenue, remaining performance obligation, expected timing of satisfaction | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation | $ 16.9 |
Revenue, remaining performance obligation, expected timing of satisfaction | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation | $ 7.6 |
Revenue, remaining performance obligation, expected timing of satisfaction |
Revenue (Disaggregated Revenue)
Revenue (Disaggregated Revenue) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 11,138.3 | $ 9,149.7 | $ 9,041.4 |
United States | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 2,116.2 | 1,763.2 | 1,787.4 |
Canada | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 436.7 | 325.9 | 302 |
Germany | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,332 | 1,280.6 | 1,194.3 |
France | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,129.1 | 1,080.2 | 1,097.6 |
United Kingdom and Ireland | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 635.3 | 557.8 | 561.9 |
Finland and Scandinavia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 836.3 | 698.5 | 772.8 |
Other Europe | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 2,104.6 | 1,613.1 | 1,629 |
South America | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,294.8 | 865.4 | 789.7 |
Middle East and Algeria | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 184.4 | 136.7 | 73.2 |
Africa | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 152.3 | 58.3 | 116.2 |
Asia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 436.5 | 373.1 | 344.7 |
Australia and New Zealand | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 360.9 | 302.6 | 257.7 |
Mexico, Central America and Caribbean | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 119.2 | 94.3 | 114.9 |
Tractors | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 6,386.9 | 5,272.2 | 5,182.7 |
Replacement parts | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,687.9 | 1,445.7 | 1,347.8 |
Grain storage and protein production systems | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,076.1 | 902 | 1,034.8 |
Combines, application equipment and other machinery | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,987.4 | 1,529.8 | 1,476.1 |
North America | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 2,659.2 | 2,175 | 2,191.8 |
North America | United States | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 2,116.2 | 1,763.2 | 1,787.4 |
North America | Canada | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 436.7 | 325.9 | 302 |
North America | Germany | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | France | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | United Kingdom and Ireland | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | Finland and Scandinavia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | Other Europe | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | South America | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | Middle East and Algeria | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | Africa | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | Asia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | Australia and New Zealand | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
North America | Mexico, Central America and Caribbean | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 106.3 | 85.9 | 102.4 |
North America | Tractors | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 940.4 | 692 | 662.4 |
North America | Replacement parts | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 379.1 | 338.4 | 310.2 |
North America | Grain storage and protein production systems | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 534.9 | 471 | 547.9 |
North America | Combines, application equipment and other machinery | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 804.8 | 673.6 | 671.3 |
South America | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,307.7 | 873.8 | 802.2 |
South America | United States | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | Canada | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | Germany | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | France | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | United Kingdom and Ireland | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | Finland and Scandinavia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | Other Europe | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | South America | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,294.8 | 865.4 | 789.7 |
South America | Middle East and Algeria | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | Africa | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | Asia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | Australia and New Zealand | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
South America | Mexico, Central America and Caribbean | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 12.9 | 8.4 | 12.5 |
South America | Tractors | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 664.6 | 469.8 | 447.7 |
South America | Replacement parts | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 131.8 | 84 | 88.2 |
South America | Grain storage and protein production systems | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 140.1 | 82.8 | 79.5 |
South America | Combines, application equipment and other machinery | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 371.2 | 237.2 | 186.8 |
Europe/ Middle East | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 6,221.7 | 5,366.9 | 5,328.8 |
Europe/ Middle East | United States | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Europe/ Middle East | Canada | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Europe/ Middle East | Germany | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,332 | 1,280.6 | 1,194.3 |
Europe/ Middle East | France | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,129.1 | 1,080.2 | 1,097.6 |
Europe/ Middle East | United Kingdom and Ireland | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 635.3 | 557.8 | 561.9 |
Europe/ Middle East | Finland and Scandinavia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 836.3 | 698.5 | 772.8 |
Europe/ Middle East | Other Europe | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 2,104.6 | 1,613.1 | 1,629 |
Europe/ Middle East | South America | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Europe/ Middle East | Middle East and Algeria | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 184.4 | 136.7 | 73.2 |
Europe/ Middle East | Africa | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Europe/ Middle East | Asia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Europe/ Middle East | Australia and New Zealand | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Europe/ Middle East | Mexico, Central America and Caribbean | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Europe/ Middle East | Tractors | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 4,338.2 | 3,814.3 | 3,772 |
Europe/ Middle East | Replacement parts | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 1,070.5 | 936.1 | 874.8 |
Europe/ Middle East | Grain storage and protein production systems | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 174 | 122.2 | 172.8 |
Europe/ Middle East | Combines, application equipment and other machinery | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 639 | 494.3 | 509.2 |
Asia/ Pacific/Africa | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 949.7 | 734 | 718.6 |
Asia/ Pacific/Africa | United States | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | Canada | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | Germany | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | France | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | United Kingdom and Ireland | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | Finland and Scandinavia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | Other Europe | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | South America | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | Middle East and Algeria | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | Africa | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 152.3 | 58.3 | 116.2 |
Asia/ Pacific/Africa | Asia | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 436.5 | 373.1 | 344.7 |
Asia/ Pacific/Africa | Australia and New Zealand | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 360.9 | 302.6 | 257.7 |
Asia/ Pacific/Africa | Mexico, Central America and Caribbean | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 0 | 0 | 0 |
Asia/ Pacific/Africa | Tractors | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 443.7 | 296.1 | 300.6 |
Asia/ Pacific/Africa | Replacement parts | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 106.5 | 87.2 | 74.6 |
Asia/ Pacific/Africa | Grain storage and protein production systems | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | 227.1 | 226 | 234.6 |
Asia/ Pacific/Africa | Combines, application equipment and other machinery | |||
Disaggregation of Revenue [Line Items] | |||
Net sales | $ 172.4 | $ 124.7 | $ 108.8 |
Leases (Narrative) (Details)
Leases (Narrative) (Details) | Dec. 31, 2021 |
Maximum | |
Lessee, Lease, Description [Line Items] | |
Lessor, operating lease, renewal term | 15 years |
Leases (Assets and Liabilities)
Leases (Assets and Liabilities) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Lease Assets | ||
Operating ROU assets | $ 154.1 | $ 165.1 |
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net |
Finance lease assets | $ 10.6 | $ 15.1 |
Total lease assets | $ 164.7 | $ 180.2 |
Current: | ||
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] | Accrued Liabilities, Current | Accrued Liabilities, Current |
Operating | $ 42.3 | $ 43.5 |
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Other current liabilities | Other current liabilities |
Finance | $ 3.8 | $ 3 |
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other noncurrent liabilities | Other noncurrent liabilities |
Noncurrent: | ||
Operating | $ 115.5 | $ 125.9 |
Finance | 6 | 9.8 |
Total lease liabilities | 167.6 | 182.2 |
Finance lease asset, accumulated depreciation | $ 7.8 | $ 15.6 |
Leases (Lease Cost) (Details)
Leases (Lease Cost) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Leases [Abstract] | ||
Operating lease cost | $ 59 | $ 54 |
Variable lease cost | 1 | 1.7 |
Short-term lease cost | 18.7 | 11 |
Amortization of lease assets | 2.4 | 3.7 |
Interest on lease liabilities | 0.3 | 0.6 |
Total lease cost | $ 81.4 | $ 71 |
Leases (Future Minimum Lease Pa
Leases (Future Minimum Lease Payments) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Operating Leases | ||
Year 1 | $ 45.7 | $ 47.6 |
Year 2 | 36.2 | 37.7 |
Year 3 | 24.5 | 28.6 |
Year 4 | 17.3 | 18.9 |
Year 5 | 12.3 | 13.6 |
Thereafter | 39.1 | 44.5 |
Total lease payments | 175.1 | 190.9 |
Less: imputed interest | (17.3) | (21.5) |
Present value of lease liabilities | 157.8 | 169.4 |
Finance Leases | ||
Year 1 | 4 | 3.3 |
Year 2 | 0.9 | 1.4 |
Year 3 | 0.6 | 1.1 |
Year 4 | 0.4 | 0.8 |
Year 5 | 0.2 | 0.6 |
Thereafter | 6.3 | 9.1 |
Total lease payments | 12.4 | 16.3 |
Less: imputed interest | (2.5) | (3.5) |
Present value of lease liabilities | $ 9.9 | $ 12.8 |
Leases (Weighted-Average Remain
Leases (Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate) (Details) | Dec. 31, 2021 | Dec. 31, 2020 |
Weighted-average remaining lease term: | ||
Operating leases | 7 years | 7 years |
Finance leases | 12 years | 15 years |
Weighted-average discount rate: | ||
Operating leases | 3.10% | 3.50% |
Finance leases | 2.40% | 2.70% |
Leases (Supplemental Cash Flow
Leases (Supplemental Cash Flow Information) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Cash paid for amounts included in the measurement of lease liabilities: | ||
Operating cash flows from operating leases | $ 59.8 | $ 54.1 |
Operating cash flows from finance leases | 0.2 | 0.4 |
Financing cash flows from finance leases | 2.6 | 3.8 |
Leased assets obtained in exchange for lease obligations: | ||
Operating leases | 50.6 | 30.8 |
Finance leases | $ 0.9 | $ 0.9 |
Schedule II - Valuation and Q_2
Schedule II - Valuation and Qualifying Account (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Other Comprehensive Income (Loss), Net of Tax | $ (39.5) | $ 219.9 | $ 37.3 |
Allowances for doubtful accounts | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at beginning of period | 36.4 | 28.8 | 31.7 |
Additions, Acquired Businesses | 0.2 | 0 | 0 |
Additions, Charged (Credited) to Costs and Expenses | 0.5 | 14.5 | 5.8 |
Deductions | (2.8) | (6.8) | (8.3) |
Foreign Currency Translation | (1.7) | (0.1) | (0.4) |
Balance at end of period | 32.6 | 36.4 | 28.8 |
Accruals of severance, relocation and other closure costs | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at beginning of period | 16.8 | 4.8 | 7.1 |
Additions, Charged (Credited) to Costs and Expenses | 19.9 | 17.6 | 6.1 |
Additions, Reversal of Accrual | (2.3) | (0.4) | (0.7) |
Deductions | (19.1) | (5.1) | (7.3) |
Foreign Currency Translation | (0.6) | (0.1) | (0.4) |
Balance at end of period | 14.7 | 16.8 | 4.8 |
Deferred tax valuation allowance | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at beginning of period | 181 | 169.1 | 83.9 |
Additions, Acquired Businesses | 0.4 | 0.9 | 0 |
Additions, Charged (Credited) to Costs and Expenses | (130.8) | 28.7 | 87.1 |
Deductions | 0 | 0 | 0 |
Foreign Currency Translation | (3.3) | (17.7) | (1.9) |
Balance at end of period | 47.3 | 181 | 169.1 |
Other Comprehensive Income (Loss), Net of Tax | $ 0 | $ 12.4 | $ 2.5 |